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Secondary metabolites are produced by numerous organisms and can either be 
benign to humans or harmful.  Genes involved in the synthesis and transport of these 
secondary metabolites are frequently found in gene clusters, which are often located in 
subtelomeric regions of the chromosome.  These clusters are often coordinately regulated, 
being almost exclusively dependent on transcription factors that are located within the 
clusters themselves.  Secondary metabolites are also regulated by a variety of factors, 
including nutritional factors, environmental factors and developmental processes.  Gliotoxin, 
which is produced by a variety of Aspergillus species, Trichoderma species, and Penicillium 
species, exhibits immunosuppressive properties and has therefore been the subject of 
research for many laboratories.  There have been a few proteins shown to regulate the 
gliotoxin cluster, most notably GliZ, a Zn2Cys6 binuclear finger transcription factor that lies 
within the cluster, and LaeA, a putative methyltransferase that globally regulates secondary 
metabolism clusters within numerous fungal organisms, although no study has 
demonstrated the direct binding of any protein to a promoter region in the gliotoxin cluster.   
I report here two novel proteins, GipA, a C2H2 transcription factor and GipB, a hybrid 
sensor kinase, which are involved in regulating the gliotoxin biosynthetic cluster. GipA plays 
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an important role in gliotoxin production, as high-copy expression of gipA induces gliotoxin 
biosynthesis and loss of gipA reduces gliotoxin biosynthesis by 50%.  GipB is also involved 
in regulating gliotoxin production, as high-copy expression of gipB induces gliotoxin 
biosynthesis, but only during certain stages of asexual development.  Furthermore, loss of 
gipB reduces gliotoxin biosynthesis by 10%.  Based on data obtained from this project, I 
propose a model for the regulation of gliA, the efflux pump of the gliotoxin cluster, which 
involves GipB signaling through both GliZ and GipA.  I propose that GliZ and GipA are 
interdependent, as mutation of the GipA DNA binding site in the gliA promoter negatively 
affects both GliZ-mediated and GipA-mediated induction of gliA.  This is further supported 
by the fact that GliZ cannot fully induce gliA in the absence of GipA and vice versa.  This is 
the first time that anyone has shown evidence of a protein directly binding to the gliotoxin 
cluster.  Even though biosynthetic clusters are often coordinately regulated, my model 
raises the possibility that gliA is independently regulated, as the layout of the binding site in 
the gliA promoter is not present upstream of any other genes in the gliotoxin cluster, except 
for gliZ.   
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Chapter 1: 
General Introduction 
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1.1 Secondary Metabolism 
 Secondary metabolites are small, low-molecular weight molecules made by 
numerous organisms that are not essential for normal growth, but can play important roles 
in defense or signaling [1-4].  Oftentimes, there is a link between production of secondary 
metabolites and specific stages of morphological differentiation [1, 5].  Although these 
compounds are manufactured by a plethora of organisms, especially soil-dwelling bacteria 
and fungi, each individual metabolite is subject to restricted taxonomic distribution, as 
metabolites are not produced in a highly conserved fashion [1-3].  For example, gliotoxin is 
produced by Aspergillus fumigatus and A. oryzae, but not A. nidulans [6, 7].   
Secondary metabolites can be benign in nature, such as pigments or molecules 
used in interspecies communication, but they can also be malignant, exhibiting 
antimicrobial or toxic activities to eliminate competing organisms [5, 8].  Some of these 
compounds have been exploited by scientists because of their potential benefit to humans.  
For example, penicillin, produced by Penicillium chrysogenum, is used as an antibiotic and 
lovastatin, produced by A. terreus, reduces cholesterol [9].  Indeed, a literature survey 
examining 1,500 fungal metabolites between 1993 and 2001 discovered that more than half 
of these molecules had antibacterial, antifungal, and antitumor activity [2].  While some of 
these secondary metabolites benefit humans, others cause harm.  Aflatoxin, produced by 
A. flavus, is carcinogenic, and gliotoxin, produced by A. fumigatus, exhibits 
immunosuppressive properties [3, 6, 10, 11].  There are also compounds produced by 
fungal species that are both harmful and beneficial to humans, such as ergot alkaloids.  
These compounds, when consumed by humans, can cause convulsions, vasoconstriction, 
and hallucinations, yet have been used medically to hasten labor and treat migraines [2].   
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 Several classes of fungal secondary metabolites exist:  polyketides, non-ribosomal 
peptides, terpenes, and indole alkaloids [1-3] (Fig. 1.1).  Polyketides are produced by type I 
polyketide synthases (PKS) and are the most abundant of all fungal secondary metabolites.  
These type I polyketide synthases are multidomain proteins that bear homology to 
eukaryotic fatty-acid synthases.  Aflatoxin, lovastatin, and the yellow spore pigment 
intermediate naphthopyrone (WA) from A. nidulans are among the best genetically 
characterized polyketides [2].  Multidomain, multimodular enzymes, known as non-
ribosomal peptide synthetases (NRPS) are responsible for creating non-ribosomal peptides 
[2, 3].  Module-specific amino acids are recognized and activated by NRPSs, which results 
in the formation of a covalent bond between each amino acid and the 4’-
phosphopantetheine cofactor, through a conserved serine.  Tethered amino acids form 
peptide bonds and the resulting peptide is subsequently released.  Penicillin, 
cephalosporin, and gliotoxin all fall within this class of fungal secondary metabolites [2].   
Terpenes, best known as odoriferous plant metabolites, such as camphor and 
turpentine, are composed of several isoprene units.  Terpene cyclases, which are essential 
for the production of terpenes, share structural homology, but exhibit low primary sequence 
similarity, suggesting these cyclases have been subject to rapid divergent evolution.  
Fungal terpenes include carotenoids, gibberellins, and trichothecenes [2].  Tryptophan and 
dimethylallylpyrophosphate commonly serve as precursors for indole alkaloids, although 
this is not absolute.  One of the best characterized pathways synthesizes ergotamine, 
although other tryptophan-derived alkaloids include fumigaclavines and fumitremorgens 
from A. fumigatus [2].   
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Figure 1.1. The main classes of fungal secondary 
metabolites.  Reprinted by permission from Macmillan 
Publishers Ltd:  Nature Reviews Microbiology [2], copyright 
2005. 
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1.2 Cluster-specific Regulation of Secondary Metabolism 
Originally, eukaryotic genes involved in functionally related pathways were believed 
to be unlinked in the genome.  Owing to the discovery of gene clusters in fungi involved in a 
variety of mechanisms, such as nutrient use, mating type, pathogenicity, and secondary 
metabolism, this dogma of unlinked pathways was abandoned [2].  It is now widely 
accepted that genes involved in these various primary and secondary metabolic processes 
are indeed frequently found as clusters [1-3, 8].  Furthermore, secondary metabolism 
clusters have more recently been shown to be oftentimes located in subtelomeric positions 
[12].  These clusters are typically coordinately regulated, being almost completely 
dependent on induction from transcription factors located within the clusters themselves [2, 
3, 8, 13, 14].  Aside from these pathway-specific transcription factors, there are numerous 
other regulatory elements that affect the expression of secondary metabolite clusters.  
Nutritional and environmental factors, as well as developmental processes, have been 
shown to affect secondary metabolite production in multiple fungal species [2, 3].   
 
1.2.1 Transcription Factors Located within Clusters 
 Secondary metabolism gene clusters often contain regulatory elements that are 
essential for the coordinate expression of the biosynthetic enzymes and transport proteins 
encoded within the cluster [2, 3].  Zinc binuclear (Zn(II)2Cys6) transcription factors are 
uniquely found in fungi and represent the most common type of regulators located within 
these clusters [2, 3, 15, 16].  AflR, a Zn2Cys6 transcription factor, is located within the 
aflatoxin/sterigmatocystin gene cluster and is required for production of both metabolites [2, 
3, 11].  The aflatoxin and sterigmatocystin gene clusters contain most of the same 
enzymes, except the sterigmatocystin gene cluster lacks the genes necessary for the final 
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biochemical steps, therefore, sterigmatocystin is a precursor to aflatoxin [11].  A. nidulans 
produces sterigmatocystin, while A. flavus and A. parasiticus produce aflatoxin.  
Aflatoxin/sterigmatocystin production is abolished when aflR is disrupted or mutated and 
amplified when aflR is over-expressed [2, 3, 11, 17].   
Zn2Cys6 transcription factors, like aflR, generally recognize and bind as homodimers 
to palindromic sequence motifs, such as CGG(Nx)CCG [15-18].  Interestingly, although the 
palindromic sequences of these binding motifs can be similar or identical for multiple 
Zn2Cys6 transcription factors, the length and base composition of the linker sequence is 
highly variable.  Therefore, this linker sequence greatly contributes to the specificity of 
binding for each individual transcription factor [16, 18, 19].  For instance, Gal4 and Ppr1 are 
two Zn2Cys6 transcription factors in Saccharomyces cerevisiae that regulate different 
pathways.  Gal4 is responsible for transcription of various galactose-inducible genes and 
Ppr1 activates transcription of genes in the pyrimidine metabolic pathway [16, 18, 19].  Both 
transcription factors recognize binding sites that are flanked by CGG palindromic repeats, 
but have differently sized linker sequences, Gal4 recognizes an 11 bp linker and Ppr1 
recognizes a 6 bp linker.  Even though the CGG repeats, which are crucial for Gal4 or Ppr1 
binding, are identical, these two proteins do not recognize the other’s binding site and 
therefore remain specific to their respective pathways [16, 18, 19]. 
Although Zn2Cys6 transcription factors represent the most common type of in-cluster 
regulatory elements, other types of cluster-specific transcription factors have been 
identified.  TRI6 and MrTRI6 are C2H2 transcription factors that control production of 
trichothecene in Fusarium sporotrichiodes and Myrothecium roridum, respectively [2, 8, 20].  
Cochliobolus carbonum contains an ankyrin repeat protein, ToxE, which regulates HC-toxin 
production.  Furthermore, CPCR1 and AcFKH1, which are members of subfamilies of 
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winged helix transcription factors, are required for the production of cephalosporin C in 
Acremonium chrysogenum [2, 8, 20].   
 
1.2.2 Alternative Pathway-specific Regulation 
 Aside from cluster-specific transcription factors, there are members of secondary 
metabolite clusters that have been shown to affect expression of other genes within the 
cluster.  For example, gliP encodes an NRPS in the gliotoxin cluster and catalyzes the first 
step in the biosynthesis of gliotoxin.  Not only does loss of gliP abolish gliotoxin production, 
but it also causes a significant decrease in the other gliotoxin-specific genes [21-24].  In 
addition, disruption of sirA, the ABC transporter for the sirodesmin biosynthetic cluster in 
Leptosphaeria maculans, positively affects the expression of sirP, the NRPS of the 
sirodesmin cluster [25, 26].  Although gene clusters are often coordinately regulated by the 
cluster-specific transcription factor, some members can be independently regulated.  For 
example, gliT encodes an oxidoreductase of the gliotoxin biosynthetic cluster, which is 
required for self-protection against gliotoxin.  Even though gliT expression is decreased 
when the Zn2Cys6 transcription factor, gliZ, is deleted, exogenous gliotoxin induces the 
expression of gliT, even in a ∆gliZ background [3, 27].   
 
1.3 Fungal Development and Secondary Metabolism 
 Within the genus Aspergillus are between 260 and 837 species, which are classified 
into ten different teleomorph genera based on their sexual stages [28].  For example, A. 
nidulans belongs to the teleomorph genus Emericella, while A. flavus and A. fumigatus are 
categorized into the Petromyces and Neosartorya genera, respectively [28].  Many 
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Aspergillus species can reproduce both asexually, by developing conidia, and sexually, via 
ascospore development [28]. Vegetative growth of filamentous fungi entails germination of 
conidia or ascospores into hyphae, which can lead to the formation of mycelial colonies, 
development of biofilms, initiation of asexual development (conidiation), or initiation of 
sexual development, among other things, depending on external stimuli [28, 29].  
Environmental cues, such as light, oxygen, salt, and nutrients, can affect the expression of 
genes involved in regulating the different developmental programs [28, 30].  Oftentimes, the 
environmental signals that promote a certain developmental program will also affect 
secondary metabolite production [31].  For instance, asexual development can be induced 
in submerged liquid cultures by nutrient starvation or stress, which can also positively 
influence production of secondary metabolites [28].  Conversely, exposure to constitutive 
darkness will promote sexual development, which also enhances secondary metabolism 
[30, 32].   
 
1.3.1 Fungal Development 
The process of germination can be divided into three stages.  In the first stage, a 
spore will abandon the dormant state in response to environmental cues, such as exposure 
to water and air, sometimes in addition to inorganic salts, amino acids, or fermentable 
sugars [28, 33].  In the second stage, spores begin to swell isotropically due to water 
uptake, which decreases the microviscosity of the cytoplasm.  Moreover, cellular functions 
are directed to the synthesis of new plasma membrane and cell wall components [28].  The 
third stage is reached when the spore initiates polarized growth to form a germ tube, which 
requires redirection of morphogenetic machinery to the site of polarization [28] (Fig. 1.2).   
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Figure 1.2. Growth and germination of A. fumigatus.  (A) 
Dormant conidia (0 hrs growth).  (B) Swollen conidia at 
the beginning of germ-tube formation (3 hrs growth).  (C) 
Germling with newly formed septum (white arrow) (6 hrs 
growth).  (D) Hyphal tip.  (E-G) Examples of hyphae with 
mature septa (white arrows).  Modified and reprinted by 
permission from American Society for Microbiology:  
Eukaryotic Cell [34], copyright 2008.   
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When grown at 37°C, A. fumigatus can achieve germ tube formation within 4.5 
hours of inoculation.  Protein synthesis is important in these early stages of germination, as 
there is an up-regulation of genes involved in protein synthesis in germinating spores of A. 
fumigatus.  Furthermore, isotropic growth of conidia can be prevented by the protein 
synthesis inhibitor cyclohexamide, but not by inhibitors of the cytoskeleton or nucleotide 
synthesis [28, 33].   
Once germination is initiated, germlings undergo hyphal proliferation.  Hyphae are 
tube-like structures that consist of repeated elongated cellular units.  Hyphae proliferate by 
polarized growth at the apex of the tip cell, similar to germ tube formation, which involves 
expansion of the plasma membrane and biosynthesis of cell wall components [1, 35] (Fig. 
1.2c).  Elongated cells within hyphae are separated by porous walls, called septae, through 
which cytoplasm and also entire nuclei can migrate towards the growing tip [1] (Fig. 1.2).  
One conidial cell or ascospore will generally give rise to multiple hyphal extensions as a 
result of apical branching [35].  Vegetative growth is a required precursor to other 
developmental programs in filamentous fungi, with the exception of dimorphic fungi [1] (Fig. 
1.3).  Differentiation capability is defined by the ability of vegetative hyphae to reach a 
competence state [35].  In A. nidulans, competence can be reached between 12 and 20 
hours after germination of the spore, depending on the growth rate [1].  In A. fumigatus, 
developmental competence is reached 9 to 10 hours after inoculation in rich medium [36]. 
 When vegetative hyphae have reached a competence state, asexual development 
(conidiation) is initiated, which involves the formation of the conidiophore [1, 35].  The 
process of conidiation can be divided into several distinct phases, beginning with the 
outgrowth of a stalk from a specialized, thick-walled foot cell within the mycelium [1, 28, 30].  
Once the stalk has fully extended (in A. nidulans, stalks reach a height of about 100 µM 
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 Figure 1.3.  The different developmental stages of A. nidulans.  Vegetative growth is a 
necessary precursor for either asexual development or sexual development.  External 
and internal signals both contribute to the switch from vegetative growth to unique 
developmental programs.  Reprinted by permission from John Wiley and Sons:  FEMS 
Microgiology Reviews [1], copyright 2011. 
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[28]), the tip of the stalk swells to form a multinucleate vesicle, from which sterigmata bud 
[1, 28, 30, 35, 37].  In uniserate organisms, such as A. fumigatus, there is only one layer of 
sterigmata, termed phialides, however, in biserate fungi, such as A. nidulans and A. niger, 
two layers of sterigmata form from budding:  (1) metulae and (2) phialides [28].  Finally, 
phialides generate multiple chains of single-celled conidia from asymmetric mitotic division, 
with the possibility of more than 10,000 conidia arising from a single conidiophore [28, 30, 
35] (Fig. 1.4a-e).  Exposure to light serves as a major activation signal for asexual 
development [30].  In addition, conidiophore formation generally occurs upon exposure to 
an air interface, which is thought to activate internal signals that regulate the genes involved 
in conidiation [28, 30, 35].  In some instances, though, conidiophore development can occur 
in submerged cultures, in response to external stress or nutrient limitations [28]. Once fully 
mature, conidia can be widely dispersed through the air or by water, contributing to fungal 
survival by widespread distribution [1, 28].    
 Although researchers have only observed a sexual cycle in about one-third of 
known Aspergillus species, genomic analysis has revealed the presence of genes 
specifically involved in sexual development in most of these fungi, indicating that they too 
may be capable of sexual development [28].  For instance, A. fumigatus has just recently 
been shown to form sexual fruiting bodies under experimental conditions, although this 
process took an extended period of time [28, 38].  With respect to sexual reproduction, a 
fungal organism is either homothallic, containing both mating types and therefore able to 
undergo sexual reproduction without a compatible partner, or heterothallic, containing only 
one mating type and thus requiring a compatible partner to undergo sexual reproduction [1, 
28].  A. fumigatus is heterothallic, while A. nidulans is homothallic [1, 28].  The beginning of 
sexual development is represented by the formation of Hülle cells, which is followed by 
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Figure 1.4. Images of asexual and sexual structures 
in A. nidulans shown by scanning electron 
micrograph.  (a) Conidiophore stalk.  (b) Vesicle 
formation at the tip of the stalk. (c) Developing 
metulae (primary sterigmata).  (d) Developing 
phialides (secondary sterigmata) (black arrows).  (e) 
Strains of conidia on a mature conidiophore.  
Modified and reprinted by permission from American 
Society for Microbiology:  Microbiology and 
Molecular Biology Reviews [35], copyright 1998.  (f) 
Mature cleistothecium (CI) (sexual fruiting body) 
surrounded by Hülle cells (H).  Modified and 
reprinted by permission from American Society for 
Microbiology:  Eukaryotic Cell [39], copyright 2012. 
f 
a b c d e 
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hyphal fusion and the emergence of a dikaryon.  These Hülle cells surround the dikaryon 
and pack into a “nest”, eventually differentiating into thick-walled globose cells believed to 
provide both protection and nutrition to the maturing cleistothecium, or sexual fruiting body 
[1, 28] (Fig. 1.4f).  Nuclear fusion followed by meiosis and post-meiotic mitosis gives rise to 
eight nuclei, which are separated by membranes to become spores.  Ascospores become 
binucleate through a second post-meiotic mitosis.  A single cleistothecium can contain a 
high number of asci, which each contain eight ascospores [28]. 
 
1.3.2 Secondary Metabolism and Asexual Development 
 There are three categories of secondary metabolites that are often associated with 
conidiation: (1) metabolites required to activate conidiation (the extracellular sporulation-
inducing factor [ESID], (2) pigments important for conidiophore development (melanin), and 
(3) mycotoxins [5].  Although production of certain mycotoxins does not appear to be 
essential for conidiation (for instance A. nidulans mutants deficient in sterigmatocystin 
production still undergo asexual development) a relationship between asexual development 
and mycotoxin production has been established.  A number of studies have reported that 
Aspergillus mutants deficient in conidiation also display a deficiency in aflatoxin production 
[5, 40].   
FluG, which produces an ESID in response to external signals, activates 
downstream targets to induce asexual development, one of these targets being FlbA [5, 28, 
30, 35, 40-43] (Fig. 1.5).  Loss of either fluG or flbA abolishes conidiophore formation and 
promotes hyperproliferative vegetative growth or the “fluffy” phenotype.  FlbA is an RGS 
(regulator of G-protein signaling) protein that negatively regulates FadA, a Gα subunit of a  
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Figure 1.5. Model of upstream and central genetic regulators of asexual development.  
Reprinted from Current Opinion in Microbiology, Vol. 15/No. 6, Hee-Soo Park and Jae-
Hyuk Yu, Genetic Control of asexual sporulation in filamentous fungi, pg. 669-677, 
2012, with permission from Elsevier [30]. 
 16 
 
heterotrimeric G-protein complex that promotes vegetative growth and represses asexual 
development [5, 28, 30, 35, 40, 42, 44] (Fig. 1.5), therefore a constitutively active form of 
FadA resembles a ∆flbA mutant [43].  In A. nidulans, loss of fluG or flbA also abolishes 
sterigmatocystin production [2, 5, 40, 45, 46].  Interestingly, although over-expression of 
flbA in A. nidulans results in premature sterigmatocystin production, over-expression of fluG 
in submerged culture does not [5, 40].  Furthermore, in a ∆flbA mutant, over-expression of 
aflR does not reinstate sterigmatocystin production, indicating that these regulatory 
networks can be complex [5].  A mutant expressing a dominant active form of FadA also 
loses the ability to produce sterigmatocystin, suggesting that FluG activates FlbA, which 
supports the inactivation of FadA and subsequent sterigmatocystin production through 
induction of AflR [5, 40, 43, 45].   
While FadA negatively regulates sterigmatocystin production, it positively regulates 
penicillin production in A. nidulans [2, 5, 47].  Furthermore, a FadA homologue in Fusarium 
sporotrichioides positively regulates trichothecene production, as expression of a dominant 
active form of FadA increases trichothecene biosynthesis [2, 5, 47].  Contrary to what is 
observed with a FadA dominant active mutant in A. nidulans, loss of either SfaD, the Gβ 
subunit, or GpgA, the Gγ subunit, causes reduced sterigmatocystin production [5, 43].  To 
positively regulate vegetative growth, FadA G-protein signaling induces the production of 
cAMP, which promotes PKA activation [5, 28, 45, 48].  Not surprisingly, over-expression of 
pkaA in A. nidulans represses conidiophore development and blocks sterigmatocystin 
production [2, 5, 45]. StuA, a transcriptional modifier of asexual development, has now 
been associated with regulation of secondary metabolism in several fungi, such as P. 
chrysogenum and F. graminear [9]. 
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1.3.3 Secondary Metabolism and Sexual Development:  Light vs. Dark 
Secondary metabolite production is also associated with sexual development [1, 
49].  When A. nidulans is grown in light, sterigmatocystin production is minimal, but when 
grown in the dark, which induces sexual development, levels of sterigmatocystin increase 
[30].  This differential expression has been linked to the formation of a heterotrimeric 
complex, called the Velvet complex, composed of VeA, VelB, and LaeA, which regulates 
the balance between sexual and asexual development [1, 28, 30, 50, 51].  Regulatory 
proteins that are in the velvet family, VeA, VelB, VosA, and VelC, are highly conserved 
among ascomycetes and basidiomycetes [1].  Velvet family proteins all contain a conserved 
velvet domain, which comprises 150 amino acids [1, 30].   
An N-terminal-truncated mutant of VeA (veA1) produces more conidia and less 
sexual fruiting bodies than a wild-type strain.  Furthermore, A. nidulans requires red light to 
induce conidiation, but the veA1 mutant allows conidial development in the absence of light, 
suggesting that a domain in the N-terminus of VeA is responsible for light-mediated VeA 
activity [1, 28, 35].  A strain in which veA or velB has been deleted does not produce any 
sexual fruiting bodies in any conditions.  In addition, over-expression of veA results in 
constitutive formation of sexual fruiting bodies, regardless of light exposure [1, 28].  LaeA is 
a putative methyltransferase that was identified in a screen for A. nidulans mutants that lost 
the ability to produce sterigmatocystin [50, 51].  LaeA contributes to light-dependent support 
of asexual development, as loss of laeA in A. nidulans renders the fungus unable to 
suppress sexual fruiting body formation in light.  This phenotype is opposite of ∆veA, which 
cannot produce any sexual fruiting bodies regardless of light or dark exposure [1, 28].  
LaeA forms a trimeric complex with VeA and VelB, which coordinates sexual development 
in darkness.  This complex is low in concentration in light, as VeA and VelB remain in the 
cytoplasm and LaeA is confined to the nucleus [28].  Upon exposure to darkness, VeA 
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levels are increased and VeA forms a complex with VelB, which translocates to the nucleus 
(Fig. 1.6).  It is here that VeA interacts with LaeA to form the trimeric complex with VelB [1, 
28]. 
VeA, VelB, and LaeA are not only important for sexual and asexual development, 
but they also control secondary metabolism.  Indeed, loss of veA in A. nidulans, results in a 
loss of penicillin and sterigmatocystin production [1].  This link of VeA to secondary 
metabolism has also been shown in other fungal species, such as A. flavus and A. 
parasiticus, which lose the ability to produce aflatoxin when veA is deleted, and F. 
verticilloides, which is unable to produce fumonisin and fusarins in a ∆ve1 (veA homologue) 
background [1].  Additionally, deletion of vel1 in F. fujikuroi represses fumonisins and 
fusarins, deletion of velA in P. chrysogenum negatively affects penicillin biosynthesis, and 
deletion of veA in A. chrysogenum drastically reduces expression of cephalosporin 
biosynthesis genes [1, 9].  VelB also plays a role in secondary metabolite production, as 
loss of velB from A. nidulans results in a decrease in sterigmatocystin [52].  A shift to dark 
increases sterigmatocystin production in this deletion strain, but only to light-exposed wild-
type levels of sterigmatocystin production [52].  LaeA is a global regulator of secondary 
metabolism, as loss of laeA abolishes overall production of secondary metabolites in 
numerous Aspergillus species [1, 51, 53].  Not surprisingly, over-expression of laeA leads to 
an abundance of penicillin and lovastatin in A. nidulans and A. terreus, respectively [50, 51].  
With the presence of the SAM methyltransferase domain, LaeA has been proposed to 
affect secondary metabolism by counteracting H3K9 methylation in the sterigmatocystin 
cluster [1, 53]. 
FphA is a phytochrome-like receptor that senses and responds to red light, while 
LreA and LreB constitute the blue-light sensing apparatus [30, 54, 55].  FphA interacts with 
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Figure 1.6. Model of light vs. dark regulation of sexual development and secondary 
metabolism.  Reprinted by permission from John Wiley and Sons:  FEMS Microgiology 
Reviews [1], copyright, 2011.   
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VeA, as well as LreA and LreB [1, 30] (Fig. 1.6).  FphA acts to promote asexual 
development, but represses sterigmatocystin production.  Alternatively, LreA and LreB 
promote sexual development, as well as the production of sterigmatocystin [1, 56].  
Interestingly, the opposite effect is seen for penicillin production in A. nidulans, as loss of 
fphA reduces penicillin production and mutations in lreA and lreB cause a slight increase in 
penicillin production [1, 56]. 
 
1.4 Regulation of Secondary Metabolism in Response to Environmental Factors 
 Fungal organisms are extremely versatile with respect to abiotic growth conditions.  
Fungi can grow in a wide range of conditions and utilize a variety of substrates for 
nutritional requirements [28].  Global regulatory proteins have been identified that react to 
specific environmental cues.  These proteins generally regulate large sets of genes that are 
involved in degradation of alternative nutrient sources or protection of intracellular 
processes against environmental extremes [20, 57].  For instance, to degrade pectin within 
plant material, fungi synthesize and secrete pectinases; to degrade starch, fungi synthesize 
and secrete amylases; and to degrade elastin in the human lung, infectious fungi can 
synthesize and secrete elastase [28].  Interestingly, optimal growth conditions favor lower 
levels of secondary metabolite production, perhaps to save energy when defense is not 
necessary.  Conversely, nutrient starvation or harsh environmental factors induce 
production of secondary metabolites.  This could be a result of the need to eliminate 
competition so as to have access to whatever alternative nutrient sources are available.  A 
link has been established between the activity of many of these global regulatory elements 
and the expression of gene clusters responsible for producing secondary metabolites [3] 
(Fig. 1.7). 
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Figure. 1.7. Environmental and developmental global regulatory elements involved in 
secondary metabolite production.  Reprinted by permission from Macmillan Publishers 
Ltd:  Nature Reviews Microbiology [3], copyright 2013. 
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1.4.1 Nitrogen Metabolite Repression 
Metabolite repression occurs in response to nitrogen source, which has been 
studied in great detail.  AreA, the global positive regulator of nitrogen metabolite repression 
in A. nidulans and A. fumigatus, induces genes involved in alternative nitrogen source 
utilization [58-60].  In the presence of a preferred nitrogen source, such as ammonium or 
glutamine, AreA is repressed by various mechanisms, physical interaction with the 
repressive element NmrA being one of them [58, 60-62].  When preferred nitrogen sources 
are not available, AreA is released from NmrA to activate its targets, some of which include 
secondary metabolism clusters, generally in conjunction with pathway-specific 
transcriptional activators [59-61].   
AreA is a member of the GATA family of transcription factors and posesses a DNA 
binding domain that contains a single Cys2/Cys2-type zinc finger motif [1, 58-60].  These 
types of DNA binding proteins are so named because they recognize binding sites that 
contain a core GATA sequence (e.g. AreA binds to 5’-HGATAR-3’) [1, 58-60, 62].  In A. 
nidulans, areA is highly expressed in the presence of non-preferred nitrogen sources, 
yielding three different mRNA transcripts of 3.9, 3.6, and 3.2 kb [60].  There are numerous 
micro open reading frames (µORFs) and 13 GATA binding elements upstream of the areA 
start site, suggesting that AreA is under transcriptional control (by autoregulation) and post-
transcriptional control [60].  Furthermore, the 3’ untranslated region (UTR) of areA affects 
mRNA stability and the turnover rate of the areA transcript varies based on nitrogen status 
[63].  In wild-type cells, areA mRNA has a half-life of 40 minutes when only non-preferred 
nitrogen sources are available, but in the presence of preferred nitrogen sources, the half-
life decreases to 7 minutes [60].  In contrast, when part of the 3’ UTR region is deleted from 
areA, the half-life of the mRNA transcript is 25 minutes, regardless of the nitrogen sources 
available [60].  Further regulation of AreA is achieved through the binding of NmrA to a 
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conserved region adjacent to the zinc finger and the 12 carboxyl-terminal residues [60].  
Indeed, deletion of nmrA from A. nidulans results in partial derepression of amdS, which 
encodes acetamidase and is subject to nitrogen metabolite repression [61].  MeaB, a bZIP 
transcription factor, binds to the promoter of nmrA and activates its transcription in both 
nitrogen-preferred and non-preferred conditions [58].   
The nitrate assimilation system has been extensively studied in A. nidulans and 
encodes the structural genes nitrate reductase (niaD) and nitrite reductase (niiA), crnA, a 
nitrate transporter, and nirA, the pathway-specific transcription factor that controls induction 
of the cluster genes [58, 62, 64-66].  The two structural genes, niaD and niiA, share an 
intergenic region and are divergently transcribed, requiring activation from both NirA and 
AreA [58, 59, 64].  Interestingly, AreA not only binds to GATA elements within the niaD-niiA 
intergenic region to induce nitrate assimilation, but also plays a role in chromatin 
remodeling [58, 59].  There are six nucleosomes present in the niaD-niiA bidirectional 
promoter when nitrate is absent from surrounding medium.  When nitrate becomes 
available, these nucleosomes are remodeled, which creates an “open” chromatin structure.  
The chromatin remodeling requires active AreA [58, 59]. 
As mentioned above, AreA also positively regulates secondary metabolite clusters.  
For example, in A. nidulans, sterigmatocystin production is repressed in the presence of 
ammonium and induced when nitrate is the sole nitrogen source [1, 5, 67].    Interestingly, 
nitrogen sources have the opposite effect in A. parasiticus, where growth in the presence of 
ammonium results in higher levels of aflatoxin production [1, 5, 67].  Furthermore, AreA 
positively regulates gibberellin production in Gibberella fujikuroi.  In Fusarium verticillioides, 
however, AreA is required for production of fumonisin B1, as an ∆areA mutant is devoid of 
fumonisin B1, even with the addition of ammonium phosphate [3].  This suggests that while 
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AreA serves as an activator for most gene clusters, there might be alternate roles for AreA 
with secondary metabolite gene expression. 
 
1.4.2 Carbon Catabolite Repression 
Carbon catabolite repression via the global transcriptional repressor, CreA, is 
present in a wide range of fungal species.  When an organism is exposed to a preferred 
carbon source, such as glucose, CreA acts to repress genes involved in the degradation 
and utilization of alternative carbon sources, such as ethanol [68, 69].  CreA also exerts 
repressive effects on secondary metabolism clusters in preferred carbon conditions, as it 
has been shown that penicillin production in A. nidulans is carbon catabolite repressed [10, 
68].   
CreA, a C2H2 transcription factor, was first discovered in A. nidulans in experiments 
searching for suppressor mutations for areA loss-of-function mutations [68, 69].   There are 
several nutrients, such as acetamide and proline, which can serve as both nitrogen and 
carbon sources and are therefore regulated by both CreA and AreA [57, 68].  For example, 
growth of A. nidulans on both preferred nitrogen and carbon sources completely represses 
proline catabolism.  Mutants deficient in areA activity are unable to use proline as a nitrogen 
source when exposed to preferred carbon sources, but a shift to a non-preferred carbon will 
alleviate this repression and allow proline to be catabolized [57, 68].  CreA generally 
recognizes the consensus sequence 5’-SYGGRG-3’ and appears to be self-regulated, as 
creA mRNA in A. nidulans is higher when cultures are grown on glycerol or L-arabinose, 
compared to growth on glucose [68, 69].  Furthermore, a number of putative CreA binding 
sites are present within its own promoter [68].  Interestingly, although several loss-of-
function mutations have been characterized, creA is an essential gene, as deletion of creA 
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in A. nidulans is lethal.  This suggests that either derepression of certain systems under 
CreA control is lethal or CreA has an unknown positive function that is essential to the 
fitness of the organism [68].   
The repressive activity of CreA is thought to occur to ensure that the energetically 
most favorable carbon sources are utilized and to prevent energy waste on the synthesis of 
alternate catabolic systems.  There are three groups of systems that are regulated by 
carbon catabolite repression:  (1) genes encoding enzymes involved in catabolism of less 
preferred carbon sources, (2) gluconeogenic and glyoxylate cycle enzymes, (3) genes 
involved in secondary metabolism [69]. Regulation of ethanol metabolism in A. nidulans is 
one of the most extensively studied examples of carbon catabolite repression.  CreA affects 
ethanol catabolism by repressing alcR, the transcriptional activator of all genes associated 
with ethanol catabolism, as well as alcA, encoding alcohol dehydrogenase I, and aldA, 
encoding aldehyde dehydrogenase [68].  The binding site of AlcR and CreA overlap in the 
alcR promoter and studies have shown that the two proteins compete for binding.  AlcR 
does not activate ethanol catabolism in the absence of ethanol, but when cultures are 
grown in both ethanol and glucose, a smooth transition between repression and induction is 
observed [68].  Upon consumption of the glucose, CreA loses affinity for its binding site in 
the alcR promoter, allowing binding of AlcR and subsequent activation of ethanol 
catabolism genes [68].   
As mentioned above, secondary metabolism is also regulated by CreA and carbon 
catabolite repression.  When A. chrysogenum is grown in high glucose concentrations, 
cephalosporin production is reduced, in part by the repression of ipnA and cefEF by Cre1 
(CreA homologue) [70].  In addition, glucose represses penicillin production in P. 
chrysogenum [10, 70].  Furthermore, penicillin production in A. nidulans is subjected to 
carbon catabolite repression, although this may not be entirely based on CreA activity.  
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Transcript levels of ipnA mRNA, involved in the production of penicillin, are decreased in 
glucose medium and a loss-of-function mutation in creA only slightly depresses ipnA.  A 
single CreA binding site is present in the promoter region if ipnA, however this binding site 
was revealed to be nonfunctional in an ipnA-lacZ expression analysis [10, 68].   
 
1.4.3 pH-mediated Regulation 
The ability to respond to a wide range of pH is advantageous to microbial 
organisms, as large variations in ambient pH are commonly encountered.  Being extremely 
versatile, Aspergillus species have been shown to survive in a pH range of 3.0 to 10.5 [28, 
71].  This versatility is in part due to the activity of PacC, a global regulatory protein that 
responds to ambient pH.  In alkaline pH, PacC induces genes primarily expressed in 
alkaline conditions and represses genes primarily expressed in acidic conditions [1, 72].  
Secondary metabolism appears to be regulated by PacC, as pH causes differential 
expression of a variety of biosynthetic clusters [3, 73]. 
PacC is a C2H2 zinc finger transcription factor that is activated in alkaline pH 
conditions.  PacC is translated as an inactive precursor and is only activated after 
proteolytic cleavage, which requires PalH and PalI, two potential plasma membrane pH 
sensors, PalB, a signaling protease, PalA, PalC, and PalF [74-76] (Fig. 1.8).  Upon 
translation, the C-terminal domain of PacC interacts with two domains upstream, which 
creates a “closed” conformation and prevents accessibility of PacC to PalB.  When alkaline 
pH is sensed, possibly by PalH and PalI, PacC shifts to an “open” confirmation, which 
allows PalB to catalyze the proteolytic cleavage of PacC after residues ~493-500, within a 
conserved signaling protease box [74-76].  The activity of PalB is assisted by PalA,  
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Figure 1.8. Model of the two proteolysis steps required for PacC activation.  
This process involves PalI, PalH, PalF, PalC, PalA, and PalB.  Reprinted by 
permission from American Society for Microbiology:  Eukaryotic Cell [75], 
copyright 2007. 
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binding to two YPXL/I motifs on either side of the signaling protease box, PalC and PalF.  
Loss of this C-terminal region, which is crucial for the “closed” conformation, leaves PacC in 
an “open” conformation and commits the protein to the second processing step, involving 
cleavage at residues ~252-254 [74-76].  The first proteolytic cleavage step is regulated by 
ambient pH, while the second cleavage step is not.  In its active form, PacC targets genes 
through the sequence 5’-GCCARG-3’ [74-76].   
Early studies of murine intraperitoneal injection with A. nidulans revealed an 
association between alkaline phosphatase production, which is activated by PacC in 
alkaline pH, and virulence, which could be partially explained by the fact that changes in pH 
affect secondary metabolism [76].  PacC induces penicillin production in A. nidulans in 
alkaline conditions [1, 3, 5, 70, 73].  In contrast, PacC represses sterigmatocystin 
production in alkaline conditions, as a mutant expressing a constitutively active PacC 
protein produces higher levels of penicillin and lower levels of sterigmatocystin [1, 3, 5, 73]. 
Genes involved in the biosynthesis of ochratoxin A in A. ochraceus are down-regulated in 
alkaline pH, which suggests that PacC is regulating this cluster [20].  Furthermore, 
fumonisin biosynthesis is negatively regulated by Pac1 (PacC homologue) in F. 
verticillioides, as a disrupted Pac1 mutant produced higher levels of fumonisin when grown 
on maize kernels [77].  This mutant also produced fumonisin in medium buffered to pH 4.5 
or pH 8.4, suggesting that this mutant does not respond to ambient pH [77]. 
 
1.4.4 Cross-pathway Control Regulation 
 Amino acid biosynthesis is vital for metabolic processes in fungi, which is controlled 
by a global regulatory system referred to as the general control of amino acid biosynthesis 
(Gcn) in S. cerevisiae and as cross-pathway control (Cpc) in filamentous fungi [1, 78, 79].  
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This global regulation enables a fungal organism to synthesize amino acids in conditions of 
amino acid starvation.   
 This regulatory system has been extensively studied in S. cerevisiae, with Gcn4 
serving as the transcriptional regulator and Gcn2 serving as the protein kinase, which 
recognizes a build-up of uncharged tRNAs [80].  Gcn4 is a member the bZIP-type family of 
transcriptional activators, with a leucine-zipper structure important for dimerization and a 
basic DNA binding domain at the C terminus [79].  Upon induction, Gcn4 binds to the 
recognition element 5’-ATGASTCAT-3’ and activates a variety of gene clusters involved in 
amino acid biosynthesis, such as the proline biosynthesis cluster and the arginine 
biosynthesis cluster [79].  Gcn4 has been shown to be under translational control due to the 
presence of four µORFs in its promoter region.  Mutational analysis has revealed that the 
first and fourth µORFs are sufficient for the translational regulation.  In normal conditions, 
these two µORFs are translated, which prevents reinitiation of the translational machinery 
at the actual gcn4 ORF.  When cells are starved for amino acids, the translational 
machinery scans past the fourth µORF and reinitiates at the actual gcn4 ORF [78-80] (Fig. 
1.9).  In addition, a negative regulator, Cpc2, reduces Gcn4 activity in nonstarvation 
conditions, independent of the translational regulation [79].   
CpcA, the homologue to Gcn4 in A. nidulans, exhibits some of the same attributes 
as Gcn4.  CpcA has a basic leucine-zipper structure in the C-terminal region, but only one 
leucine, as opposed to Gcn4, which has four repeated leucines [79].  Furthermore, cpcA 
has only two µORFs in its 5’ UTR, as opposed to gcn4, which has four µORFs, although 
only two appear to be sufficient for the translational regulation [79].  The 5’ UTR of cpcA 
also contains two CpcA/Gcn4 recognition elements, suggesting that cpcA is autoregulated 
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Figure 1.9. Model of post-transcriptional control of gcn4 involving µORFs 1 and 4.  (a) 
In normal conditions, ribosomal machinery translates µORF 1 and reinitiates at µORF 
4, preventing reinitiation and translation at the gcn4 start site.  (b) Under amino acid 
starvation, ribosomal machinery translates µORF 1, scans past µORF 4 and reinitiates 
at the gcn4 start site.  Modified and reprinted from Trends in Biochemical Sciences, 
Vol. 31/No. 10, Alan G. Hinnebusch, elF3:  a versatile scaffold for translation initiation 
complexes, pg. 553-562, 2006, with permission from Elsevier [81]. 
 31 
 
at the transcriptional level, in addition to the translational regulation.  Indeed, when point 
mutations were introduced to both µORFs, there was an increase in cpcA mRNA and 
protein levels, but when point mutations were additionally added to the recognition 
elements, mRNA and protein levels of cpcA were drastically reduced [79].   
Not much research has been done to explore the effect of CpcA on secondary 
metabolism, although CpcA does appear to negatively regulate the production of 
sirodesmin PL in L. maculans.  Exposure of wild-type L. maculans to artificially-induced 
amino acid starvation did not induce the sirodesmin cluster, as mRNA transcript levels of 
sirZ, the cluster-specific transcription factor, and sirP, remained unchanged to those in 
normal conditions [82].  However, when cpcA was silenced, mRNA transcript levels of sirZ 
and sirP increased in artificially-induced amino acid starvation.  Furthermore, sirP mRNA 
transcript levels in the cpcA-silenced mutant were higher than those of the wild-type strain 
even in normal conditions.  Although CpcA does seem to regulate sirodesmin PL 
biosynthesis, it is unknown whether this regulation is a consequence of CpcA directly 
binding to promoter regions within the cluster or of an indirect effect of CpcA activity [26, 
82].  Furthermore, studies have shown that CpcA negatively regulates penicillin 
biosynthesis in A. nidulans, as over-expression of cpcA results in reduced expression of 
ipnA and acvA, two genes essential to penicillin biosynthesis [26, 70, 83].     
 
1.5 Additional Regulatory Elements of Secondary Metabolism 
 An additional complex of proteins that regulates secondary metabolism is the HAP-
like CCAAT-binding complex (Fig. 1.7).  This complex is evolutionarily conserved in 
eukaryotic organisms and has been designated with various names in different organisms 
[2, 3, 5, 20].  For instance, this complex is HAP in S. cerevisiae and Arabidopsis thaliana, 
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AnCF (formally PENR1) in Aspergilli, and CBF in Xenopus laevis.  Within the AnCF 
complex are three subunits:  HapB, HapC, and HapE [2, 3, 5, 20].  Complete formation of 
the complex is required for DNA binding and transcriptional regulation.  Numerous genes 
are positively regulated by this complex, including ipnA and aatA, which are part of the 
penicillin biosynthetic cluster in A. nidulans [2, 3, 5, 20].  Furthermore, penicillin production 
in a number of fungal species is dependent on the activity of this HAP-like complex [70].   
 RsmA, a putative YAP-like bZIP protein, was identified in A. nidulans in a multicopy 
suppressor screen for restoration of sterigmatocystin production in mutants lacking 
members of the velvet complex [84].  Over-expression of AnRsmA partially restores 
sterigmatocystin production in ΔlaeA and ΔveA backgrounds and significantly enhances 
sterigmatocystin production in the presence of an intact velvet complex.  Furthermore, 
mutation of one or both RsmA binding sites, which are present in the AflR-AflJ intergenic 
region, reduces sterigmatocystin production [84]. 
  
1.6 Aspergillus fumigatus 
A. fumigatus is a saprophytic ascomycete that is ubiquitous in nature, thanks to the 
dispersion of conidia in air and by water. Conidia are hydrophobic and are generally 
between 2 to 3 µm in diameter, giving them buoyancy that aids in dispersion [6].  Any given 
environment is estimated to contain between 1 and 100 conidia/m3, which results in 
humans experiencing daily exposure to A. fumigatus.  Due to the size of conidia, upon 
inhalation, they can avoid mucociliary clearance and reach the alveoli of the lungs [6].  A. 
fumigatus has the ability to grow in a wide range of temperatures and pH, making it easy for 
this organism to adapt to various ecological environments.  For instance, being a 
thermophilic organism, A. fumigatus can survive in temperatures as high as 70°C [6, 85].  
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The ability to adapt to harsh environments gives A. fumigatus an advantage over other 
organisms and contributes to the infectious nature of the fungus [85].   
A. fumigatus, an opportunistic pathogen, is the leading cause of mold infections 
worldwide that causes severe problems in immune-compromised populations [6, 86].  
These populations include:  AIDS patients, cancer patients receiving chemotherapy, solid 
organ transplant/skin graft patients and victims of chronic granulomatous disease [13, 21, 
87, 88]. Exposure to conidia can cause invasive aspergillosis or severe allergic reactions [6, 
85].  Even with current antifungal medications, the mortality rates of infected individuals can 
still exceed 50% [21, 22, 32].  Over the past 20 years, hospitals have witnessed an increase 
in A. fumigatus infections, possibly due to an increase in patient transplants, widespread 
use of immunosuppressive therapies, as well as a higher incidence in HIV or AIDS [89, 90].  
Inhalation of conidia through the airways is the primary route of infection for A. fumigatus.  
Once inside the alveoli, spores are exposed to alveolar neutrophils and macrophages, 
which serve as the first line of defense [6, 89, 90].  In immune-competent individuals, 
clearance of spores is quick and further invasive disease is not allowed to occur.  However, 
immune dysfunction can result in improper elimination and subsequent germination of the 
spores [86].  Hyphae of A. fumigatus can penetrate tissue, allowing for a more severe or 
disseminated infection [86].  There are numerous virulence factors produced by this fungus 
that contribute to its pathogenesis.  True virulence factors contribute to the damage the 
fungus can inflict upon the host, but do not greatly affect growth of the fungus. Among these 
are secondary metabolites or mycotoxins that can possess carcinogenic or immune-
modulating properties [8].  
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1.7 Aspergillus fumigatus and Secondary Metabolism 
 A. fumigatus is predicted to contain 30 secondary metabolism clusters, the majority 
of which have not been characterized [53, 91].  There has been debate on the number of 
secondary metabolism clusters, which are usually predicted based on the presence of a 
PKS, NRPS, or the like.  In 2007, one group published data defining 22 secondary 
metabolism clusters in A. fumigatus, at least 50% of which were regulated by LaeA [91].  In 
2012, another paper was published, which listed 34 PKS and NRPS genes, possibly 
defining 9 additional secondary metabolism clusters in A. fumigatus, based on web-based 
programs specifically designed to define these clusters through algorithms [53].  Among the 
secondary metabolites that have been identified are melanin, gliotoxin, fumagillin, 
fumitremorgen B, pseurotin A, gibberellin, helvolic acid, and aflatoxin [4, 6].  As seen in 
other organisms, secondary metabolism cluster dispersal in A. fumigatus displays a bias 
towards sub-telomeric regions of the chromosome [12, 91] (Fig. 1.10).  Evidence suggests 
that secondary metabolites produced by A. fumigatus contribute to its virulence, which is 
supported by the fact that loss of laeA, a global regulator of secondary metabolite 
production, severely attenuates the virulence of this fungus in a murine model of infection 
[24, 53].  One of the most well-studied secondary metabolites produced by A. fumigatus is 
gliotoxin, which is also produced by Eurotium chevalieri, Gliocladium fimbriatum, and 
several other Aspergillus species, Trichoderma species, and Penicillium species [14, 24, 
25, 92].   
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Figure 1.10.  Schematic of A. 
fumigatus chromosomes with 
locations of secondary 
metabolite gene clusters 
(indicted as black bars).  Red 
arrows identify clusters that are 
partially or completely regulated 
by LaeA [91].  Open-access 
article. 
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1.7.1 Gliotoxin 
Gliotoxin (C13H14N2O4S2) is a member of the epipolythiodioxopiperazine (ETP) class 
of toxins, which are characterized by a disulfide bridge across a dioxopiperazine ring [14, 
21-25, 53, 87, 88, 93-95].  The oxidized form of gliotoxin is taken up into host immune cells 
in a glutathione- dependent fashion, where it is rapidly reduced to the dithiol form [26, 94] 
(Fig. 1.11).  Constant redox cycling causes accumulation of this dithiol form within the target 
cell, with only a small percentage of gliotoxin existing in the oxidized form at any given time 
[26, 53].  The oxidized form is thought to be the biologically active form, but some scientists 
believe the reduced form has activities of its own [92].  Once inside target cells, gliotoxin is 
able to affect cellular functions essential to the immune response.  For instance, gliotoxin 
has been shown to prevent neutrophils from engulfing surrounding fungal cells by targeting 
the actin cytoskeleton and can prevent the generation of superoxide anions by targeting the 
activation of NADPH oxidase [24, 25, 87, 95, 96].  Gliotoxin has recently been shown to 
inhibit angiogenesis [92, 97].  In addition, gliotoxin is able to inhibit NFkB via prevention of 
IkB degradation in several cell types [24, 88, 92, 98].  This leads not only to apoptosis, but 
also a loss of cytokine production, therefore the cell cannot signal to other cells of the 
immune system about the fungal invasion [24, 88, 94].  Several other actions of gliotoxin 
result in apoptosis of the host cell, such as the activation of BAK via conformational 
changes and the production of reactive oxygen species via redox cycling [24, 26, 99].  
Being a redox active toxin, gliotoxin can also induce internal disulfide bond formation of 
cysteine residues in the host cell, which results in inhibition of protease activities. [24, 87, 
88, 93-96].  Once the target cell begins the process of apoptosis and glutathione levels are 
depleted, gliotoxin is converted back to its oxidized form and exits the target cell, after 
which uptake into surrounding target cells occurs [93].  Gliotoxin has been detected in lungs  
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Figure 1.11. Redox cycling of gliotoxin between the oxidized (disulphide) form and the 
reduced (dithiol) form.  This continuous process generates reactive oxygen species.  
Reprinted with permission of Society for General Microbiology:  Microbiology [100], 
copyright 2005. 
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and sera of mice and humans suffering from aspergillosis [24, 101].  Furthermore, out of 
100 clinical and environmental strains of A. fumigatus, more than 96% produced gliotoxin 
[102]. 
 
1.7.2 Regulation of Gliotoxin 
As with other secondary metabolites, most of the genes responsible for the 
production and transport of gliotoxin exist within a gene cluster.  The gliotoxin biosynthesis 
cluster was first identified based on its homology to the sirodesmin PL biosynthesis gene 
cluster in the ascomycete L. maculans [7, 14, 25, 26] (Fig. 1.12).  Within this cluster lies a 
Zn2Cys6 binuclear finger transcription factor, GliZ, thought to be responsible for general 
gliotoxin induction and regulation.  Indeed, over-expression of gliZ leads to an increase in 
gliotoxin production and deletion of gliZ results in loss of gliotoxin production [13, 24, 92].  A 
DNA binding site has been proposed for GliZ (TCGGN3CCGA), but has not been tested.  
This site is present within the promoter region of every gene within the gliotoxin cluster, 
except gliZ and gliA [15].  Gliotoxin itself positively regulates expression of the genes within 
the gliotoxin cluster, as deletion of gliP, the non-ribosomal peptide synthetase (NRPS) 
responsible for the first step in the biosynthetic pathway for gliotoxin, virtually eliminates 
expression of the other genes in the cluster [22, 24, 27].  This loss in gene expression can 
be reversed by the addition of exogenous gliotoxin to culture medium [22, 24, 27].  
Interestingly, gliT, encoding an oxidoreductase required for resistance of the fungus to 
gliotoxin, is induced by exogenous gliotoxin even in the absence of gliZ [27].  In addition, 
FlbA, mentioned above, negatively regulates gliT expression, as a ∆flbA mutant in A.  
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Figure 1.12. Layout of the sirodesmin biosynthetic gene cluster from L. maculans and 
the gliotoxin biosynthetic gene cluster from A. fumigatus. Homologues between the two 
clusters are colored.  Reprinted with permission of Society for General Microbiology:  
Microbiology [100], copyright 2005.   
 40 
 
fumigatus displays an accumulation of gliT mRNA and protein, without affecting gliZ 
expression or overall gliotoxin production [103].  This demonstrates regulation of genes 
within the cluster that are independent of the coordinate regulation by GliZ.   
LaeA, mentioned above, has also been shown to regulate the gliotoxin cluster, as 
gliotoxin is among the secondary metabolites that are lost with deletion of laeA [32, 50, 51].  
Furthermore, loss of vel1 in T. virens (homologous to VeA in Aspergilli) results in a loss in 
gliotoxin production [104].  This is not surprising, since VeA, VelB, and LaeA form a 
heterotrimeric complex that regulates secondary metabolism and sexual development in 
several fungal species [1, 28, 30, 50, 51].  SfaD and GpgA, encoding the only Gβ subunit 
and Gγ subunit, respectively, in A. fumigatus, are involved in spore germination and 
vegetative growth.  In addition, SfaD and GpgA contribute to gliotoxin production, as loss of 
either protein reduces gliotoxin synthesis [105].  FlbB, a bZIP transcription factor involved in 
asexual development, is required for gliotoxin production in liquid submerged cultures, but 
not in air-exposed solid cultures [106].  Additionally, StuA, involved in asexual development, 
appears to partially regulate the gliotoxin cluster, as loss in stuA results in a down-
regulation of several genes within the gliotoxin cluster [107].   
RsmA positively regulates the gliotoxin cluster through LaeA and GliZ, as loss of 
either protein abolishes the inducing effects of RsmA over-expression [108].  Interestingly, 
over-expression of RsmA is able to partially restore sterigmatocystin production in a ∆laeA 
background in A. nidulans, but this is not the case in A. fumigatus.  In addition, loss of rsmA 
negatively affects sterigmatocystin production in A. nidulans, but has no effect on gliotoxin 
production in A. fumigatus [84, 108].  Map kinase signaling is another element that is 
important for gliotoxin production, as a strain lacking mpkA, the map kinase in the cell wall 
integrity pathway, is significantly reduced in gliotoxin production [109].  Nutrient starvation, 
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murine infection, and exposure of germlings to neutrophils have also been shown to up-
regulate the gliotoxin biosynthesis cluster through microarray analysis [12, 24].   
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Chapter 2:   
Materials and Methods 
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All primers used in this study are listed in Table 2.1. 
2.1 Strains and Growth Conditions 
 All strains used in this study and genotypes are listed in Table 2.2.  I maintained 
Af293.1, Af293.1-GL, 1160, Af293.1-SD1, and Af293.1-SD2 on YAG medium supplemented 
with uridine and uracil (0.5% yeast extract, 1% glucose, trace elements and vitamin mix as 
modified [110], 10 mM MgCl2, 1.5% agar, 5 mM uridine, and 10 mM uracil,).   I grew Ama.G, 
Ama.Z, Ama.A, Ama-gliZ.G, Ama-gliZ.Z, Ama-gliZ.A, Ama-gipA.G, Ama-gipA.Z, Ama-
gipA.A, Ama-gipB.G, Ama-gipB.Z, and Ama-gipB.A on YAG medium with 400 µg/ml 
hygromycin.  I maintained all other strains on YAG medium.  Unless otherwise noted, I grew 
all strains at 37°C for 48 hrs.  For phenotypic growth assays of high-copy and deletion 
strains, I inoculated approximately 1000 spores of each strain onto MMVAT (1× MM salts 
[20 mM ammonium tartrate, 7 mM KCl, 2 mM MgSO4·7H2O], 1% glucose, 12 mM KPO4 pH 
6.8, trace elements, vitamin mix as modified [110], and 1.25% agar), MMVAT with 10 µg/ml 
gliotoxin, and YAG.  MMVAT plates were incubated for 72 hours.  I repeated plate growth 
assays twice for a total of three independent tests.  I measured radial growth of each colony 
and scanned plates on the final day of growth.  For spore counts, I evenly spread 1x1010 
spores onto YAG medium and incubated plates for 48 hours at 37°C.  I collected all spores 
from the plate with 1x Tween-20 solution and counted total spores with a hemocytometer.  I 
calculated spores/cm2 based on the surface area of the medium. 
 
2.2 Genetic Screen 
 I used fusion PCR (f-PCR) to create a gliAP-lacZ-gliAT construct.  For the first 
reaction, I created three cassettes:  gliAP, lacZ, and gliAT, using primer pairs GliA F1 and 
GliA 5’ R, lacZ F and lacZ R, and GliA 3’ F and GliA R, respectively.  I obtained these three  
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Name Sequence 
GliA F1 5’-ggggacaagtttgtacaaaaaagcaggctaagatagcaacagtagccaatgt-3’ 
GliA 5’ R 5’-cgtaatcatggtcataatggtcgatgtcagtagagagctg-3’ 
lacZ F 5’-ctgacatcgaccattatgaccatgattacggattcactgg-3’ 
lacZ R 5’-gtttcgaccagatacttatttttgacaccagaccaactgg-3’ 
GliA 3’ F 5’-tggtgtcaaaaataagtatctggtcgaaacatgtctgctt-3’ 
GliA R 5’-ggggaccactttgtacaagaaagctgggtctaagctcgggatggagtgatt-3’ 
GliZ attB 1 5’-ggggacaagtttgtacaaaaaagcaggctgcgaccgcagctgattggag-3’ 
GliZ attB 2 5’-ggggaccactttgtacaagaaagctgggtcgattccctttgtgccgcc-3’ 
AMA-NotI F 5’-aaataagcttgcatgcgc-3’ 
AMA-NotI R 5’-gccagtgaattcgagctc-3’ 
6g01910 F 5’-ggggacaagtttgtacaaaaaagcaggctgcgggtttggtttggttgttgtgctt-3’ 
6g01910 R 5’-ggggaccactttgtacaagaaagctgggtcgagggcgtggtgaacgttc-3’ 
4g00320 F 5’-ggggacaagtttgtacaaaaaagcaggctgccagcagaccattctcgtttgcattc-3’ 
4g00320 R 5’-ggggaccactttgtacaagaaagctgggtcttcgaggaacctgggttgcg-3’ 
M13F 5’-cgccagggttttcccagtcacgacg-3’ 
M13R 5’-ggaaacagctatgaccatga-3’ 
01910 5’ F 5’-ggggacaactttgtatagaaaagttgaaGCGGCCGCgcttacttacagtacggagtacgg-3’ 
01910 5’ R 5’-ggggactgcttttttgtacaaacttgcgcccggcggaggaat-3’ 
01910 3’ F 5’-ggggacagctttcttgtacaaagtggaatccgttttctacgagcattgttctc-3’ 
01910 3’ R 5’-ggggacaactttgtataataaagttgcttcatggtgccgtgctcg-3’ 
gipA 3kb F 5’-ggggacaagtttgtacaaaaaagcaggctgcaccccgtttttgtggttgcgc-3’ 
gliZ 5’ F 5’-ggggacaactttgtatagaaaagttgaaGCGGCCGCgggagtcgagagatgcatgaa-3’ 
gliZ 5’ R 5’-ggggactgcttttttgtacaaacttgctgtggatgtcggggacga-3’ 
gliZ 3’ F 5’-ggggacagctttcttgtacaaagtggaagctgttctcacctcttttttttttttt-3’ 
gliZ 3’ R 5’-ggggacaactttgtataataaagttgccgagctcgtcgaccagta-3’ 
gipA C2H2 F 5’-ggggacaagtttgtacaaaaaagcaggctgccagcaaatgtacggcgggca-3’ 
gipA C2H2 R 5’-ggggaccactttgtacaagaaagctgggtctcagctgtgcccattggtatcaacg-3’ 
SDMut1 F 5’-gacttaacggagactctgccgccacgccgaatcacagcgg-3’ 
SDMut1 R 5’-ccgctgtgattcggcgtggcggcagagtctccgttaagtc-3’ 
SDMut2 F 5’-gacttaacggagactttgggtgagcgccgaatcacagcgg-3’ 
SDMut2 R 5’-ccgctgtgattcggcgctcacccaaagtctccgttaagtc-3’ 
Table 2.1.  Oligonucleotides used throughout this study.  Bolded regions are att 
sites.  Underlined regions are extensions for fusion PCR.  Uppercase regions are 
NotI sites. 
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Strain Genotype Origin 
Af293 Wild type FGSC 
Af293.1 pyrG1 This Lab[111] 
Af293.1-GL pyrG1; pDHGL This Study 
AMA.GL pyrG1; pDHGL; pDONR AMA This Study 
AMA-gliZ.GL pyrG1; pDHGL; pDONR AMA-gliZ This Study 
AMA-gipA.GL pyrG1; pDHGL; pDONR AMA-gipA This Study 
AMA-gipB.GL pyrG1; pDHGL; pDONR AMA-gipB This Study 
1160 pyrG1; nkuB::AfpyrG; pyrG::5FOA FGSC[112] 
1160G pyrG1; nkuB::AfpyrG; pyrG::5FOA; pDONR G This Lab 
∆gliZ pyrG1; nkuB::AfpyrG; pyrG::5FOA; pDHGL; gliZ::pyrG This Study 
∆gipA pyrG1; nkuB::AfpyrG; pyrG::5FOA; gipA::pyrG This Study 
gipA(R) pyrG1; nkuB::AfpyrG; pyrG::5FOA; gipA::pyrG; pDONR HPH-gipA This Study 
∆gipB pyrG1; nkuB::AfpyrG; pyrG::5FOA; gipB::pyrG This Study 
gipB(R) pyrG1; nkuB::AfpyrG; pyrG::5FOA; gipB::pyrG; pDONR HPH-gipB This Study 
∆gipA.0 pyrG1; nkuB::AfpyrG; pyrG::5FOA; gipA::pyrG; pyrG::5FOA This Study 
∆gliZ/∆gipA pyrG1; nkuB::AfpyrG; pyrG::5FOA; gipA::pyrG; pyrG::5FOA; gliZ::pyrG This Study 
∆gipB.0 pyrG1; nkuB::AfpyrG; pyrG::5FOA; gipB::pyrG; pyrG::5FOA This Study 
∆gipA/∆gipB pyrG1; nkuB::AfpyrG; pyrG::5FOA; gipB::pyrG; pyrG::5FOA; gipA::pyrG This Study 
Af293.1-SD1 pyrG1; pDHSD1 This Study 
Af293.1-SD2 pyrG1; pDHSD2 This Study 
Af293.1-SD3 pyrG1; pDHSD3 This Study 
AMA.SD1 pyrG1; pDHSD1; pDONR AMA This Study 
AMA-gliZ.SD1 pyrG1; pDHSD1; pDONR AMA-gliZ This Study 
AMA-gipA.SD1 pyrG1; pDHSD1; pDONR AMA-gipA This Study 
AMA.SD2 pyrG1; pDHSD2; pDONR AMA This Study 
AMA-gliZ.SD2 pyrG1; pDHSD2; pDONR AMA-gliZ This Study 
AMA-gipA.SD2 pyrG1; pDHSD2; pDONR AMA-gipA This Study 
pyrG+ pyrG1; AnpyrG This Study 
∆gliZ.1 pyrG1; gliZ::pyrG This Study 
∆gipA.1 pyrG1; gipA::pyrG This Study 
AMA.G pyrG1; pyrG; pDONR AMA/HPH This Study 
AMA-gliZ.G pyrG1; pyrG; pDONR AMA/HPH-gliZ This Study 
AMA-gipA.G pyrG1; pyrG; pDONR AMA/HPH-gipA This Study 
AMA-gipB.G pyrG1; pyrG; pDONR AMA/HPH-gipB This Study 
AMA.Z pyrG1; gliZ::pyrG; pDONR AMA/HPH This Study 
AMA-gliZ.Z pyrG1; gliZ::pyrG; pDONR AMA/HPH-gliZ This Study 
AMA-gipA.Z pyrG1; gliZ::pyrG; pDONR AMA/HPH-gipA This Study 
AMA-gipB.Z pyrG1; gliZ::pyrG; pDONR AMA/HPH-gipB This Study 
AMA.A pyrG1; gipA::pyrG; pDONR AMA/HPH This Study 
AMA-gliZ.A pyrG1; gipA::pyrG; pDONR AMA/HPH-gliZ This Study 
AMA-gipA.A pyrG1; gipA::pyrG; pDONR AMA/HPH-gipA This Study 
AMA-gipB.A pyrG1; gipA::pyrG; pDONR AMA/HPH-gipB This Study 
Table 2.2. Genotype of all strains used in this study. 
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fragments by PCR using e2TAK DNA polymerase (Takara Bio Inc., Otsu, Shiga, Japan), 
following manufacturer recommendations.  The gliAP fragment had a 3’ extension identical 
to the first 15 base pairs of lacZ.  The lacZ fragment had a 5’ extension identical to the last 
15 base pairs of gliAP and a 3’ extension identical to the first 15 base pairs of gliAT.  The 
gliAT fragment had a 5’ extension identical to the last 15 base pairs of lacZ.  I used Af293 
genomic DNA as template for the gliAP and gliAT regions and λGT11 as template for lacZ.  
For the second reaction, I fused the three fragments together using GliA F1 and GliA R as 
primers.  I amplified a 50 µl reaction containing 50 fmol of each fragment, 0.3 µM of each 
primer, 500 µM of deoxynucleoside triphosphates, buffer 3 at a 1X concentration, and 1 µl 
of Expand Long DNA Template Mix (Roche Applied Science, Indianapolis, IN) per 
manufacturer’s instructions (briefly, 94°C for 2 min, 10 cycles of 94°C for 10 sec, 62°C for 
30 sec, 68°C for 4.5 min and 15 cycles of 94°C for 15 sec, 62°C for 30 sec, 68°C for 4.5 
min, increasing the final extension time by 20 sec with each cycle).   
I cloned the fusion product into pDONR HPH A using a BP recombination reaction 
(Invitrogen, Grand Island, NY).  I transformed the reaction mix into TOP10 cells (Invitrogen, 
Grand Island, NY) by electroporation, as recommended by the manufacturer.  I grew the 
transformation mix on LB (1% Tryptone, 0.5% yeast extract, 1X SOB salts [10mM NaCl, 
2.5mM KCl], 1.5% agar) + 50 µg/ml kanamycin at 37ºC overnight.  I picked colonies and 
transferred to 2 ml of LB liquid + 50 µg/ml kanamycin to grow overnight in a 37ºC shaking 
incubator.  I isolated plasmid DNA from each culture using a miniprep kit (Qiagen, Hilden, 
Germany).  I digested plasmid DNA with specific enzymes to verify the correct insertion.  I 
designated this vector as pDHGL. 
I grew Af293.1 in MAG medium (2% malt extract, 0.2% peptone, 1% glucose, trace 
elements and vitamin mix as modified [110]) supplemented with 5 mM uridine and 10 mM 
uracil.  I performed the transformation as previously described [113], keeping pDHGL as a 
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circular vector.  I grew transformants on MMVAT supplemented with 5 mM uridine, 10 mM 
uracil, 0.2 M sucrose, and 400 µg/ml hygromycin at 37ºC for 3-5 days.  I identified the 
presence of pDHGL by Southern hybridization [114] of the lacZ coding region (Fig. 2.1a).  I 
also streaked transformants onto MMVSN supplemented with uridine and uracil (as 
described above for MMVAT, except 1xMM salts contain 20mM sodium nitrate instead of 
ammonium tartrate) and 40 µg/ml X-gal to grow at 37°C for 2 days.  I screened for 
transformants that grew in the presence of hygromycin and developed a blue pigment on 5-
bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal), signaling that lacZ expression was 
working properly (Fig. 2.1b).  I designated this strain as Af293.1-GL. 
For the first round of the high-copy inducer screen, I grew Af293.1-GL in MAG 
supplemented with uridine and uracil.  I transformed the AMA1-Not1 A. fumigatus genomic 
library [115] into Af293.1-GL as described previously [113], but with changes.  I combined 
each transformation mix with 50 ml CM top agar (MMVAT, as described above, 0.1% yeast 
extract, 0.2% peptone, 0.1% tryptone, 1% CM supplement [27 mM adenine HCl, 33.5 mM 
methionine, 173 mM arginine, and 1.3 mM riboflavin], and 1% agar) supplemented with 1 M 
sucrose and spread the mixture over 10 plates (5 ml/plate).  I grew transformants on CM 
supplemented with 0.2 M sucrose and 40 µg/ml X-gal at 37°C for 3-5 days.  I screened for 
transformants that were both prototrophic for uridine and uracil and producing blue pigment.  
I prepared genomic DNA from transformants [51] and transformed 1 µl of genomic DNA into 
TOP10 cells (Invitrogen, Grand Island, NY) by electroporation, as recommended by the 
manufacturer.  I grew the transformation mix on LB + 100 µg/ml ampicillin at 37ºC 
overnight.  I picked colonies and transferred to 2 ml of LB liquid + 100 µg/ml ampicillin to 
grow overnight in a 37ºC shaking incubator.  I isolated plasmid DNA from each culture 
using a miniprep kit (Qiagen, Hilden, Germany) and digested it with KpnI to identify 
individual plasmids.   
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    WT   1       2*     3       4*      5      6*      7       8*       9 
Figure 2.1. Presence and activity of lacZ expression cassette in 
Af293.1-GL transformants.  (a) Southern hybridization of Af293.1-
GL transformants.  Genomic DNA was digested with EcoRI 
overnight at 37°C then run on a 0.8% agarose gel.  The lacZ 
coding region was used as the probe.  WT is wild-type (Af293.1) 
and is expected to have no band.  Proper transformants should 
only have one band of unknown size.  Lanes with asterisks are 
transformants that produced blue pigment when grown on 
MMVSN U/U (non-repressing) medium with X-gal.  (b) Example of 
blue pigment production in Af293.1-GL transformants.  The left 
panel shows activation of the lacZ expression cassette, while the 
right panel displays colonies that are not induced for lacZ 
expression. 
 23 kb 
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          For the second round of the high-copy inducer screen, I grew Af293.1-GL in MAG 
supplemented with uridine and uracil.  I transformed each individual plasmid isolated from 
the first round of the genetic screen as described above, but with the following changes.  I 
plated two amounts of protoplasts (20 µl and 100 µl) each in 4 ml MMVAT top agar (as 
described above but with 1% agar) supplemented with 1 M sucrose.  I grew transformants 
on MMVAT supplemented with 0.2 M sucrose and 40 µg/ml X-gal at 37°C for 3-4 days and 
put plates in the 4°C refrigerator to facilitate blue pigment production.  Plasmids causing at 
least 80% of colonies to turn blue were sequenced using primers AMA-NotI F and AMA-
NotI R.  I also grew transformants in 10 ml CM at 37°C stationary overnight.  I collected 
mycelia, froze in liquid nitrogen, and lyophilized overnight.  I collected total protein and 
performed β-galactosidase assays to measure LacZ levels quantitatively (detailed below). 
For the third round of the high-copy inducer screen, I PCR amplified individual 
genes from genomic library plasmids, flanked by native 5’ and 3’ non-coding regions 
(NCRs).  For gipA (Afu6g01910) and gipB (Afu4g00320) I used the primer pair 6g01910 F 
and 6g01910 R and the primer pair 4g00320 F and 4g00320 R, respectively.   I amplified 
the fragments from Af293 genomic DNA using e2TAK DNA polymerase (Takara Bio Inc., 
Otsu, Shiga, Japan) and following manufacturer recommendations.  I cloned the PCR 
fragments into pDONR AMA with a BP recombination reaction (Invitrogen, Grand Island, 
NY).  I transformed the reaction mix into TOP10 cells (Invitrogen, Grand Island, NY) by 
electroporation, as recommended by the manufacturer.  I grew the transformation mix on 
LB + 100 µg/ml ampicillin at 37ºC overnight.  I picked colonies and transferred to 2 ml of LB 
liquid + 100 µg/ml ampicillin to grow overnight in a 37ºC shaking incubator.  I isolated 
plasmid DNA from each culture using a miniprep kit (Qiagen, Hilden, Germany).  I digested 
plasmid DNA with specific enzymes to verify the correct insertion.  I designated these 
vectors as pDONR AMA-gipA and pDONR AMA-gipB.  I created a control vector, pDONR 
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AMA-gliZ, which contained the gliZ coding region flanked by promoter and terminator 
regions.  I generated this vector as described above for pDONR AMA-gipA and pDONR 
AMA-gipB using primers GliZ attB 1 and GliZ attB 2.   
I grew Af293.1GL in MAG medium, supplemented with uridine and uracil.  I 
performed the transformation as previously described [113], with changes, using pDONR 
AMA, pDONR AMA-gliZ as controls.  After the 3 hour incubation of protoplasts, I carried out 
all reactions at half the specified volume.  I used 500 ng – 750 ng of circular vector DNA for 
each reaction.  I plated two amounts of protoplasts (20 µl and 50 µl) each in 4 ml of MMVAT 
top agar supplemented with 1 M sucrose.  I grew transformants on MMVAT medium 
supplemented with 0.2 M sucrose at 37ºC for 2-3 days.  To measure LacZ levels 
quantitatively, I grew transformants in 10 ml CM at 37°C stationary overnight.  I collected 
mycelia, froze in liquid nitrogen, and lyophilized overnight.  I collected total protein and 
performed β-galactosidase assays (detailed below).  I chose three strains to use for future 
analysis:  AMA.GL, AMA-gliZ.GL, and AMA-gipA.GL.   
 
2.3 λ Phage Library Screen 
 I isolated gipA and gipB cDNA clones from a λ phage library constructed with the 
UniZAP vector and poly(A)+ mRNA, as described by the manufacturer (Stratagene, La 
Jolla, California).  I performed a primary screen of the λ phage library as recommended by 
manufacturer (Stratagene, La Jolla, California), with changes.  I plated 6 plates (150 mm) 
for primary screening with host strain LE392 (Stratagene, La Jolla, California) and the λ 
phage library at 40,000 plaque-forming-units (pfu)/plate (3 plates) and 60,000 pfu/plate (3 
plates).  I lifted plaques with nylon membranes and crosslinked the DNA to the membranes 
by baking for 2 hours in an oven.  I prehybridized and hybridized membranes at 42°C for 6 
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hours and overnight, respectively.  I used gipA and gipB genomic DNA PCR products for 
probes [114].  I excised plugs containing positive plaques and placed them in SM (.1 M 
NaCl, 10 mM MgSO4·7H2O, 50 mM Tris·HCl [pH 7.5], and .01% gelatin) at 4°C overnight.  
After determining pfu concentration of plaques, I performed a secondary screen, as 
performed for the primary screen, with changes.  I combined 500-1000 pfu with LE392 and 
spread over 8 plates (100 mm).  I hybridized membranes using gipA and gipB genomic 
DNA as probes [114].  I plated excised phagemids as recommended by manufacturer 
(Stratagene, La Jolla, California) and plated on LB + 100 µg/ml ampicillin to grow at 37°C 
overnight.  I PCR amplified cDNA from excised phagemids using e2TAK DNA polymerase 
(Takara Bio Inc., Otsu, Shiga, Japan) and following manufacturer recommendations.  I used 
M13 F and M13 R as primers for the reaction.  Based on the PCR band sizes, I picked 
colonies from selected plates and transferred to 2 ml of LB liquid + 100 µg/ml ampicillin to 
grow overnight in a 37ºC shaking incubator.  I isolated plasmid DNA from each culture 
using a miniprep kit (Qiagen, Hilden, Germany) and sequenced the cDNA insert using M13 
F and M13 R primers.  I used DNASTAR software (DNASTAR Inc., Madison, WI) to 
assemble and analyze the sequences obtained from the library screen.   
 
2.4 RNA Dot Blot Analysis 
 For all dot blot assays, I grew stationary cultures in 25 ml CM (repressing) 
(described above) or CD (non-repressing) (87.6 mM sucrose, 35.3 mM Na2NO3, 5.8 mM 
K2HPO4, 2 mM MgSO4·7H2O, 6.7 mM KCl, and 0.025 mM (NH4)2Fe(SO4)2·6H2O) at a 
concentration of 5x106 spores/ml at 37ºC for 48 hours.  I included 400 µg/ml hygromycin in 
dot blot assays involving Ama.G, Ama.Z, Ama.A, Ama-gliZ.G, Ama-gliZ.Z, Ama-gliZ.A, 
Ama-gipA.G, Ama-gipA.Z, Ama-gipA.A, Ama-gipB.G, Ama-gipB.Z, and Ama-gipB.A.  I 
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prepared total RNA from freeze-dried mycelia using the TRIzol method [110].  I incubated 
total RNA with denaturing solution (50% formamide, 16% formaldehyde, 1X borate buffer 
[20X borate buffer:  0.4 M Boric Acid, 4 mM EDTA, pH 8.3 with NaOH], 0.025% 
bromophenol blue) for 10 minutes at 65°C.  I quenched samples on ice for 10 minutes, then 
added equal volume 20x SSC (3 M NaCl, 0.3 M C6H5O7Na3 •2H2O, pH 7.0).  I placed a 
nylon membrane that had been equilibrated in 10x SSC for 10 minutes into a 96-well dot 
blot apparatus attached to a vacuum manifold.  I collected samples, each containing 3 µg of 
RNA unless otherwise noted, in 100 µl volumes by aspiration.  I aspirated 50 µl of 10x SSC 
through the membrane in duplicate immediately before and after samples were collected.  
Once all samples were aspirated, I air dried nylon membranes overnight and then baked 
them in an oven for 2 hours.  For prehybridization and hybridization, I sealed nylon 
membranes in a bag using a heated sealer.  I prehybridized membranes for 4-6 hours at 
42°C and hybridized membranes overnight at 42°C.  For DNA probes, I only used the 
coding region of each gene of interest (gliA, gliP, gliZ, gliT, gipA, gipB, actin).  I used 
different combinations of these probes in different experiments, which is noted in the figure 
legends.  After hybridization, I washed membranes as I would for Southern hybridization 
[114] and exposed them to a Typhoon 8600 PhosphorImager (GE Healthcare Life 
Sciences, Pittsburgh, PA) overnight.  I quantified the intensity of hybridization using 
ImageQuant5.1 software (GE Healthcare Life Sciences, Pittsburgh, PA).   
 
2.5 Gliotoxin Extraction and HPLC Analysis 
 I extracted spent culture medium from RNA dot blot assays in 15 ml chloroform for 
30 minutes at room temperature on an orbital shaker set to 250 rpm.  I transferred the 
chloroform phase to a 50 ml conical tube (BD Biosciences, San Jose, California) and 
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repeated the extraction twice for a total of 45 ml chloroform.  I dried open tubes under a 
hood until the chloroform was completely evaporated.  I added 15 ml chloroform to each 
tube and mixed, to concentrate the extracted material at the bottom.  I dried open tubes 
under a hood until chloroform was completely evaporated.  I added 1 ml methanol to each 
tube and mixed to dissolve all methanol-soluble substances and transferred extracts to 
microcentrifuge tubes (Fisher Scientific, Pittsburgh, PA).  I dried open tubes under a hood 
until all methanol was completely evaporated.   
 I dissolved extracts in 50 µl of dimethyl sulfoxide (DMSO), spun tubes to pellet 
insoluble debris, and transferred DMSO to fresh microcentrifuge tubes.  I quantified 
gliotoxin levels by running samples through a reverse-phase high performance liquid 
chromatography (RP-HPLC) system with a Waters 996 photodiode array detector (Waters, 
Milford, MA).  I ran samples through a Sonoma 2.1 x 250 mm C18 column (100 Å pore size) 
packed with 5 µM particles (VWR, Radnor, PA).  The mobile phase consisted of H2O, 0.1% 
TFA (solution A) and 100% Acetonitrile, 0.1% TFA (solution B):  10% B up to 80% B over 
30 minutes.  The injection volume was 10 µl and flow rate was set at 0.4 ml/min.  Gliotoxin 
eluted from the column at 14.7 minutes and absorbance was read at 268 nm wavelength.  I 
determined gliotoxin concentrations by interpolation from a 9 point standard curve (39 ng to 
10 µg) prepared using purified gliotoxin (Sigma-Aldrich Corp., St. Louis, MO).   
 
2.6 Microarray 
 The DNA amplicon microarray for Af293 was created previously [116].  I grew 
AMA.GL and AMA-gipA.GL in 25 ml CM (described above) at 37°C for 24 hours in 
stationary cultures.  The spore concentration was 5x106 spores/ml.  I used two independent 
biological replicates for AMA.GL and AMA-gipA.GL growth assays.  I prepared total RNA 
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from freeze-dried mycelia using the TRIzol method [110].  I carried out RNA labeling 
reactions and hybridizations as described in the J. Craig Venter Institute Microarray 
Protocols (http://pfgrc.jcvi.org/index.php/microarray/protocols.html).  I repeated all the 
hybridizations in dye-swap sets.  I scanned and analyzed hybridized slides as described 
previously [116].  I averaged all replicates for the official data used in our analysis. 
 
2.7 Virulence Assays with Toll-deficient Drosophila melanogaster 
 I injected the dorsal side of the thorax of CO2-anesthetized, adult, Toll-deficient D. 
melanogaster flies with a sterile 0.25 mm needle that had been dipped in a solution 
containing 107 spores/ml of A. fumigatus conidia.  I infected 20-25 flies per strain for each 
virulence assay, which was repeated at least twice.  Flies were kept in a 29°C incubator to 
maximize susceptibility to microbial challenge and monitored for 7 days.  Flies that died 
within 3 hours of the injection were not included in the survival graph, as these flies most 
likely died as a result of the puncture wound.   
 
2.8 Deletion and Complementation of gipA and gipB in Af1160 
I amplified the 5’ flanking region (FR) and the 3’ FR from gipA using primers 01910 
5’ F, 01910 5’ R, 01910 3’ F, and 01910 3’ R and gipB using primers 00320 5’ F, 00320 5’ 
R, 00320 3’ F, and 00320 3’ R.  I engineered a unique NotI site into 01910 5’ F and 00320 
5’ F to linearize the final deletion constructs.  I amplified the fragments from Af293 genomic 
DNA using e2TAK DNA polymerase (Takara Bio Inc., Otsu, Shiga, Japan) and following 
manufacturer recommendations.  I cloned the gipA 5’ FR and gipB 5’ FR into pDONR P4-
P1R and I cloned the gipA 3’ FR and gipB 3’ FR into pDONR P2R-P3, using BP 
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recombination reactions (Invitrogen, Grand Island, NY).  I transformed BP reaction mixes 
into TOP10 cells (Invitrogen, Grand Island, NY) by electroporation, as recommended by the 
manufacturer.  I grew transformed cells on LB (described above) + 50 µg/ml kanamycin at 
37ºC overnight.  I picked colonies and transferred to 2 ml LB liquid + 50 µg/ml kanamycin to 
grow overnight in a 37ºC shaking incubator.  I isolated plasmid DNA from each culture 
using a miniprep kit (Qiagen, Hilden, Germany).  I digested plasmid DNA with specific 
enzymes to verify the correct fragment orientation.   
To create the deletion constructs, I combined pDONR P4-P1R-gipA 5’ FR, pDONR 
P2R-P3-gipA 3’ FR, and pDONR 221-AnpyrG for the gipA construct and pDONR P4-P1R-
gipB 5’ FR, pDONR P2R-P3-gipB 3’ FR, and pDONR 221-AnpyrG for the gipB construct in 
two LR recombination reactions with pDEST R4-R3 as the destination vector (Invitrogen, 
Grand Island, NY) [117].  I transformed the LR reaction mixes into TOP10 cells (Invitrogen, 
Grand Island, NY) by electroporation, as recommended by the manufacturer.  I grew 
transformed cells on LB + 100 µg/ml ampicillin at 37ºC overnight.  I picked colonies and 
transferred to 2 ml LB liquid + 100 µg/ml ampicillin to grow overnight in a 37ºC shaking 
incubator.  I isolated plasmid DNA from each culture using a miniprep kit (Qiagen, Hilden, 
Germany).  I digested plasmid DNA with specific enzymes to verify the correct fragment 
orientation.  I grew bacterial cultures containing the correct plasmids in 250 ml LB liquid + 
100 µg/ml ampicillin overnight in a 37ºC shaking incubator.  I purified plasmid DNA by 
banding on cesium chloride ethidium bromide gradients [114].  I designated the plasmids 
pDEST R4-R3-gipA 5’ FR-AnpyrG-gipA 3’ FR and pDEST R4-R3-gipB 5’ FR-AnpyrG-gipB 
3’ FR. 
I grew A. fumigatus 1160 (obtained from FGSC) in MAG supplemented with uridine 
and uracil (described above).  I performed the transformation as previously described [113], 
linearizing both deletion constructs with NotI to facilitate homologous recombination.  I grew 
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transformants on MMV (described above) supplemented with 0.2 M sucrose at 37ºC for 3-5 
days.  I screened for mutants that were prototrophic for uridine and uracil.  I prepared 
genomic DNA from transformant strains [51], and I identified deletion mutants by Southern 
blot analysis (Fig. 2.2a & b) [114].  I made two DNA probes using the gipA 5’ and 3’ FRs 
and the gipB 5’ and 3’ FRs to verify ΔgipA and ΔgipB, respectively.   
To create a vector for complementation, I PCR amplified the gipA coding region, 
flanked by a 3 kilobase promoter region and 500 base pair terminator region, using primers 
gipA 3kb F and 6g01910 R.  I used primers 4g00320 F and 4g00320 R to isolate the gipB 
coding region.  I amplified the fragments from Af293 genomic DNA using e2TAK DNA 
polymerase (Takara Bio Inc., Otsu, Shiga, Japan) and following manufacturer 
recommendations.  I cloned the PCR products into pDONR HPH B, as described previously 
for pDHGL.  I designated these vectors pDONR HPH-gipA and pDONR HPH-gipB.  I grew 
∆gipA and ∆gipB in MAG medium (as described above).  I performed the transformations 
as previously described for pDHGL.  For Southern hybridization, I made DNA probes using 
the coding region of gipA and gipB (Fig. 2.3a&b).  I designated these strains as gipA(R) and 
gipB(R).  I obtained controls (1160G and ∆gliZ) for growth assays deletion mutants.  I 
created 1160G by transforming pDONR G into Af1160 and I created ∆gliZ by transforming 
pDEST R4-R3-gliZ 5’ FR-AnpyrG-gliZ 3’ FR into Af1160, performed as described above for 
∆gipA.  I created the gliZ deletion construct as described previously for ∆gipA using primers 
gliZ 5’ F, gliZ 5’ R, gliZ 3’ F, and gliZ 3’ R.  I used gliZ 5’ and 3’ flanking regions as a DNA 
probe for Southern hybridization (Fig. 2.2c). 
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Figure 2.2. Southern hybridizations 
of gipA, gipB, and gliZ deletion 
mutants.  Samples were run on a 
0.8% agarose gel.  WT is wild-type 
(Af1160).  (a) ∆gipA transformants 
digested with PstI.  WT should 
have a 4769 bp band and a 3275 
bp band, while correct 
transformants are expected to 
have one 8627 bp band.  The gipA 
5’ FR and 3’ FR was used as a 
probe.  (b) ∆gipB transformants 
digested with ClaI.  WT should 
have a 11488 bp band and a 3852 
bp band, while correct 
transformants should have one 
13619 bp band. The gipB 5’ FR 
and 3’ FR was used as a probe.  
(c) ∆gliZ transformant digested 
with KpnI.  WT should have one 
8775 bp band, while correct 
transformant should have a 6314 
bp band and a 2945 bp band. The 
gliZ 5’ FR and 3’ FR was used as a 
probe. 
8 kb 
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1.7 kb 
Figure 2.3. Southern 
hybridizations of gipA(R) 
and gipB(R) transformants.  
WT is wild-type (Af1160).  
(a) gipA(R) transformants 
digested with SphI.  WT 
should have two bands, 
one at 4131 bps and one 
at 3404 bps (the lower 
band is extremely light).  
The ΔgipA mutant should 
not display any band.  
Correct transformants 
should display two bands 
at 3404 bps and 1967 bps, 
which indicates 5’ 
integration of the 
complement plasmid.  (b) 
gipB(R) transformants 
digested with EcoRI.  WT 
should display two bands 
at 5423 bps and 1225 bps.  
The ΔgipB mutant should 
not display any band, while 
correct transformants 
should display two bands 
at 7793 bps and 1225 bps, 
indicating 5’ integration of 
the complement plasmid.  
 59 
 
2.9 Construction of ∆gliZ/∆gipA and ∆gipA/∆gipB 
I grew ∆gipA on YAG supplemented with uridine and uracil (described above) + 1 
mg/ml 5-Fluororotic acid (5-FOA) at 37ºC.  Colonies that reverted to a pyrG- phenotype 
grew as outgrowths from the original streak.  I prepared genomic DNA from these pyrG- 
fans [51] and tested them for the presence of gipA by Southern hybridization (Fig. 2.4a) 
[114].  I used the gipA coding region as a DNA probe.  I designated this mutant as ∆gipA.0.  
I transformed pDEST R4-R3-gliZ 5’ FR-AnpyrG-gliZ 3’ FR into ∆gipA.0, as described above 
for ∆gipA.  I used the gliZ, gipA, and gipB coding regions as a DNA probe for Southern 
hybridization (Fig. 2.5a). 
I grew ΔgipB on 5-FOA medium, as described above for ∆gipA.0, and designated 
this strain as ΔgipB.0.  I prepared genomic DNA from these pyrG- fans [51] and tested them 
for the presence of gipB by Southern hybridization (Fig. 2.4b) [114].  I used the gipB coding 
region as a DNA probe.  I transformed pDEST R4-R3-gipA 5’ FR-AnpyrG-gipA 3’ FR into 
∆gipB.0, as described above for ∆gipA.  I used the gipA and gipB coding regions as a DNA 
probe for Southern hybridization (Fig. 2.5b). 
 
2.10 Protein Binding Microarray 
 I amplified the C2H2 DNA binding region from gipA using primers gipA C2H2 F and 
gipA C2H2 R.  I used Af293 as template and AccuPrime Pfx DNA polymerase (Life 
Technologies Grand Island, NY) and per manufacturer’s recommendations.  I cloned the 
PCR product into pDONR 221 using a BP recombination reaction (Invitrogen, Grand Island, 
NY).  I transformed the reaction mix into TOP10 cells (Invitrogen, Grand Island, NY) by  
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10 kb 
 7 kb 
Figure 2.4. Southern hybridization of ∆gipA and ∆gipB 
mutants treated with 5-FOA.  Samples were run on a 
0.8% agarose gel.  WT is wild-type (Af1160) and ∆ is the 
untreated deletion strain.  (a) ∆gipA.0 mutants digested 
with EcoRV and probed with the gipA coding region.  Only 
WT should display a band, which is 7616 bp.  (b) ∆gipB.0 
mutants digested with ScaI and probed with the gipB 
coding region.  Only WT should display a band, which is 
13828 bp. 
WT    ∆A     1     2   WT    ∆B     1     2 a b 
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  WT   ∆A     1    2      3      4      5      6     7     8 
WT    ∆A    ∆B     1        2        3       4       5 
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Figure 2.5. Southern hybridization of ∆gliZ/∆gipA and 
∆gipA/∆gipB double mutants.  Samples were run on a 
0.8% agarose gel.  WT is wild-type (Af1160).  (a) 
∆gliZ/∆gipA transformants digested with SacI and probed 
with the gliZ, gipA, and gipB coding regions.  WT should 
display three bands, which are 11712 bps (gipB), 7474 
bps (gipA), and 4566 bps (gliZ).  The ∆gipA control should 
display two bands, which are 11712 bps (gipB) and 4566 
bps (gliZ).  Correct transformants should display only one 
band at 11712 bps, for gipB.  (b) ∆gipA/∆gipB 
transformants digested with SacI and probed with the gipA 
and gipB coding regions.  WT should display two bands, 
which are 11712 bps (gipB) and 7474 bps (gipA).  The 
∆gipA control should display one band at 11712 bps for 
gipB and the ∆gipB control should display one band at 
7474 bps for gipA.  Correct transformants should not 
display any bands. 
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electroporation, as recommended by the manufacturer.  I grew the transformation mix on 
LB + 50 µg/ml kanamycin at 37ºC overnight.  I picked colonies and transferred to 2 ml of LB 
liquid + 50 µg/ml kanamycin to grow overnight in a 37ºC shaking incubator.  I isolated 
plasmid DNA from each culture using a miniprep kit (Qiagen, Hilden, Germany).  I digested 
plasmid DNA with specific enzymes to verify the correct insertion.  I recombined the gipA 
C2H2 region into pDEST 15 using an LR recombination reaction (Invitrogen, Grand Island, 
NY).  I transformed the reaction mix into TOP10 cells (Invitrogen, Grand Island, NY) by 
electroporation, as recommended by the manufacturer.  I grew the transformation mix on 
LB + 100 µg/ml ampicillin at 37ºC overnight.  I picked colonies and transferred to 2 ml of LB 
liquid + 100 µg/ml ampicillin to grow overnight in a 37ºC shaking incubator.  I isolated 
plasmid DNA from each culture using a miniprep kit (Qiagen, Hilden, Germany).  I digested 
plasmid DNA with specific enzymes to verify the correct insertion.  This vector, pDEST 15-
gipA C2H2, was used in a protein binding microarray analysis as previously described [118].   
 
2.11 Mutagenesis of the GipA DNA Binding Site in the gliA Promoter 
I created mutated gipA DNA binding sites in pDHGL using a QuikChange II XL Site-
Directed Mutagenesis Kit (Agilent Technologies Inc., Santa Clara, CA), as recommended 
by the manufacturer.  I utilized primers SDMut1 F and SDMut1 R, SDMut2 F and SDMut2 R 
to create vectors pDHSD1 and pDHSD2, respectively.  I transformed pDHGL, pDHSD1 and 
pDHSD2 into Af293.1, as previously described for Af293.1-GL, except I plated 
transformants on YAG supplemented with uridine and uracil (described above), 0.2 M 
sucrose, and 300 µg/ml hygromycin.  I verified correct transformants by Southern 
hybridization using the lacZ coding region as a probe (Fig. 2.6).  I designated these strains  
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WT GL   1   2   3   4   5    6    7  a b 
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6 kb 
6 kb 6 kb 
WT  GL    1     2     3      4  
       |------------GL------------| |----------SD1----------| 
 GL  1  2   3   4   5   6  7   8   1   2  3   4   5   6  7 GL  1   2  3   4   5   6   7   8 
Figure 2.6. Southern hybridizations of promoter mutagenesis transformants.  Samples 
were digested with EcoRI and run on a 0.8% agarose gel.  WT is wild-type (Af293.1) and 
GL is Af293.1-GL.  The lacZ coding region was used as the probe.  WT should not display 
a band and GL should have a single band ~6500bps.  Correct transformants should 
display a single band, any size.  (a) First group of Af293.1-SD1 transformants.  Isolate 5 
was chosen for experiments.  (b) First group of Af293.1-SD2 transformants.  Isolate 4 was 
chosen for experiments.  (c) Second group of Af293.1-GL and Af293.1-SD1 transformants.  
Isolate 6 and 4 were chosen for experiments, respectively.  (d) Second group of Af293.1-
SD2 transformants.  Isolate 6 was chosen for experiments.  Notice that isolates chosen for 
independent experiments for Af293.1-SD1 and Af293.1-SD2 display different sized bands, 
indicating that the pDHSD1 and pDHSD2 plasmids integrated in different places in the 
genome, respectively.   
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as Af293.1-GL, Af293.1-SD1 and Af293.1-SD2, respectively.  I repeated transformations 
until I obtained two independent isolates for experiments, therefore, I used the AMA.GL, 
AMA-gliZ.GL, and AMA-gipA.GL obtained from the high-copy library screen for one set of 
experiments and made a new Af293.1-GL strain (Fig. 2.6c) for the second set of 
experiments.  To test the effect of the different gipA binding site mutants, I transformed 
pDONR AMA, pDONR AMA-gliZ, and pDONR AMA-gipA into two independent isolates of 
Af293.1-GL, Af293.1-SD1 and Af293.1-SD2, as described above for AMA-gipA.GL, except I 
grew transformants on YAG supplemented with 0.2 M sucrose.  I designated the promoter-
mutated strains as AMA.SD1, AMA-gliZ.SD1, AMA-gipA.SD1, AMA.SD2, AMA-gliZ.SD2 
and AMA-gipA.SD2. 
 
2.12 β-galactosidase Assays 
 I ground 50 µl lyophilized mycelia to a fine powder with acid-washed glass beads 
(400-650 µm) (Sigma-Aldrich Corp., St. Louis, MO).  I suspended the ground powder in 200 
µl protein extraction buffer (PEB) (60mM Na2HPO4·7H2O, 40mM NaH2PO4·H2O, 10mM KCl, 
1mM MgSO4·7H2O, 1mM EDTA, and 20µM PMSF [added fresh], pH 7.0) by vortexing and 
incubated the samples on ice for 15 minutes, with additional vortexing every 5 minutes.  I 
spun tubes for 15 minutes at 15,600 x g at 4°C to pellet cellular debris and beads.  I 
transferred supernatants, containing total protein, to fresh tubes on ice and measured 
protein concentration using a Bio-Rad protein assay kit (Bio-Rad, Hercules, CA).   In a 96-
well plate, I added 10 µl of protein in PEB and 90 µl Z Buffer (60mM Na2HPO4·7H2O, 40mM 
NaH2PO4·H2O, 10mM KCl, 1mM MgSO4·7H2O, 50mM β-mercaptoethanol [added fresh], 
pH to 7.0).  For samples grown in repressing conditions (CM), the total protein added was 1 
µg.  For samples grown in non-repressing conditions (CD), the total protein added was 0.1 
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µg.  To begin the β-galactosidase assay, I added 20 µl of 2-Nitrophenyl-β-D-
galactopyranoside (ONPG) (Sigma-Aldrich Corp., St. Louis, MO), at a concentration of 4 
mg/ml in Z Buffer, and placed the 96-well plate in a 37°C incubator.  I timed reactions and 
stopped samples with 50 µl 1 M Na2CO3.  I measured absorbance at OD420 and calculated 
Units of β-galactosidase activity/mg protein with the following equation:  (OD420 x 
TV)/(0.0045 x T x V x C), where TV is total volume of the reaction in ml, T is time in 
minutes, V is volume of protein added in ml, and C is concentration of protein used in µg/µl. 
   
2.13 Creation of Strains for High-copy Gene Expression in Deletion Backgrounds 
 I grew Af293.1 in MAG supplemented with uridine and uracil (described above).  I 
transformed pDEST R4-R3-gliZ 5’ FR-AnpyrG-gliZ 3’ FR and pDEST-gipA 5’ FR-AnpyrG-
gipA 3’ FR into Af293.1, as previously described for ∆gipA, except I plated transformants on 
YAG supplemented with 0.2 M sucrose.  I used gliZ 5’ and 3’ FRs and gipA 5’ and 3’ FRs 
for Southern hybridization and designated these strains ∆gliZ.1 and ∆gipA.1 (Fig. 2.7).  I 
chose one strain from the ∆gliZ transformation that did not show homologous 
recombination at the gliZ locus, but was prototrophic for uridine and uracil.  I designated this 
strain pyrG+.  I collected total RNA and performed dot blot analysis on pyrG+, ∆gliZ.1, and 
∆gipA.1 to verify loss of gliZ and gipA, respectively (described above) (Fig. 2.8).  I cloned 
gliZ, gipA, and gipB into pDONR AMA/HPH, as described above for pDONR AMA-gliZ, 
pDONR AMA-gipA, and pDONR AMA-gipB, respectively, except I used primers gipA 3kb F 
and 6g01910 R for the gipA cassette.  I designated these plasmids pDONR AMA/HPH-gliZ, 
pDONR/HPH-gipA, and pDONR AMA/HPH-gipB.  I transformed these plasmids, along with 
pDONR AMA/HPH empty vector, into pyrG+, ∆gliZ.1, and ∆gipA.1, as described above for  
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Figure 2.7. Southern hybridizations of ∆gliZ.1 and 
∆gipA.1 transformants.  Samples were run on a 
0.8% agarose gel.  WT is wild-type (Af293.1).  (a) 
∆gliZ.1 transformants digested with KpnI.  WT 
should display a 8775 bp band and correct 
transformants should display two bands at 6314 
bps and 2945 bps.  The gliZ 5’ and 3’ FRs were 
used as a probe.  (b) ∆gipA.1 transformants 
digested with PstI.  WT should display two bands at 
4769 bps and 3275 bps, while correct 
transformants should display one band at 8627 bps.  
The gipA 5’ and 3’ FRs were used as a probe. 
a 
b 
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a 
Figure 2.8. Verification of ΔgliZ and ΔgipA mutants in an Af293.1 
background.  (a)  Cultures were grown in non-repressing conditions 
at 37°C for 48 hrs.  Total RNA was collected and dot blot analysis 
was performed in triplicate with 3 µg RNA/spot.  RNA levels are 
relative to pyrG+.  The results of one representative experiment of 
two biological replicates are shown.  The asterisk ( ) indicates a 
statistically significant difference (p-value <0.05), compared to 
PyrG+, calculated by one-way ANOVA and Tukey comparison test.  
(b) Gliotoxin was measured with RP-HPLC.   
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AMA-gipA.GL, except I grew transformants on YAG supplemented with uridine and uracil 
(described above), 0.2 M sucrose, and 400 µg/ml hygromycin.  I designated these strains 
as AMA.G, AMA-gliZ.G, AMA-gipA.G, AMA-gipB.G, AMA.Z, AMA-gliZ.Z, AMA-gipA.Z, 
AMA-gipB.Z, AMA.A, AMA-gliZ.A, AMA-gipA.A, and AMA-gipB.A.  
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Chapter 3:   
Identification of High-copy Inducers of gliA 
Expression 
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3.1 Introduction 
Although a number of proteins have been shown to affect gliotoxin production in a 
generalized way, no direct regulation through promoter binding has been experimentally 
proven.  Not even the cluster-specific transcription factor, GliZ, has been experimentally 
shown to bind to any promoter regions within the cluster [15].  To identify novel proteins that 
possibly directly regulate the gliotoxin biosynthesis cluster, I performed a high-copy inducer 
screen to identify genes that, when present in extra copies, induced the gliotoxin 
biosynthesis cluster in repressing conditions.  I used a LacZ reporter system, under the 
control of the gliA promoter, for the screen.  GliA encodes an efflux pump within the 
gliotoxin cluster.  I chose gliA for several reasons.  First, it has been shown that expression 
of gliA peaks when the amount of gliotoxin in surrounding medium is maximal [14, 25].  
Second, experiments in the May laboratory have revealed that gliA is induced within 30 
minutes of A. fumigatus germlings being exposed to human neutrophils (Fig. 3.1).  These 
data led me to conclude that gliA expression would be an excellent indicator of gliotoxin 
cluster expression, as well as gliotoxin production. 
 
3.2 Results 
3.2.1 Creation of an Expression Cassette for the High-copy Inducer Screen 
 I created a gliAP-lacZ-gliAT cassette with fusion PCR and cloned this into pDONR 
HPH A, creating vector pDHGL.  This cassette contained 588 base pairs (bp) of the gliA 5’ 
non-coding region (NCR) (gliAP), immediately upstream of the start codon, and 386 bp of 
the gliA 3’ NCR (gliAT), immediately downstream of the stop codon.  I transformed pDHGL 
into Af293.1 and screened for transformants that contained only a single copy of lacZ by 
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Min:    0            30            60   
gliA mRNA 
Figure 3.1. Northern analysis of gliA mRNA transcript levels in 
response to human neutrophils.  Af293 germlings were exposed 
to human neutrophils (1:2) in RPMI with HEPES for 60 min.  
RNA was collected for each time point.  The top panel is the 
Northern hybridization with the gliA coding region used as a 
probe.  The bottom panel is an image of the RNA gel for loading 
control.   
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Southern hybridization (Fig. 2.1a).  This strain was designated Af293.1-GL.  I further 
screened transformants for the ability to produce a blue pigment when grown on non-
repressing medium with X-gal (Fig. 2.1b).  This indicated to us that the lacZ cassette was 
functional and responded to induction of the gliotoxin cluster.   
 
3.2.2 High-copy Inducer Screen:  First Round 
The first round of the high-copy inducer screen involved transforming an A. 
fumigatus genomic library into Af293.1-GL (Fig. 3.2a).  This library was cloned into pRG3-
AMA1-NotI, which is an autonomously replicating plasmid [115].  Due to the presence of 
AMA1 from A. nidulans, this plasmid does not insert into the genome, but remains as a 
circular plasmid [119, 120].  This facilitates the recovery of the plasmid by transformation of 
fungal genomic DNA into bacteria.  This plasmid is also present in anywhere from 10 to 30 
extra copies on average in each haploid genome.  Therefore, this genomic library was an 
ideal choice for our high-copy inducer screen.  I grew transformants on repressing medium 
with X-gal and screened for colonies that produced a blue pigment.  This indicated that the 
AMA1-NotI plasmid within the genome was inducing the gliA-lacZ reporter in repressing 
conditions.  I recovered plasmids from 70 colonies. 
 
3.2.3 High-copy Inducer Screen:  Second Round  
For the second round of the high-copy inducer screen, I transformed 70 individual 
plasmids, isolated in the first round of the high-copy inducer screen, into Af293.1-GL (Fig. 
3.2b).  I again grew transformants on repressing medium with X-gal and screened for  
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Figure 3.2.  Schematic of the three rounds of the high-copy inducer screen.  (a) Round 
one:  transformation of the genomic library into Af293.1-GL.  (b) Round two:  
transformation of single plasmids from the genomic library into Af293.1-GL.  (c) Round 
three:  transformation of single genes into Af293.1-GL. 
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colonies with blue pigment production.  For this round, I transformed individual vectors to be 
sure that the effect I observed from the first round was the result of only one plasmid and 
not multiple plasmids.  Since I transformed single plasmids, I also expected plates to 
contain a high number of colonies producing blue pigment.  I sequenced all 70 plasmids to 
identify what genes were contained within the insert, using primers that flanked the insert 
cloning site (Ama NotI F and Ama NotI R).  To measure LacZ levels in a more quantitative 
manner, I isolated total protein from transformants and measured β-galactosidase activity 
(Fig. 3.3).  I transformed the pDONR AMA empty vector and pDONR AMA-gliZ as a 
negative control (AMA.GL) and positive control (AMA-gliZ.GL), respectively. Based on 
results, I grouped vectors into three categories:  extreme inducing (>70-fold lacZ induction), 
moderate inducing (5 to 70-fold lacZ induction), and low inducing (<5-fold lacZ induction).  
This was based on fold change relative to the AMA.GL negative control.  Of the 70 
plasmids tested, 7 were in the extreme inducing category and 7 were in the moderate 
inducing category (Figure 3.4/Table 3.1).   
 
3.2.4 High-copy Inducer Screen:  Third Round  
The third round of the high-copy inducer screen entailed isolating the individual 
genes from each AMA1-NotI library plasmid and transforming them into Af293.1-GL (Fig. 
3.2c).  For this process, I decided to focus on the extreme inducing plasmids.  Most 
plasmids had anywhere from 1 to 4 genes.  I amplified each gene and cloned it into pDONR 
AMA.  For this round, I did not screen for blue pigment formation, but rather I collected total 
protein from transformants and measured β-galactosidase activity (Fig. 3.5).  The two 
genes that induced lacZ the most were a C2H2 transcription factor (Afu6g01910) and a  
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Figure 3.3. β-galactosidase assays from the second round of the high-copy inducer 
screen.  Data is presented as fold-change relative to AMA.  The results of one 
representative experiment of three independent experiments are shown as mean ± 
SD. 
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Extreme LacZ Inducing Plasmids Moderate LacZ Inducing Plasmids 
Plasmid Locus Gene Plasmid Locus Gene 
S15 
Afu1g10860 Hypothetical 
S16 
Afu1g11890 Serine palmitoyltransferase 2 
Afu1g10870 Cyanamide Hydratase Afu1g11990 PQ Loop repeat protein 
S20 
Afu3g11430 Arginase 
L14 
Afu6g08360 Thiazole biosynthesis enzyme 
Afu3g11440 Glutamyl-tRNA amidotransferase Afu6g08370 
Neutral 
shingomyelinase 
S21 
Afu7g04460 Rab geranlygeranyl transferase Afu6g08380 WD Repeat protein 
Afu7g04470 Hypothetical Afu6g08390 Conserved hypothetical 
Afu7g04480 DNA mismatch repair protein (Msh3) 
L17 
Afu2g01110 Hypothetical 
L7 Afu5g10940 Conserved hypothetical Afu2g01120 DNA Repair protein 
L8 
Afu6g10650 ATP Citrate lyase subunit 1 Afu2g01130 Ubiquitin conjugating enzyme (UbcJ) 
Afu6g10660 ATP Citrate lyase Afu2g01140 GPI Anchored protein 
L12 
Afu6g01900 Hypothetical 
L18 
Afu3g02560 Hypothetical 
Afu6g01905 Hypothetical Afu3g02570 Polyketide synthase 
Afu6g01910 C2H2 Zinc finger domain protein L19 Afu2g01700 
Serine/threonine 
protein kinase (Snf1) 
L13 
Afu4g00300 Hypothetical Afu2g01710 GPI Anchored protein 
Afu4g00310 Hypothetical 
L21 
Afu6g13370 SSU processome component (Utp10) 
Afu4g00320 Sensor histidine kinase/response regulator Afu6g13380 Hypothetical 
Afu4g00330 Hypothetical 
L24 
Afu6g06760 
Eukaryotic translation 
initiation factor 3 
subunit (EifCj) 
  
 Afu6g06770 Enolase 
Figure 3.4. β-galactosidase assays of the extreme inducing group (left panel) and the 
moderate inducing group (right panel). Data is presented as fold-change relative to AMA.  
The results of one representative experiment of three independent experiments are 
shown as mean ± SD. 
Table 3.1.  Genes that were represented in the extreme inducing and moderate 
inducing categories.  
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b 
a 
Figure 3.5. β-galactosidase assays for individual genes from extreme inducing 
plasmids.  Data is presented as fold-change relative to AMA.  (a) All genes from 
the extreme inducing plasmids.  The results of one representative experiment of 
three independent experiments are shown as mean ± SD.  (b) Activity of AMA-
gliZ.GL, AMA-gipA.GL, and AMA-gipB.GL, relative to AMA.GL.  The data 
presented is an average of three biological replicates.  The asterisk ( ) indicates a 
statistically significant difference (p-value <0.05), compared to AMA.GL, 
calculated by one-way ANOVA and Tukey comparison test.   
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hybrid sensor kinase (Afu4g00320); I have designated them gipA and gipB, respectively, for 
gliotoxin inducing protein.  As shown in Figure 3.5b, AMA-gipA.GL, which has extra copies 
gipA, induced a 400-fold increase in LacZ levels and AMA-gipB.GL, which has extra copies 
of gipB, induced a 50-fold increase in LacZ levels, compared to the empty vector control.  
The level of lacZ in our positive control, AMA-gliZ.GL, was almost 30-fold higher than the 
empty vector control, AMA.GL, indicating that GipA and GipB positively regulate gliA 
expression, similar to GliZ. 
 
3.2.5 Isolation and Sequencing of gipA and gipB cDNA 
 Since gipA and gipB are novel genes, I confirmed the gene structure and protein 
sequence through isolation and sequencing of cDNAs for each.  As shown in Figure 3.6a, 
gipA has an open reading frame (ORF) of 1314 bp with one intron and is predicted to 
encode a 419 amino acid protein.  There are two C2H2 regions at the 3’ end, the first as X2-
C-X2-C-X12-H-X3-H and the second as X2-C-X2-C-X12-H-X5-C.  The 5’ untranslated region 
(UTR) of gipA is unusually long (at least 877 bp) with three µORFs and the 3’ UTR of gipA 
consists of at least 360 bp, which indicates that gipA is under post-transcriptional control, 
possibly due to reduced translational efficiency and mRNA stability.  I confirmed the length 
of the 5’ and 3’ UTR using a λ phage library screen, which does not always reveal the full 
length mRNA transcript, but Northern analysis of total RNA verified that the size of the gipA 
transcript is around 2.4 kb, which supports the size I predicted (3.6b).  A Blastp search of 
the entire protein sequence revealed that there are only a few proteins that are homologous 
to GipA, the closest being a C2H2 transcription factor in N. fischeri, a close relative to A. 
fumigatus (Fig. 3.7a).  The rest of the proteins from the Blastp search were from other  
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b    WT        ΔZ        ΔA      A(R)1    A(R)2     ΔB        B(R)1   B(R)2 
6 kb 
4 kb 
3 kb 
 
2 kb 
gipB 
mRNA 
gipA 
mRNA 
Figure 3.6. Characterization of gipA and gipB mRNA.  (a)  
Schematic of mRNA size and composition.  Yellow bars signify 
µORFs.  For gipA, the green bars display the two zinc finger 
domains.  For gipB, the pink bar is the histidine kinase A 
domain, the grey bar is the GHKL domain, and the green bar is 
the response regulator domain.  Sizes indicated for the coding 
regions include introns.  (b) Northern hybridization of gipA and 
gipB from total RNA.  WT is wild-type (Af1160), Δ signifies 
deletion strains, and (R) signifies complemented strains.   
a 
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a 
b 
Figure 3.7. Cladograms of GipA and GipB homologues.  (a) Afu6g01910 is 
GipA, NFIA is N. fischeri, ACLA is A. clavatus, PDIP is P. digitatum, Pc is P. 
chrysogenum, ANI and AN is A. niger, AK is A. kawachii, AO is A. oryzae, and 
AF is A. flavus.  (b) Afu4g00320 is GipB, NFIA is N. fischeri, ACLA is A. 
clavatus, and ANIA is A. nidulans. 
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Aspergillus species and a few Penicillium species, which suggests that GipA is not highly 
conserved at the primary sequence.  The coding region of gipB is 3618 bp with two introns 
and is predicted to encode a protein of 1170 amino acids.  Within the coding region is a 
histidine kinase A (phospho-acceptor) domain, a GHKL (ATPase) domain, and a response 
regulator receiver domain.  Results from the λ phage library screen indicated that the 5’ 
UTR of gipB is 150 bp and contains two µORFs and the 3’ UTR of gipB is 204 bp (Fig. 
3.6a), suggesting that gipB is also possibly under post-transcriptional regulation.  However, 
gipB mRNA appeared to be over 4 kb in size from Northern analysis, indicating that gipB 
could encode UTRs that are longer than what was predicted from the λ phage library 
screen (Fig. 3.6b).  As with gipA, only a few proteins show a high level of similarity to GipB, 
the closest being from N. fischeri, suggesting that GipB is not highly conserved at the 
primary sequence (Fig. 3.7b).   
 
3.2.6 Model of gliA Regulation 
 I offer a model for gliA induction, involving GliZ, the Zn2Cys6 binuclear finger 
transcription factor located within the gliotoxin cluster, GipA, the novel C2H2 transcription 
factor I identified, and AreA, the positive-acting global regulator of nitrogen metabolite 
repression (Fig. 3.8) I propose that GliZ and GipA work together to induce gliA transcription, 
not in a linear pathway, but interdependently.  I also posit that AreA acts as a co-activator of 
gliA expression in nitrogen-specific non-repressing conditions.  To achieve this, AreA likely 
induces gliZ, which is required for the complete induction of the cluster.  Figure 3.9a 
illustrates an example of the differential gene expression observed in the repressing and 
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Figure 3.8. Model for gliA regulation involving GliZ, GipA, and AreA.  (a) I propose that 
GliZ and GipA both work interdependently to induce gliA.  (b) Furthermore, I propose 
that in nitrogen-specific non-repressing conditions, AreA acts to further enhance the 
expression of gliA, likely through induction of gliZ. 
a 
b 
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b 
a 
Figure 3.9. Regulation of gliA and other gliotoxin cluster genes.  (a) 
Differential mRNA transcript levels of gliotoxin cluster genes in 
repressing (CM) and non-repressing (CD) media used in this study.  
(b) Differential mRNA transcript levels of gliotoxin cluster genes in 
nitrogen-specific non-repressing (SN) and nitrogen-specific repressing 
(AT) media.  mRNA levels are displayed relative to actin.  The results 
of one representative experiment of three independent experiments 
are shown as mean ± SD. 
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non-repressing conditions used in this study.  Figure 3.9b shows an example of the 
differential gene expression when cultures are grown in nitrogen-specific repressing or 
nitrogen-specific non-repressing conditions, implicating AreA in the regulation of the 
gliotoxin cluster.  I present this model as a product of the experiments I describe in the 
chapters to follow.  Although this model does not include GipB, the hybrid sensor kinase 
from this study, I will discuss later how GipB could be involved in the regulation of gliA. 
 
3.3 Summary 
 I performed a high-copy library screen in a strain of A. fumigatus that contains a 
lacZ expression plasmid under the control of the gliA promoter.  I screened for plasmids 
that induce lacZ expression in repressing conditions.  Of the 70 plasmids I recovered from 
the screen, 7 were extreme-inducing (>50-fold lacZ induction) and 7 were moderate-
inducing (50 to 5-fold lacZ induction) (Fig. 3.4/Table 3.1).  From the extreme-inducing 
plasmids, I chose two genes for further studies:  gipA, a C2H2 transcription factor, and gipB, 
a hybrid sensor kinase.  High-copy expression of GipA induced lacZ over 400-fold and high-
copy expression of GipB induced lacZ 50-fold, compared to AMA.GL (Fig. 3.5b).   
 Upon sequencing, I discovered that gipA has an unusually long 5’ UTR, which 
contains three µORFs.  This suggests that gipA is under post-transcriptional control, most 
likely involving translational regulation through one or all of the µORFs.  The 3’ UTR of gipA 
is also longer than what is seen on average in fungi (200 bps).  This could be involved in 
targeting of the gipA transcript for Nonsense Mediated Decay (NMD) [121].  Being a C2H2 
transcription factor, gipA contains two DNA binding regions at the 3’ end, the first as X2-C-
X2-C-X12-H-X3-H and the second as X2-C-X2-C-X12-H-X5-C (Fig. 3.6).  There are two µORFs 
in the 5’ UTR of gipB, raising the possibility that gipB, like gipA, is under some form of post-
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transcriptional regulation.  As gipB is a hybrid sensor kinase, three domains are present 
that are involved in signal transduction:  histidine kinase A (phospho-acceptor) domain, a 
GHKL (ATPase) domain, and a response regulator receiver domain (Fig. 3.6).  At the 
protein sequence level, neither GipA nor GipB appear to be highly conserved, as only a few 
proteins in other fungal species showed a high level of similarity, the most conserved being 
in N. fischeri for both proteins (Fig. 3.7).  This does not mean that there are not proteins in a 
variety of other fungal species that function similar to GipA or GipB, as research has shown 
that primary sequences evolve much more rapidly than tertiary sequences.  Therefore, 
there could be a protein in another fungal organism that has a completely dissimilar 
sequence to GipA, but has the exact same folding pattern and consequently functions in a 
similar manner. 
 Based on experiments performed in this study, I propose a model for GipA-mediated 
regulation of gliA, involving GliZ, the Zn(II)2Cys6 transcription factor located within the 
gliotoxin cluster, and AreA, the global positive regulator of nitrogen metabolite repression 
(Fig. 3.8).  My model depicts a situation where GliZ and GipA are both binding to the same 
site, or within close proximity, and interdependently regulating expression of gliA.  I propose 
that AreA is also contributing to the overall induction of gliA by inducing gliZ in nitrogen-
specific non-repressing conditions.   
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Chapter 4:   
Characterization of GipA 
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4.1 Introduction 
 C2H2 DNA binding regions of transcription factors are the most common type of zinc 
finger domains, which are stabilized when bound to a zinc ion [122, 123].  The C2H2 DNA 
binding domain, which forms a ββα structure when folded, is so named for the conserved 
cysteine and histidine residues that bind to the zinc ion (Fig. 4.1).  The consensus 
sequence for the zinc finger domain of these transcription factors is (F/Y)-X-C-X2-5-C-X3-
(F/Y)-X5-Ψ-X2-H-X3-4-H, where X is any amino acid and Ψ is any hydrophobic residue, 
although natural variants that contain a cysteine instead of a histidine as the final zinc-
chelating residue (C2HC) produce the same structure (not to be confused with the C-X2-C-
X4-H-X4-C class of zinc finger proteins, which folds into a completely different structure) 
[122, 123].  One transcription factor can contain multiple zinc finger domains, which are 
often clustered together.  C2H2 zinc finger domains, ubiquitous to all kingdoms, are one of 
the most commonly found domains within eukaryotes.  In fact, recent reports have 
estimated that 3% of genes within humans contain C2H2 zinc finger domains, securing their 
spot as the second most common protein motif [122, 123].  Typically assumed to take part 
in DNA binding, C2H2 zinc finger domains have also been proposed to be capable of 
interacting with RNA and protein [122, 123].   
 
4.2 Results 
4.2.1 High-copy Expression of gipA and Its Effect on Gliotoxin Production 
 As previously shown, high-copy expression of gipA induces lacZ expression, under 
the control of the gliA promoter, which suggests that GipA positively regulates gliA.  Since 
the gliotoxin cluster is co-regulated, I predicted that the other genes within the cluster would 
also be induced in a high-copy gipA strain.  To verify this, I grew AMA.GL,  
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Figure 4.1. The canonical structure of the C2H2 zinc finger domain.  A 
ribbon diagram representing the third C2H2 domain from TFIIIA in 
Xenopus laevis, which shows the stabilization of the ββα fold by the 
interaction of a zinc ion (yellow) with the two cysteine residues (green) 
and two histidine residues (blue).  Reprinted with permission of 
Springer Science and Business Media:  Cell Biochemistry and 
Biophysics [122], copyright 2008. 
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AMA-gliZ.GL, and AMA-gipA.GL in repressing conditions and isolated total RNA from 
mycelia.  I quantified RNA levels of multiple genes within the gliotoxin biosynthesis cluster 
with RNA dot blot analysis.  I also measured gliotoxin levels via RP-HPLC.  As expected, 
AMA-gipA.GL had higher levels of gliA mRNA, compared to AMA.GL, at both 24 and 48 
hours.  Transcript levels of gliA in AMA-gipA.GL were 7-fold higher and 4.5-fold higher, 
compared to AMA.GL, at 24 and 48 hours growth, respectively (Fig. 4.2a & b).  The mRNA 
levels of the other gliotoxin-specific genes tested were also significantly higher in AMA-
gipA.GL, compared to AMA.GL, as gliZ was induced 2-fold and 12-fold, gliP was induced 
4.5-fold and 5-fold, and gliT was induced 8-fold and 2-fold, at 24 and 48 hours of growth, 
respectively.  Gliotoxin levels reflected what was seen with RNA, as AMA-gipA.GL 
produced gliotoxin at higher levels than AMA.GL (7-fold by 24 hours) (Fig. 4.2c).  AMA-
gliZ.GL was the positive control and showed the same pattern as AMA-gipA.GL, with 
respect to induction of the gliotoxin biosynthesis cluster.  Therefore, high-copy expression 
of gipA causes an increase in gliotoxin production in conditions where gliotoxin production 
is repressed.   
 
4.2.2 High-copy Expression of gipA and Its Effect on Growth and Virulence of A. fumigatus 
 Producing extra gliotoxin could possibly prove advantageous to the fungus with 
respect to evading the immune system in a model host, although it could also have 
disadvantages.  For instance, over-expression of gliZ displays a trend of increased death in 
an immune-suppressed murine model of infection [13], but A. fumigatus, if not properly 
protected, is sensitive to the toxic effects of this secondary metabolite, therefore too much 
gliotoxin could harm the fungus rather than help it [27].  Since high-copy expression of gipA  
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b 
c 
a 
Figure 4.2. High-copy 
expression of gipA induces 
gliotoxin production.  All 
cultures were grown in 
repressing conditions.  
Total RNA was isolated 
and quantified by dot blot 
analysis in triplicate.  
Gliotoxin levels were 
quantified by RP-HPLC.  
(a) mRNA transcript levels 
of several gliotoxin cluster 
genes after 24 hours of 
growth.  Each data set is 
normalized to AMA.GL  (b) 
mRNA transcript levels of 
several gliotoxin cluster 
genes after 48 hours of 
growth.  Each data set is 
normalized to AMA.GL.  (c) 
Gliotoxin levels in growth 
medium, normalized to 
AMA.GL.  The asterisk ( ) 
indicates a statistically 
significant difference (p-
value <0.05), compared to 
AMA.GL, calculated by 
one-way ANOVA and 
Tukey comparison test.  
The results of one 
representative experiment 
of three independent 
experiments are shown as 
mean ± SD. 
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results in increased gliotoxin production, I aimed to test whether this affected growth or 
virulence of A. fumigatus.  For growth assays, I inoculated spores of each strain onto rich 
medium (YAG) and minimal medium (MMVAT), as well as minimal medium with exogenous 
gliotoxin.  AMA.GL, AMA-gliZ.GL, and AMA-gipA.GL all grew similarly on all medium tested, 
indicating that growth of the fungus is not affected by high-copy expression of gliZ or gipA 
(Fig. 4.3).  For virulence studies, I infected Toll-deficient D. melanogaster fruit flies by 
needle puncture.  This system has been suggested to mimic a steroid-treated, non-
neutropenic murine model [23, 124].  Neither AMA-gipA.GL nor AMA-gliZ.GL showed a 
statistically significant difference in virulence in the Toll-deficient D. melanogaster model 
system, compared to AMA.GL (Fig. 4.4).  These data suggest that the high-copy expression 
of gipA is not sufficient to alter the mortality in this model system.   
 
4.2.3 Microarray Analysis of GipA regulation  
To expand our view of GipA regulation, a microarray analysis of AMA-gipA.GL vs. 
AMA.GL, grown in repressing conditions for 24 hours, was performed.  Of the 9,436 total 
genes analyzed, 443 genes were up-regulated > 2-fold and 75 genes were down-regulated 
> 2-fold in the AMA-gipA.GL strain, compared to the AMA.GL control.  There were several 
genes common to secondary metabolism clusters (e.g. transporters, oxidoreductases, 
methyltransferases, nonribosomal peptide synthetases and polyketide synthases) up-
regulated (Table 4.1).  30 secondary metabolism clusters have been proposed using 
genomic mapping and microarray techniques [53, 91].  Of these 30 potential secondary 
metabolism clusters, 20 contained at least one gene that was up-regulated > 2-fold in 
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Figure 4.3. High-copy expression of gipA does not significantly affect 
growth of A. fumigatus.  1000 spores were spotted onto each plate and 
incubated at 37°C for 48 hours (YAG) or 72 hours (MMVAT).   
 93 
 
  
 
 
  
Figure 4.4. High-copy expression of gipA does not significantly affect 
virulence of A. fumigatus.  Toll-deficient D. melanogaster fruit flies were 
infected by needle puncture and incubated at 29°C for 7 days.  This 
graph includes three independent virulence assays.   
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Genes Number up-regulated >2-fold 
Transporters/Pumps 20 
NRPS/PKS 9 
Oxidoreductase 5 
Methyltransferase 4 
Acetyltransferase 1 
C6 Transcription Factors 8 
Cluster Cluster range* Product 
1 Afu1g17710-Afu1g17740 Unknown 
2 Afu2g05730-Afu2g05840 Unknown 
3 Afu2g17930-Afu2g18060 Ergot alkaloids:  Festuclavine, Elymoclavine, Fumigaclavines A, B, and C 
4 Afu3g01400-Afu3g01560 Unknown 
5 Afu3g02570-Afu3g02640 Unknown 
6 Afu3g02670-Afu3g02760 Unknown 
7 Afu3g03280-Afu3g03580 Possibly two compounds: (a siderophore and a distinct toxin) 
8 Afu3g12770-Afu3g13000 Putative ETP 
9 Afu3g14690-Afu3g14880 Unknown 
10 Afu3g15250-Afu3g15290 Unknown 
11 Afu4g00210-Afu4g00260 Unknown 
12 Afu4g14440-Afu4g14730 Unknown 
13 Afu5g09940-Afu5g10220 Unknown 
14 Afu5g12720-Afu5g12840 Unknown 
15 Afu6g08540-Afu6g08560 Unknown 
16 Afu6g09580-Afu6g09740 Gliotoxin 
17 Afu6g12040-Afu6g12160 Unknown 
18 Afu7g00120-Afu7g00180 Unknown 
19 Afu8g00100-Afu8g0280 Fumitremorgen B 
20 Afu8g02350-Afu8g02460 Unknown 
Table 4.2. Secondary metabolism clusters I predict to be positively regulated by GipA.  
*Cluster ranges were predicted using SMURF [125] and can be found at 
http://jcvi.org/smurf/index.php.   
Table 4.1. Genes commonly found to be involved in secondary metabolism possibly 
regulated by GipA. 
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AMA-gipA.GL, compared to AMA.GL (Table 4.2). Based on microarray data obtained 
previously [91], loss of laeA, a global regulator of secondary metabolism, affected 13 of 22 
identified secondary metabolite clusters.  This suggests that GipA is not specific to the 
gliotoxin cluster, but potentially acts on numerous other secondary metabolism gene 
clusters in A. fumigatus, similar to LaeA.   
 
4.2.4 Deletion of gipA and Its Effect on Gliotoxin Production 
 Since GipA can induce gliotoxin production, I sought to discover if loss of gipA has 
any effect on the gliotoxin cluster.  I replaced the coding region of gipA with pyrG and 
designated this strain as ΔgipA.  I created a complemented strain, gipA(R), using 
hygromycin (hph) as the selective marker.  I also created a gliZ deletion strain as a control, 
since previous studies have shown that loss of gliZ results in a significant decrease in RNA 
levels of gliotoxin-specific genes [13].  As shown in Figure 4.5a, loss of gipA caused a 
significant decrease in mRNA levels of gliA, gliZ, gliP, and gliT in non-repressing conditions, 
as most genes exhibited close to a 50% reduction.  The gliotoxin biosynthesis cluster is not 
completely dependent on gipA, as there was still RNA being made for the genes I tested.  
The gipA deletion mutant also produced significantly less gliotoxin than the 1160G control 
strain (50% reduction) (Fig. 4.5b), which suggests that gipA may be an important positive 
regulator of gliotoxin production.  Gliotoxin-specific gene expression and gliotoxin 
production of gipA(R) were restored beyond wild-type levels, which demonstrates that the 
effect I observed with the gipA deletion was due to the absence of gipA.  As expected, loss 
of gliZ caused almost a complete loss in gene expression for gliA, gliP, and gliT and 
abolished gliotoxin production.   
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Figure 4.5. Loss of gipA negatively affects gliotoxin production.  All cultures 
were grown for 48 hours in non-repressing conditions.  Total RNA was 
isolated and quantified by dot blot analysis in triplicate.  Gliotoxin levels were 
quantified by RP-HPLC.  (a) mRNA transcript levels of several gliotoxin 
cluster genes.  Each data set is normalized to 1160G.  The results of one 
representative experiment of three independent experiments are shown as 
mean ± SD.  (b) Gliotoxin levels in growth medium, normalized to 1160G.  
The results of one representative experiment of three independent 
experiments are shown.  The asterisk ( ) indicates a statistically significant 
difference (p-value <0.05), compared to 1160G, calculated by one-way 
ANOVA and Tukey comparison test. 
 97 
 
4.2.5 Deletion of gipA and Its Effect on Growth and Virulence of A. fumigatus 
As gipA is important for gliotoxin production, I sought to determine if loss of gipA 
would affect the growth or pathogenicity of A. fumigatus.  Loss of gliT, which plays a role in 
self-protection of the fungus against gliotoxin, results in the inability of A. fumigatus to grow 
in the presence of exogenous gliotoxin [27].  Loss of gipA causes a significant decrease in 
gliT mRNA transcript levels, which could adversely affect the ability of the fungus to grow in 
the presence of exogenous gliotoxin.  Furthermore, deletion of gliP, which is required for 
the biosynthesis of gliotoxin and consequently abolishes gliotoxin production, was found to 
cause a significant attenuation in virulence of A. fumigatus in a Toll-deficient D. 
melanogaster model system [23].  Therefore, a significant reduction in gliotoxin production 
from loss of gipA could negatively affect the virulence of A. fumigatus in this model system.   
Growth of ΔgliZ and ΔgipA on minimal and rich media was comparable to the 1160G 
control, indicating that loss of either gliZ or gipA does not adversely affect radial growth or 
conidiation on the medium tested.  Addition of exogenous gliotoxin (10 µg/ml) did not 
significantly affect the growth of either deletion strain, compared to the 1160G control (Fig. 
4.6).  These data support previous findings that gliT is independently regulated and does 
not require GliZ for self-protection [27].  Furthermore, even though gliotoxin is being 
produced at significantly reduced levels in both ΔgliZ and ΔgipA, there was no statistically 
significant difference in virulence of either deletion strain, compared to 1160G, in a Toll-
deficient D. melanogaster model system (Fig. 4.7), suggesting neither gene is essential for 
A. fumigatus pathogenicity in this model system.  This does not rule out the possibility that 
GipA may affect the ability of A. fumigatus to modulate immune-cell functions, but any 
effects that might be there are not enough to alter the overall mortality rate in the model 
system I tested. 
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Figure 4.6. Loss of gipA does not significantly affect growth of A. 
fumigatus.  1000 spores were spotted onto each plate and 
incubated at 37°C for 48 hours (YAG) or 72 hours (MMVAT).   
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Figure 4.7. Loss of gipA does not significantly affect virulence of A. 
fumigatus.  Toll-deficient D. melanogaster fruit flies were infected by 
needle puncture and incubated at 29°C for 7 days.  This graph includes 
three independent virulence assays.   
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4.2.6 Identification of a DNA Binding Site for GipA 
 Since GipA is a C2H2 transcription factor, it is highly likely that GipA is directly 
binding to DNA.  I sought to identify a consensus sequence and to discover if this sequence 
was present within the gliotoxin biosynthesis cluster.  I fused a GST tag onto the 5’ end of 
the DNA binding region of GipA for a protein-binding microarray analysis (done by Tim 
Hughes’ Laboratory), which identified a consensus DNA binding sequence for GipA (5’-
TNNVMGCCNC-3’) (Fig. 4.8).  This putative sequence is 10 nucleotides, which coincides 
with one complete turn of the DNA double helix.  The protein-binding microarray verified 
direct DNA binding of GipA, as the purified DNA-binding region, and not whole cell extract, 
was analyzed in the microarray.  I analyzed the genomic sequence of the gliotoxin 
biosynthesis cluster to locate potential GipA binding sites.  Indeed, I found variations of this 
consensus sequence scattered throughout the gliotoxin biosynthesis cluster.  In fact, I 
identified a possible GipA binding site within the intergenic region of gliA (5’-
TTGCCGCCAC-3’ 315 bp upstream of the start site), as well as all other gliotoxin-specific 
genes, except gliM.   
 
4.2.7 gliA Promoter Mutagenesis 
To verify that GipA was in fact exerting its effects through this sequence, I mutated 
the GipA binding site on pDHGL, which contains lacZ flanked by the gliA 5’ and 3’ NCRs.  I 
created two mutated binding sites:  SD1 (TTGCCGCCAC  CTGCCGCCAC) and SD2 
(TTGCCGCCAC  TTGGGTGAGC).  I transformed these plasmids into an Af293.1 
background and then transformed pDONR AMA, pDONR AMA-gliZ, and pDONR AMA-gipA 
  
 
Figure 4.8. Consensus sequence representing the putative DNA 
binding site for GipA obtained by protein binding microarray analysis.  
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into each strain.  Therefore, each version of the binding site was exposed to extra copies of 
gliZ (AMA-gliZ.GL, AMA-gliZ.SD1, and AMA-gliZ.SD2), extra copies of gipA (AMA-gipA.GL, 
AMA-gipA.SD1, and AMA-gipA.SD2), or a pDONR AMA empty vector control (AMA.GL, 
AMA.SD1, and AMA.SD2).  The pDONR AMA empty vector control served as a negative 
control.  I grew these strains in both repressing and non-repressing conditions.  Under 
repressing conditions, expression would be based solely on extra copies of the gene within 
the pDONR AMA plasmid or any other transcriptional activator present, while under non-
repressing conditions, expression would show induction of lacZ in response to the 
nutritional environment, as well as the pDONR AMA plasmids.  Two different patterns 
emerged between LacZ levels that were normalized to actin and LacZ levels that were 
additionally normalized to the pDONR AMA control.  The LacZ levels that are normalized to 
actin depict the overall expression of lacZ in each strain, which could be affected by GliZ or 
GipA specifically, but also any other regulatory elements.  By further normalizing data to 
pDONR AMA, I was able to observe induction of lacZ based solely on extra copies of GliZ 
or extra copies of GipA.   
In Figure 4.9a, I present lacZ expression levels of AMA.GL, AMA.SD1, and 
AMA.SD2, relative to actin.  I did not include the data for the pDONR AMA-gliZ or pDONR 
AMA-gipA strains, because all three pDONR AMA strains followed the same pattern, 
regardless of which pDONR AMA vector was being expressed.  In AMA.GL, which harbors 
the wild-type binding site, there was a moderate level of LacZ in repressing conditions.  
This could be due to the presence of endogenous GliZ or GipA, as well as any other 
endogenous inducers specific to gliA expression.  When AMA.GL was grown in non-
repressing conditions, LacZ levels increased 30-fold, compared to repressing conditions 
(Fig. 4.9a).  This is to be expected because the gliotoxin cluster is being induced in these 
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Figure 4.9. GipA and GliZ both induce gliA through the GipA binding site.  Strains 
were grown in stationary cultures.  Total protein was collected from lyophilized 
mycelia and β-galactosidase activity was measured.  (a) LacZ levels of AMA.GL 
in both repressing and non-repressing conditions.  The results of one 
representative experiment of three independent experiments are shown as mean 
± SD.  (b) LacZ levels of each strain in repressing conditions, relative to the AMA 
control.  The results of one representative experiment of six independent 
experiments are shown as mean ± SD.  The asterisk ( ) indicates a statistically 
significant difference (p-value <0.05) for each data set, compared to the AMA 
control strain, calculated by one-way ANOVA and Tukey comparison test.   
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conditions.  Furthermore, carbon sources used in all conditions are known to suppress 
endogenous β-galactosidase activity, therefore the β-galactosidase activity reported in 
these experiments should be specific to the gliAP-lacZ expression plasmid.  AMA.SD1 
displayed decreased expression of lacZ (8-fold in repressing conditions and 4-fold in non-
repressing conditions), compared to AMA.GL (Fig. 4.9a).  This suggests that mutation of 
the single 5’ T residue interferes with the binding of an unknown transcriptional activator.  
This could also be a result of a lower affinity of GipA for the binding site, instead of an 
unidentified transcriptional activator, however if this were the case, I would expect 
AMA.SD2 to have lower β-galactosidase activity, similar to AMA.SD1.  In fact, LacZ levels 
of AMA.SD2 were higher than those of AMA.GL (5-fold in repressing conditions and almost 
2-fold in non-repressing conditions), supporting my hypothesis that an unidentified 
transcriptional activator is being displaced by mutation of the 5’ T residue (Fig. 4.9a).  Since 
the 5’ T residue is present in AMA.SD2, the binding of an unknown transcriptional activator 
would be restored and LacZ levels would increase.  AMA.SD2 harbors a mutation in the 
core region of the GipA binding site, so the increased levels of LacZ in AMA.SD2, 
compared to AMA.GL, could be due to the loss of some form of repression.  The fold 
changes in non-repressing conditions were not as robust as those in repressing conditions, 
but this is to be expected as gliA is also being induced in response to nutritional sources in 
the non-repressing medium. 
Figure 4.9b depicts lacZ expression relative to AMA.GL in repressing conditions.  
With the wild-type binding site, the presence of pDONR AMA-gipA increased LacZ levels 
13-fold, relative to the pDONR AMA control, as to be expected from previous results (Fig. 
4.9b).  With the SD1 binding site, pDONR AMA-gipA also induced lacZ significantly (53-
fold), relative to the pDONR AMA strain (Fig. 4.9b).  The magnitude of induction was 
enhanced with the SD1 mutation when compared to the wild-type binding site (13-fold vs. 
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53-fold, respectively), possibly due to background LacZ levels being lower.  This difference 
in magnitude could also due to an increased affinity of GipA to the DNA binding site, as a 
result of mutating the 5’ T residue to C.  With the SD2 binding site, in which the core region 
has been mutated, the pDONR AMA-gipA strain only weakly induced lacZ (4-fold), as the 
fold-change relative to pDONR AMA was greatly reduced, compared to the wild-type 
binding site (13-fold vs. 4-fold, respectively) (Fig. 4.9b).  This suggests that mutation of a 
core sequence in the binding site significantly reduces the ability of GipA to induce lacZ, 
likely as a result of decreased binding affinity.  When grown in non-repressing conditions, 
LacZ levels of the pDONR AMA-gipA strain were comparable to the pDONR AMA empty 
vector control in all binding site backgrounds (data not shown).  This indicates that induction 
of gliA, in response to nutrient availability, is already sufficiently robust, so extra copies of 
gipA add no further induction.  Interestingly, expression of lacZ in the pDONR AMA-gliZ 
strains followed a similar pattern to that of the pDONR AMA-gipA strains (Fig. 4.9b).  
Therefore, lacZ was induced by GliZ with the wild-type binding site (19-fold) and the SD1 
binding site (93-fold).  The level of induction was enhanced by the SD1 binding site, 
compared to the wild-type binding site (19-fold vs. 93-fold, respectively).  Furthermore, lacZ 
was only weakly induced by GliZ, relative to the pDONR AMA control, when exposed to the 
SD2 binding site (4-fold).  Therefore, mutation of the GipA binding site is also affecting the 
ability of GliZ to induce gliA.   
 
4.3 Summary 
 As a high-copy gipA strain was able to induce lacZ, under the control of the gliA 
promoter, in repressing conditions, I sought to identify what effects this transcription factor 
has on the gliotoxin cluster.  Being a C2H2 transcription factor, I also wanted to determine if 
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GipA is binding to the gliA promoter region to elicit the response I observed.  High-copy 
expression of gipA not only induced gliA, the efflux pump of the gliotoxin cluster, but also 
induced several other genes within the gliotoxin cluster and enhanced production of 
gliotoxin in repressing conditions at both time points, suggesting that GipA plays a positive 
role in regulating the cluster (Fig. 4.2).  This did not significantly affect growth of A. 
fumigatus, nor did it change the virulence of the fungus in a toll-deficient D. melanogaster 
model system, indicating that artificially inducing the gliotoxin cluster through gipA does not 
render the fungus growth deficient or more virulent in the model tested (Fig. 4.3 & 4.4).  
Microarray data revealed that 20 out of 30 possible secondary metabolism clusters in A. 
fumigatus, including the gliotoxin cluster, are also possibly induced in a high-copy gipA 
strain, revealing the possibility that GipA is not strictly regulating the gliotoxin cluster, but 
may be acting as a general regulator of secondary metabolism, similar to LaeA (Table 4.2).   
Furthermore, loss of gipA negatively affected the expression of several gliotoxin-
specific genes, as mRNA transcript levels were reduced close to 50%, compared to a wild-
type strain (Fig. 4.5a).  Gliotoxin production was also significantly reduced in a ∆gipA strain 
in non-repressing conditions, indicating that GipA is important for full induction of the 
gliotoxin cluster in the conditions I tested, but not essential (Fig. 4.5b).  Growth was not 
significantly affected by the loss of gipA, indicating that gipA is not essential to the growth 
rate of the fungus (Fig. 4.6).  The ∆gipA strain did not show an alteration in virulence in a 
Toll-deficient D. melanogaster model, signifying that GipA is not essential to the virulence of 
A. fumigatus, although this does not rule out the possibility that GipA is important in the 
fungal virulence at the cellular level (Fig. 4.7).   
A consensus sequence was identified for GipA in vitro (5’-TNNVMGCCNC-3’), and 
verified in vivo using a gliAP-lacZ expression plasmid and mutagenesis of the GipA DNA 
binding site (Figs. 4.8 & 4.9).  Mutation of the 5’ T residue did not eliminate GipA-mediated 
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lacZ expression, however, mutation of a core region almost completely abolished the ability 
of GipA to induce lacZ.  Interestingly, GliZ-mediated induction of lacZ was also dependent 
on the core region, suggesting that GliZ and GipA signal through the same binding site, or 
at least in close proximity.  Even though the mutation of the 5’ T residue did not negatively 
affect the ability of GipA or GliZ to induce lacZ, it did reduce background levels of lacZ 
expression, suggesting that disrupting the T residue altered binding of an unidentified 
activator.  Cultures were grown in conditions that promote suppression of endogenous β-
galactosidase activity, indicating that my observations were based on lacZ expression 
specifically from the gliAP-lacZ plasmid.    
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Chapter 5:   
Characterization of GipB 
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5.1 Introduction 
 Hybrid sensor kinases are involved in two-component signaling in response to 
external stimuli.  These proteins are termed hybrid sensor kinases because they contain 
both a histidine kinase domain and a response regulator domain [126, 127].  Two-
component systems were first discovered in prokaryotes and entail two elements:  (1) a 
sensor histidine kinase that is autophosphorylated, in response to external signals, at a 
conserved histidine residue and (2) a response regulator that obtains the activation signal 
from the sensor histidine kinase via phosphorylation of a conserved aspartate residue [126, 
127].  Although these two-component systems remain highly similar in different genera, 
fungal two-component systems are different, in that they involve three elements:  (1) a 
hybrid sensor kinase, which is composed of a histidine kinase domain and a response 
regulator domain, (2) a histidine-containing phosphotransfer (HPt) domain, and (3) a 
separate response regulator [126, 127].   
As with bacterial two-component systems, the histidine kinase domain 
autophosphorylates at a conserved histidine residue, after which the phosphate is relayed 
to an aspartate residue located in the response regulator domain of the same protein [126, 
127].  The phosphate is then relocated to the HPt protein, at a conserved histidine residue, 
and is subsequently transferred to the second response regulator, again to an aspartate 
residue.  Downstream targets of this two-component signaling network can either be 
directly modulated by the second response regulator protein or they can be activated by a 
signaling cascade, oftentimes a MAPK pathway, responding to the response regulator 
protein [126, 127] (Fig. 5.1).  This system of two-component phosphorelay has been 
reported in prokaryotes and lower eukaryotes, but not the animal kingdom, as sensor-type 
histidine kinases have not been discovered, making these proteins unique targets for 
antimicrobial therapies [126, 127].   
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Figure 5.1. General regulatory mechanism of a fungal hybrid 
sensor kinase, involving the HOG MAPK pathway.  
Abbreviations: HK, histidine KD; RR, response regulator receiver 
domain; S/T kinase, Ser/Thr protein KD; SBD, Ssk2/Ssk22 
binding domain; HDS, Hog1 docking site; S/T-Y KD, Ser/Thr and 
Tyr dual-protein KD.  Reprinted with permission of American 
Society for Microbiology:  Eukaryotic Cell [127], copyright 2008. 
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One of the best-characterized fungal two-component systems is the Sln1-Ypd1-
Ssk1 phosphorelay system in S. cerevisiae.  Sln1, a transmembrane hybrid sensor kinase 
that serves as an osmosensor, transfers a phosphoryl group to Ypd1, the HPt protein [55, 
126, 127].  Under normal conditions, Ssk1, the response regulator, remains constitutively 
phosphorylated via Sln1 and Ypd1, which renders it inactive.  However, under hyperosmotic 
shock, Ssk1 becomes dephosphorylated, through down-regulation of the Sln1-Ypd1-
dependent phosphorylation, which allows Ssk1 to activate the HOG pathway via interaction 
with the MAPKKK, Ssk2 [55, 126, 127].  Some hybrid sensor kinases are transmembrane 
domains, while others lack transmembrane regions and therefore remain cytosolic.  Of the 
cytosolic hybrid sensor kinases that have been studied so far in filamentous fungi, most 
appear to be more important in regulating morphogenesis and developmental processes 
than the transmembrane histidine kinases [127].  
 
5.2 Results 
5.2.1 High-Copy Expression of gipB and Its Effect on Gliotoxin Production 
 Similar to what is seen with gipA, high-copy expression of gipB induces lacZ 
expression, under the control of the gliA promoter, which suggests that GipB positively 
regulates gliA.  Since the gliotoxin cluster is co-regulated, I predicted that the other genes 
within the cluster would also be induced in a high-copy gipB strain.  To test the effect of 
gipB on the gliotoxin cluster, I performed RNA dot blot analysis and measured gliotoxin 
production as described for gipA.  Comparable to what I observed with gipA, extra copies of 
gipB (AMA-gipB.GL) caused an increase in transcription of several genes within the 
gliotoxin cluster at 24 hours, but not after 48 hours of growth (Fig. 5.2a).  Furthermore,  
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Figure 5.2. High-copy 
expression of gipB induces 
gliotoxin production at 24 
hours growth, but not 48 
hours growth.  All cultures 
were grown in repressing 
conditions.  Total RNA was 
isolated and quantified by 
dot blot analysis in triplicate.  
Gliotoxin levels were 
quantified by RP-HPLC.  (a) 
mRNA transcript levels of 
several gliotoxin cluster 
genes after 24 hours of 
growth.  (b) mRNA 
transcript levels of several 
gliotoxin cluster genes after 
48 hours of growth.  Each 
data set for (a) and (b) is 
normalized to AMA.GL.  
The results of one 
representative experiment 
of three independent 
experiments are shown as 
mean ± SD.  (c) Gliotoxin 
levels in growth medium, 
normalized to AMA.GL.  
The results of one 
representative experiment 
of three independent 
experiments are shown.  
The asterisk ( ) indicates a 
statistically significant 
difference (p-value <0.05), 
compared to AMA.GL, 
calculated by one-way 
ANOVA and Tukey 
comparison test. 
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gliotoxin was made at higher levels in AMA-gipB.GL at both time points, compared to the 
AMA.GL control (Fig. 5.2b).  The lack of induction of gliotoxin-specific genes after 48 hours 
growth suggests that GipB is not activated during the later phase of asexual development.  
Although gene expression was not affected by high-copy expression of gipB after 48 hours 
growth, a higher amount of gliotoxin was detected in the surrounding medium, compared to 
the AMA.GL strain (Fig. 5.2c).  This is not surprising as high-copy expression of gipB did 
induce gliotoxin production after 24 hours growth, therefore the gliotoxin detected at 48 
hours growth was likely produced at an earlier time point.  The level of induction was not as 
robust as in AMA-gipA.GL, which is to be expected, as GipB is a hybrid sensor kinase 
possibly acting upstream of several proteins.   
 
5.2.2 High-copy Expression of gipB and Its Effect on Growth and Virulence of A. fumigatus 
 Since high-copy expression of gipB results in increased gliotoxin production at 24 
hours, I aimed to test whether this affected growth or virulence of A. fumigatus, as 
dysregulation of the gliotoxin cluster could cause adverse effects.  Furthermore, over-
expression of gliZ displays a trend towards increased death in an immune-suppressed 
murine model of infection [13].  For growth assays, I inoculated 1000 spores of each strain 
onto rich medium (YAG) and minimal medium (MMVAT), as well as minimal medium with 
exogenous gliotoxin.  AMA-gipB.GL grew similarly on all medium tested, indicating that 
high-copy expression of gipB does not affect radial growth of A. fumigatus (Fig. 5.3).  For 
virulence studies, I infected Toll-deficient D. melanogaster fruit flies by needle puncture.  
This system has been suggested to mimic a steroid-treated, non-neutropenic murine model 
[23, 124].  There was no statistically significant difference in virulence between 
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Figure 5.3. High-copy expression of gipB does not significantly 
affect growth of A. fumigatus.  1000 spores were spotted onto 
each plate and incubated at 37°C for 48 hours (YAG) or 72 
hours (MMVAT).   
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AMA-gipB.GL and AMA.GL, which suggests that gipB does not contribute to the virulence 
of A. fumigatus in this model system (Fig. 5.4).   
 
5.2.3 Deletion of gipB and Its Effect on Gliotoxin Production 
 I also wanted to test the effects of gipB deletion on gliotoxin production.  As with 
gipA, I created a gipB deletion strain by replacing the coding region of gipB with pyrG.  I 
designated this mutant as ΔgipB.  I also created a strain complemented for gipB 
expression, gipB(R).  As shown in Figure 5.5a, loss of gipB did not drastically reduce the 
RNA levels of the gliotoxin cluster genes I tested.  There was a 10% reduction for gliA and 
gliZ mRNA, a 30% reduction for gliT mRNA, and almost a 2-fold increase in gliP mRNA.    
Gene expression was restored to 1160G control levels in the gipB(R) strain, indicating that 
the effects I observed were specific to the loss of gipB.  Furthermore, gliotoxin levels were 
reduced by 10% in the ΔgipB mutant, compared to the 1160G parent strain and the gipB(R) 
complement (Fig. 5.5b).  These data suggest that gipB is important for full induction of the 
gliotoxin cluster, but not essential.  The minor level of reduction observed with the genes 
tested is not surprising as GipB is likely acting upstream of several proteins and could 
possibly be redundant for another hybrid sensor kinase.  Furthermore, GipB is possibly only 
activated during earlier phases of conidiation, making it likely that its activity is not essential 
to gliotoxin production in later phases of conidiation or other conditions.   
 
  
 116 
 
  
Figure 5.4. High-copy expression of gipB does not significantly affect 
virulence of A. fumigatus.  Toll-deficient D. melanogaster fruit flies were 
infected by needle puncture and incubated at 29°C for 7 days.  This 
graph includes three independent virulence assays.   
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Figure 5.5. Loss of gipB does not significantly affect gliotoxin production.  All 
cultures were grown for 48 hours in non-repressing conditions.  Total RNA was 
isolated and quantified by dot blot analysis in triplicate.  Gliotoxin levels were 
quantified by RP-HPLC.  (a) mRNA transcript levels of several gliotoxin cluster 
genes.  Each data set is normalized to 1160G.  The results of one representative 
experiment of three independent experiments are shown as mean ± SD.  (b) 
Gliotoxin levels in growth medium, normalized to 1160G.  The results of one 
representative experiment of three biological replicates are shown.  The asterisk ( ) 
indicates a statistically significant difference (p-value <0.05), compared to 1160G, 
calculated by one-way ANOVA and Tukey comparison test. 
 118 
 
5.2.4 Deletion of gipB and Its Effect on Growth and Virulence of A. fumigatus 
Even though loss of gipB did not exhibit a dramatic effect on gliotoxin production, I 
aimed to determine if GipB is important for growth and virulence of A. fumigatus.  I 
inoculated 1000 spores of 1160G, ∆gliZ, ∆gipB, and gipB(R) onto rich medium (YAG), 
minimal medium (MMVAT), and MMVAT with exogenous gliotoxin.  Deletion of gipB did not 
drastically affect growth of A. fumigatus, which suggests that GipB does not play a major 
role in growth of the fungus (Fig. 5.6).  For virulence studies, I infected Toll-deficient D. 
melanogaster fruit flies by needle puncture, as described previously.  Loss of gipB did not 
affect virulence of A. fumigatus in a Toll-deficient D. melanogaster model system, compared 
to the 1160G parent strain, indicating that loss of gipB does not attenuate the virulence of 
this fungus (Fig. 5.7).  This does not rule out the possibility that loss of gipB could be 
affecting the ability of A. fumigatus to effectively combat host immune cells. 
 
5.3 Summary 
 To uncover the effects of GipB on gene regulation of the gliotoxin cluster and 
gliotoxin production, I measured mRNA transcript levels of several genes within the cluster, 
as well as gliotoxin levels in the surrounding medium.  High-copy expression of gipB 
increased mRNA levels of several genes in the gliotoxin cluster after 24 hours growth in 
repressing conditions, compared to the control strain, although this effect was not observed 
after 48 hours growth (Fig. 5.2a).  Furthermore, gliotoxin was produced at higher levels with 
high-copy expression of gipB, compared to the control strain (Fig. 5.2b).  This indicates that 
GipB does act to induce the gliotoxin biosynthetic cluster, but not as strongly as GipA, 
which is not surprising as GipB is a hybrid sensor kinase likely acting upstream of other  
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Figure 5.6. Loss of gipB does not significantly affect growth of A. 
fumigatus.  1000 spores were spotted onto each plate and 
incubated at 37°C for 48 hours (YAG) or 72 hours (MMVAT). 
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Figure 5.7. Loss of gipB does not significantly affect virulence of A. 
fumigatus.  Toll-deficient D. melanogaster fruit flies were infected by 
needle puncture and incubated at 29°C for 7 days.  This graph includes 
three independent virulence assays.   
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proteins.  This could also indicate that GipB is only activated during specific stages of 
development, as high-copy expression during the later phase of conidiation did not induce 
the gliotoxin cluster. 
Deletion of gipB had a slight negative effect on the gliotoxin cluster, as gliotoxin 
levels were reduced by 10% in the ∆gipB mutant in non-repressing conditions, compared to 
the control strain (Fig. 5.5b).  These data suggest that GipB activity is not essential to 
gliotoxin production in the conditions tested.  Neither the high-copy gipB strain nor the 
∆gipB grew differently than the control strain on rich or minimal medium (Fig. 5.3 & 5.6).  
Therefore differential expression of gipB does not affect normal growth in A. fumigatus.  In 
addition, all strains tested were not significantly different in virulence, compared to the 
control strain.  This indicates that alterations in gipB expression do not make A. fumigatus 
significantly more or less virulent in the Toll-deficient D. melanogaster model (Fig. 5.4 & 
5.7).   
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Chapter 6:   
GliZ, GipA, and GipB:  Independent or 
Interdependent? 
 123 
 
6.1 Introduction 
 In chapter 3, I presented a model for gliA regulation, involving GliZ, GipA, and AreA 
(Fig. 3.8a).  In this model, I propose that GliZ and GipA are both binding to the promoter 
region of gliA to induce gene expression, not in an independent fashion, but 
interdependently, in which both proteins bind in close proximity and require the presence of 
the other for signaling.  In the conditions tested, non-repressing medium contained sodium 
nitrate, instead of ammonium tartrate, releasing nitrogen metabolite repression.  As shown 
in Figure 3.9b, a non-preferred nitrogen source causes induction of the gliotoxin cluster, 
indicating that AreA is acting on the gliotoxin cluster to induce gene expression.  This most 
likely occurs via AreA-mediated induction of gliZ first, possibly followed by direct binding of 
AreA to promoter regions of other genes in the cluster.  There is an AreA recognition 
sequence in the gliA promoter, 37 base pairs upstream of the ATG start site, which could 
indicate that AreA is directly binding to the promoter of gliA, although this may not be likely 
as the recognition element is so close to the ATG start site for gliA (Fig. 6.1).  This model 
was proposed based on the experiments performed for this project.   
As discussed in Chapter 4, mutation of the core region within the GipA recognition 
sequence in the gliA promoter drastically reduced both GliZ- and GipA-dependent lacZ 
expression, indicating that both proteins rely on this binding site for activity.  Upon further 
examination, I discovered that the GipA recognition sequence is embedded within a 
potential GliZ binding site, which supports my proposed model that both proteins are 
binding in close proximity (Fig. 6.1).  This does not, however, give evidence of an 
interdependent relationship between GliZ and GipA, as these two proteins could possibly 
be binding at separate times and inducing gliA independently. 
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Figure 6.1. Layout of the GipA/GliZ binding sites in the gliA promoter 
region, relative to the gliA start site. GliZ tandem repeats are purple and 
the GipA DNA binding site is underlined in orange.  The AreA recognition 
element is signified by the yellow triangle. 
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6.2 Results 
6.2.1 A ΔgliZ/ΔgipA Double Mutant and Its Effect on Gliotoxin Production 
 I created a double deletion mutant, ΔgliZ/ΔgipA and measured RNA levels via dot 
blot analysis and gliotoxin production via RP-HPLC in non-repressing conditions.  I sought 
to determine if GipA and GliZ signal independently of each other or work together within a 
pathway.  The gliZ/gipA double deletion mutant revealed a pattern of gene expression 
similar to the gliZ single deletion mutant (Fig. 6.2a).  Furthermore, gliotoxin production in 
the double mutant was abolished, similar to what I observed in the gliZ single deletion strain 
(Fig. 6.2b).  These results indicate that GipA is signaling cooperatively with GliZ and not 
independently, but it’s not completely clear from these data.  RNA levels and gliotoxin levels 
were already so low with the gliZ deletion strain, an additive effect could be difficult to 
identify for the gliZ/gipA double mutant.   
 
6.2.2 A ΔgliZ/ΔgipA Double Mutant and Its Effect on Growth and Virulence of A. fumigatus 
Both ΔgliZ and ΔgipA single deletion mutants grew comparable to the control strain, 
so I tested the growth of the ΔgliZ/ΔgipA mutant by inoculating 1000 spores onto YAG, 
MMVAT, and MMVAT with exogenous gliotoxin.  The growth of ΔgliZ/ΔgipA appeared 
comparable to 1160G, signifying that loss of both gliZ and gipA does not adversely affect 
growth of A. fumigatus, even in the presence of exogenous gliotoxin (Fig. 6.3).  
Furthermore, neither ΔgliZ nor ΔgipA display a statistically significant difference in virulence, 
compared to 1160G, so I sought to verify if this would be the same case with a ΔgliZ/ΔgipA 
double mutant.  Indeed, the ΔgliZ/ΔgipA mutant did not show statistically significant  
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b 
Figure 6.2. Loss of gliZ and gipA negatively affects gliotoxin production.  All cultures 
were grown for 48 hours in non-repressing conditions.  Total RNA was isolated and 
quantified by dot blot analysis in triplicate.  Gliotoxin levels were quantified by RP-
HPLC.  (a) mRNA transcript levels of several gliotoxin cluster genes.  Each data set 
is normalized to 1160G.  The results of one representative experiment of three 
independent experiments are shown as mean ± SD.  (b) Gliotoxin levels in growth 
medium, normalized to 1160G.  The results of one representative experiment of 
three biological replicates are shown.  The asterisk ( ) indicates a statistically 
significant difference (p-value <0.05), compared to 1160G, calculated by one-way 
ANOVA and Tukey comparison test. 
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Figure 6.3. Loss of gliZ and gipA does not significantly affect growth 
of A. fumigatus.  1000 spores were spotted onto each plate and 
incubated at 37°C for 48 hours (YAG) or 72 hours (MMVAT).   
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attenuation of virulence in a Toll-deficient D. melanogaster model system (Fig. 6.4). 
Therefore, no adverse additive effects were observed with respect to virulence in the model 
I tested. 
 
6.2.3 A ΔgipA/ΔgipB double mutant and Its Effect on Gliotoxin Production 
I created a ΔgipA/ΔgipB double deletion mutant and grew this strain, along with 
controls, in non-repressing conditions.  I measured RNA levels via dot blot analysis and 
gliotoxin levels via RP-HPLC to determine if GipA and GipB are signaling independently of 
each other or in a linear pathway.  RNA levels of the gliotoxin-specific genes in the 
gipA/gipB double deletion mutant were similar to what I observed in the ΔgipA single mutant 
(Fig. 6.5a).  Gliotoxin was also being produced in ΔgipA/ΔgipB at an amount comparable to 
the ΔgipA single mutant (50% reduction compared to 1160G) (Fig. 6.5b).  These data 
suggest that there is no additive effect when removing both GipA and GipB from the 
genome, although loss of gipB alone does not produce a significant decrease in gliotoxin 
production.  Therefore, these two proteins possibly work in a pathway and do not signal 
independent of each other.   
 
6.2.4 A ΔgipA/ΔgipB double mutant and Its Effect on Growth and Virulence of A. fumigatus 
I sought to determine if the ΔgipA/ΔgipB double mutant would have an abnormal 
phenotype on rich or minimal medium.  The ΔgipA/ΔgipB mutant grew at a similar rate to 
the 1160G control, but loss of both gipA and gipB appeared to negatively affect condiation  
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Figure 6.4. Loss of gliZ and gipA does not significantly affect 
virulence of A. fumigatus.  Toll-deficient D. melanogaster fruit flies 
were infected by needle puncture and incubated at 29°C for 7 days.  
This graph includes three independent virulence assays.   
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Figure 6.5. Loss of gipA and gipB negatively affects gliotoxin production.  All cultures were 
grown for 48 hours in non-repressing conditions.  Total RNA was isolated and quantified by dot 
blot analysis in triplicate.  Gliotoxin levels were quantified by RP-HPLC.  (a) mRNA transcript 
levels of several gliotoxin cluster genes.  Each data set is normalized to 1160G.  The results of 
one representative experiment of three independent experiments are shown as mean ± SD.  (b) 
Gliotoxin levels in growth medium, normalized to 1160G.  The results of one representative 
experiment of three biological replicates are shown.  The asterisk ( ) indicates a statistically 
significant difference (p-value <0.05), compared to 1160G, calculated by one-way ANOVA and 
Tukey comparison test. 
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(Fig. 6.6).  Indeed, when spores/cm2 was calculated, the ΔgipA/ΔgipB mutant poduced 
approximately 50% less spores than the 1160G control when grown on rich medium.  This 
significant reduction in spore number was not observed for either the ΔgipA or ΔgipB single 
deletion mutants, suggesting that in regards to conidiation, gipA and gipB are possibly 
involved in separate pathways.  Furthermore, I performed a virulence assay with the 
ΔgipA/ΔgipB mutant to establish if loss of both genes affected virulence of A. fumigatus. 
The ΔgipA/ΔgipB double mutant did not show a statistically significant attenuation in 
virulence in a Toll-deficient D. melanogaster model system, compared to the 1160G control, 
indicating that the compound loss of both GipA and GipB does not alter the ability of the 
fungus to kill Toll-deficient fruit flies (Fig. 6.7).   
 
6.2.5 High-copy Expression of GipA and GipB in a gliZ deletion background 
 I performed a series of experiments to determine if GipB or GipA are dependent on 
GliZ for signaling.   I created two strains in Af293.1:  (1) pyrG+ (wild-type background) and 
(2) ΔgliZ.1 (∆gliZ background).  Into each of these strains, I transformed pDONR AMA 
(AMA.G, AMA.Z), pDONR AMA-gliZ (AMA-gliZ.G, AMA-gliZ.Z), pDONR AMA-gipA (AMA-
gipA.G, AMA-gipA.Z), and pDONR AMA-gipB (AMA-gipB.G, AMA-gipB.Z) to produce 
strains with extra copies of GliZ, GipA, or GipB in a wild-type or gliZ deletion background 
(strains and genotypes are listed in Table 2.2).  High-copy expression of gliZ served as a 
control, as extra copies of GliZ would rescue for loss of gliZ.  I grew all strains in non-
repressing conditions for 48 hours and quantified RNA levels of gliotoxin-specific genes 
(gliA and gliP) by RNA dot blot analysis.  For this experiment, I present data that is 
normalized to AMA.G, as this strain is the empty vector control in the wild-type background. 
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Figure 6.6. Loss of gipA and gipB negatively affects conidiation in A. 
fumigatus.  1000 spores were spotted onto each plate and incubated at 
37°C for 48 hours (YAG) or 72 hours (MMVAT).   
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Figure 6.7. Loss of gipA and gipB does not significantly affect virulence 
of A. fumigatus.  Toll-deficient D. melanogaster fruit flies were infected 
by needle puncture and incubated at 29°C for 7 days.  This graph 
includes three independent virulence assays.   
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            In the pyrG+ background, AMA-gliZ.G, AMA-gipA.G, and AMA-gipB.G had 
increased mRNA levels for gliP, while only AMA-gipA.G had increased mRNA levels for 
gliA, compared to AMA.G (Fig. 6.8).  These changes were slight because growth in non-
repressing conditions already induced these genes to high levels, so having extra copies of 
GipA or GipB did not greatly contribute to gene expression.  In AMA.Z, mRNA levels for 
both gliA and gliP were almost completely undetectable, as to be expected from previous 
experiments.  High-copy expression of gliZ brought transcript levels of both genes back to 
AMA.G levels (Fig. 6.8).  AMA-gipA.Z displayed a reduction in mRNA levels similar to 
AMA.Z.  For gliA, the level of mRNA present in AMA-gipA.Z was slightly higher (close to 5-
fold) than what was observed for AMA.Z.  However, the level of gliP RNA did not exceed 
that of the AMA.Z empty vector control.  Therefore, GipA was not able to induce gliA or gliP 
in the absence of GliZ.  Additionally, transcription of both gliA and gliP in AMA-gipB.Z did 
not reach levels above AMA.Z (Fig. 6.8).  This suggests that GliZ is required for GipA to 
induce both gliP and gliA.  Furthermore, the lack of gliA and gliP induction in AMA-gipB.Z 
indicates that GliZ is required for GipB-mediated signaling for both genes.   
 
6.2.6 High-copy expression of GliZ and GipB in a gipA deletion background 
 I created two strains in Af293.1:  (1) pyrG+ (wild-type background), and (2) ∆gipA.1 
(∆gipA background).  Into each of these strains, I transformed pDONR AMA (AMA.G, 
AMA.A), pDONR AMA-gliZ (AMA-gliZ.G, AMA-gliZ.A), pDONR AMA-gipA (AMA-gipA.G, 
AMA-gipA.A), and pDONR AMA-gipB (AMA-gipB.G, AMA-gipB.A).  AMA-gipA served as a 
control, as high-copy expression of gipA should rescue for loss of gipA.  As described 
above, strains were grown in non-repressing conditions and RNA was quantified by RNA 
dot blot analysis.  Data presented are normalized to AMA.G. 
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Figure 6.8. GliZ and GipA are dependent on each other for gliA induction.  Cultures 
were grown in non-repressing conditions and RNA was quantified by dot blot 
analysis in triplicate.  Data are normalized to AMA.G (pyrG+ background).  These 
graphs are an average of three biological replicates.  (a) mRNA levels of gliA in all 
backgrounds.  (b) mRNA levels of gliP in all backgrounds.  The asterisk ( ) indicates 
a statistically significant difference (p-value <0.05), compared to AMA.G, calculated 
by one-way ANOVA and Tukey comparison test. 
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 As expected from previous experiments, mRNA levels in AMA.A of both gliA and 
gliP were reduced significantly, 50% and 80%, respectively.  RNA levels of gliP in AMA-
gliZ.A were comparable to those of AMA.G; however RNA levels of gliA were not 
significantly higher than background levels (AMA.A) (Fig. 6.8).  This indicates that GliZ is 
not dependent on GipA for induction of gliP, however induction of gliA by GliZ does appear 
to be dependent on GipA.  Moreover, RNA levels of both gliA and gliP in AMA-gipB.A were 
not significantly higher than those in AMA.A.  Although gliP did have a slight increase in 
gene expression in AMA-gipB.A (1.5-fold), it did not reach the level of gliP in the wild-type 
background (Fig. 6.8b).  Therefore, GipB appears to be dependent on GipA for full gliA and 
gliP induction.  An alternative interpretation of the high-copy gipB results are discussed in 
the next chapter.    
 
6.3 Summary 
 To determine if GliZ, GipA, and GipB are part of a single pathway, I performed a 
series of epistasis and bypass suppression experiments.  Transcript levels of several 
gliotoxin-specific genes were reduced in the ∆gliZ/∆gipA mutant to the level of the single 
∆gliZ strain, as were gliotoxin levels in the surrounding medium (Fig. 6.2).  This suggests 
that deletion of both gliZ and gipA does not produce an additive effect in gene expression 
or gliotoxin production and that signaling of both proteins is through GliZ, although loss of 
gliZ causes such as severe reduction in gliotoxin production that an additive effect from the 
additional deletion of gipA might be difficult to discern.  No additive effects were observed 
with regards to the growth of the fungus on different media or with the virulence of the 
fungus in a Toll-deficient D. melanogaster model system, further supporting the idea of GliZ 
and GipA working interdependently and not separately (Fig. 6.3 & 6.4).  In the ∆gipA/∆gipB 
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mutant, mRNA transcript levels of the gliotoxin-specific genes tested were comparable to 
the single ∆gipA strain, as were gliotoxin levels in the surrounding medium (Fig. 6.5).  This 
indicates that deletion of both gipA and gipB does not cause an additive effect in gene 
expression or gliotoxin production and that GipB acts upstream of GipA, supporting the idea 
that they are both involved in a linear pathway with regards to gliotoxin production.  Even 
though the ∆gipA/∆gipB double mutant grew at a rate similar to the 1160G control strain on 
all media tested, sporulation appeared to be negatively affected by loss of both genes on 
rich medium (Fig. 6.6).  The ∆gipA/∆gipB mutant exhibited a mortality rate similar to the 
1160G control in the Toll-deficient D. melanogaster model system, suggesting that 
virulence of the fungus is not affected by loss of both genes (Fig. 6.7). 
 The gliA promoter mutagenesis experiments revealed that both GliZ and GipA are 
dependent on a single binding site for induction of gliA expression. Therefore, I sought to 
determine if GliZ is dependent on GipA for induction of gliA and vice versa.  I also 
measured gliP mRNA transcript levels to determine if what I have observed is unique to gliA 
regulation or also affected other genes of the gliotoxin cluster.  In a ∆gliZ background, high-
copy expression of gipA did not raise mRNA transcript levels of gliP above basal levels, 
although it did slightly increase (almost 5-fold) mRNA transcript levels of gliA (Fig. 6.8).  
This suggests that GliZ is required for GipA-mediated induction of both gliP and gliA, 
although it appears that GipA can stimulate a slight elevation in gliA expression 
independent of GliZ.  Furthermore, high-copy expression of gipB in a ∆gliZ background did 
not result in an increase in gliP or gliA mRNA above basal levels, indicating that GliZ is 
required for GipB-mediated induction of both gliP and gliA (Fig. 6.8).  These results are not 
entirely surprising, as in-cluster transcription factors are usually essential for expression of 
other genes in the cluster.   
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In a ∆gipA background, high-copy expression of gliZ caused an increase in gliP 
mRNA transcript to wild-type levels.  Surprisingly, gliA mRNA transcript levels in the high-
copy gliZ strain were comparable to basal levels, suggesting that GliZ induces gliP 
independent of GipA, but cannot induce gliA in the absence of GipA (Fig. 6.8).  
Furthermore, high-copy expression of gipB in a ∆gipA background only slightly increased 
gliP mRNA levels above basal levels (1.5-fold) and gliA mRNA levels did not exceed basal 
levels, indicating that GipB-mediated induction of both gliP and gliA is dependent on GipA 
(Fig. 6.8).   
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Chapter 7:   
General Discussion 
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 Although recent studies have revealed gliotoxin intermediates, which have led to a 
better understanding of the biosynthesis of gliotoxin, information on regulation of the genes 
involved in the biosynthesis pathway is lacking [92].  There have been a number of proteins 
shown to affect gliotoxin production, but these have only been studied in a general way [13, 
22, 23, 32, 50, 64, 91, 107-109, 128, 129].  No proteins have been demonstrated to bind 
directly to the gliotoxin cluster, not even GliZ, the in-cluster transcription factor [15].  The 
goal of this project was to uncover novel proteins that regulate gliotoxin production in A. 
fumigatus and to possibly piece together a signaling pathway that responds to external or 
internal signals.  I have performed a high-copy inducer screen and uncovered two proteins, 
GipA and GipB, which appear to be involved in the regulation of the gliotoxin cluster. 
 
7.1 Characterization of GipA  
GipA is a C2H2 transcription factor, which harbors a long 5’ UTR (at least 877 bps) 
and a moderate 3’ UTR (at least 360 bps).  Furthermore, there are three µORFs within the 
5’ UTR, which suggests that gipA could be under post-transcriptional regulation (Fig. 3.6a).  
The length of 5’ UTRs appears to remain invariable between taxonomic classes, ranging 
from 100 to 200 nucleotides on average, however 3’ UTRs can be more variable, ranging 
from 200 nucleotides in plants and fungi to 800 nucleotides in vertebrates [130].  Many 
proteins that are tightly regulated, such as growth factors, transcription factors, or proto-
oncogenes, are encoded by messenger RNAs containing 5’ UTRs that are longer than 
average, with µORFs and stable secondary structures that negatively affect translation 
efficiency and mRNA stability [130].  RNA levels of gipA remained relatively low in all 
growth conditions tested, which further supports controlled regulation of this gene (data not 
shown).  µORFs can affect translation efficiency in several ways, such as preemptively 
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initiating translation, affecting ribosome reinitiation, or causing arrest of translational 
machinery [80].  For instance, reinitiation of translation is reduced as the µORF length is 
increased, as shown in mammalian systems.  In addition, one group demonstrated a linear 
relationship between µORF length and translation of downstream ORFs, whereas longer 
µORFs decreased translation of the downstream ORFs in human immunodeficiency virus 
type 1 [131].   
Of the three µORFs within the 5’ UTR of gipA, the first is 7 codons, the second is 33 
codons, and the third is 4 codons.  Interestingly, the first µORF overlaps with the second, 
longer µORF (Fig. 3.6a).  Perhaps in certain situations where gipA translation is favorable, 
the translational machinery targets the first µORF, causing the second µORF to be passed 
over and favoring reinitiation at the gipA start codon, whereas in situations where gipA 
translation is unfavorable, the translational machinery targets the second µORF, preventing 
reinitiation downstream.  This could possibly be tested through mutational analysis of each 
µORF in the gipA 5’ UTR, involving either complete deletion of each µORF or mutation of 
the AUG of each µORF.  Differential µORF translation has been demonstrated for many 
genes, one of the most studied being Gcn4 in Saccharomyces cerevisiae.  The 5’ UTR of 
gcn4 contains 4 µORFs, which modify translation of Gcn4 based on amino acid levels [78-
80].  Studies have shown that under normal conditions, the translation complex will initiate 
translation at µORF1 and then reinitiate at µORF4, which prevents translation of gcn4. 
However, in conditions of amino acid limitation, scanning of the translation complex is 
leakier and will scan past µORF4 to reinitiate at the gcn4 start site [78-80].  It would also be 
advantageous to analyze the mRNA stability of gipA, as both µORFs and 3’ UTR 
sequences have been shown to affect mRNA stability through NMD [121].  The mRNA half-
life of areA, which is tightly regulated in response to nitrogen source, is 40 minutes in 
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nitrogen-non-repressing conditions, but is only 7 minutes in nitrogen-repressing conditions 
[60, 63]. 
GipA positively regulates the gliotoxin cluster, as high-copy expression of gipA in 
repressing conditions resulted in increased mRNA levels of several genes within the 
gliotoxin cluster, compared to the empty vector control (gliA was induced 7-fold and 4.5-
fold, gliZ was induced 2-fold and 12-fold, gliP was induced 4.5-fold and 5-fold, and gliT was 
induced 8-fold and 2-fold, at 24 and 48 hours of growth, respectively) (Fig. 4.2a).   In 
addition, I observed higher levels of gliotoxin in the surrounding medium, compared to an 
empty vector control (7-fold higher by 24 hours) (Fig. 4.2b).  Although high-copy expression 
of gipA did enhance gliotoxin production, neither growth nor virulence in a Toll-deficient D. 
melanogaster model was significantly affected (Fig. 4.3 & 4.4).  This does not rule out the 
fact that high-copy expression of gipA could be enhancing the ability of A. fumigatus to fight 
host immune cells, which could be verified by measuring phagocytosis of spores, cytokine 
production, apoptosis of immune cells, and neutrophil infiltration at the site of infection. 
Based on microarray data, out of 30 potential secondary metabolism clusters, 20 
contain at least one gene that was up-regulated >2-fold in a high-copy gipA strain, 
compared to an empty vector control (Table 4.2). LaeA, widely accepted as a general 
regulator of secondary metabolism in numerous fungal species, has been shown to 
regulate 13 out of 22 identified secondary metabolism clusters in A. fumigatus [91].  This 
indicates that GipA could possibly also be acting in a general fashion to regulate secondary 
metabolism and not specifically on the gliotoxin biosynthetic cluster.  Interestingly, LaeA, a 
proposed methyltransferase, has been suggested to affect chromatin remodeling when 
regulating secondary metabolism.  This is supported by studies conducted in A. nidulans on 
the sterigmatocystin biosynthesis cluster.  During active growth, histone H3 lysine 9 
trimethylation (H3K9me3) and high levels of heterochromatin protein 1 (HepA) are 
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detectable at the sterigmatocystin cluster.  Upon growth arrest and sterigmatocystin cluster 
induction, the levels of H3K9me3 and HepA decrease concurrently with increasing levels of 
acetylated histone H3 associated with sterigmatocystin cluster genes.  Furthermore, in a 
ΔlaeA background, HepA occupancy in the promoter aflR, the sterigmatocystin in-cluster 
transcription factor, is significantly increased [3].  These data suggest that the 
sterigmatocystin cluster is subject to a repressive chromatin structure through H3K9 
trimethylation and HepA binding and that LaeA is involved in the derepression of this 
heterochromatic signature inside the cluster.  It would be interesting to study the chromatin 
structure of the gliotoxin cluster and how it contributes to gene expression.  For instance, 
nucleosome displacement upon gliotoxin cluster derepression could contribute to higher 
gene expression.   
As mentioned earlier, AreA is proposed to exhibit chromatin remodeling in 
connection to the nitrate assimilation pathway.  In 1999, Claudio Scazzocchio’s group 
showed through DNase I and micrococcal nuclease (MNase) digestion that the intergenic 
region between two divergently transcribed genes within the nitrate assimilation cluster is 
occupied by six nucleosomes in nitrogen-repressing conditions [132].  Therefore, in the 
presence of ammonium, these six nucleosomes occupy the intergenic region between the 
two genes (niiA and niaD) and contribute to the repression of cluster gene expression.  
Upon derepression of the cluster, in response to the loss of ammonium and the addition of 
nitrate, multiple nucleosomes in this intergenic region are displaced, creating an “open” 
region to facilitate binding of AreA and the in-cluster transcription factor, NirA, followed by 
induction of cluster gene expression.  The group reported that this nucleosome 
rearrangement is dependent on AreA, as a ΔareA strain did not show the same pattern of 
chromatin remodeling at the nitrate assimilation cluster, even in nitrogen-derepressing 
conditions [132].  Since nitrogen metabolite repression does affect the gliotoxin gene 
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cluster, it would be interesting to test if AreA specifically contributes to any nucleosome 
remodeling within the gliotoxin cluster to induce gene expression. 
GipA appears to play a considerable role in gliotoxin production, but is not essential, 
as mRNA levels of several gliotoxin-specific genes were significantly decreased in a ∆gipA 
mutant in non-repressing conditions (Fig. 4.5a).  Most genes I tested experienced at least 
50% reduction in mRNA levels, compared to the wild-type control.  Furthermore, gliotoxin 
levels in the surrounding medium were reduced by 50% (Fig. 4.5b).  Even though gliotoxin 
was drastically reduced in the ΔgipA mutant, loss of gipA did not cause a significant 
difference in growth of the fungus, even in the presence of exogenous gliotoxin (Fig. 4.6).  
This indicates that loss of gipA does not affect growth or sporulation of A. fumigatus.  Loss 
of gipA did not affect virulence of A. fumigatus in a Toll-deficient D. melanogaster model, 
signifying that gipA is dispensable for virulence of the fungus in the model system I tested 
(Fig. 4.7).   It is possible that GipA serves to enhance expression of the gliotoxin cluster in 
certain environmental conditions.  Both high-copy expression and loss of gipA affects gliZ 
expression, so the effects I see for the entire cluster could be the direct consequence of 
GipA binding to each promoter region, or an indirect consequence of GipA partially 
regulating gliZ, which in turn regulates other genes within the cluster. 
Interestingly, GipA does not appear to be highly conserved at the protein level, as 
only a few proteins showing high similarity were identified, the closest being a hypothetical 
protein in N. fisheri that shares 96% identity (Fig. 3.7a).  There are also a few other 
Aspergillus species and some Penicillium species that contain a protein relatively similar to 
GipA.  Although the gliotoxin biosynthetic cluster is not conserved throughout all Aspergilli, 
most of the Aspergillus species that came out of the query are gliotoxin-producing or 
contain homologues to gliotoxin genes (e.g. A. niger, A. flavus, A. terreus, A. oryzae and A. 
kawachii).  Interestingly, A. clavatus also contains a C2H2 protein with sequence similarity to 
 145 
 
GipA.  Although a putative gliotoxin cluster has not been identified in A. clavatus, it is 
possible that gliotoxin is produced in this fungus.  For proteins, primary sequences evolve 
and change much more rapidly than do the tertiary structures.  There have been numerous 
examples where two proteins have low sequence similarity, but once crystallized, exhibit 
almost identical folding patterns and subsequently share similar functions [133].  For 
example, Gcn4 of S. cerevisiae and CpcA of A. niger share a 35% identity, yet they both 
function in amino acid biosynthesis.  Furthermore, CpcA is able to complement a Δgcn4 
mutant in S. cerevisiae [134].  When solely comparing the putative DNA binding domain of 
cpcA, the identity between CpcA and Gcn4 increases to 70% [134].  Therefore, the lack of 
homologous counterparts to GipA in other organisms does not necessarily mean that there 
is not a protein present in other fungi that functions similarly to GipA.  In addition, a search 
for homologues to the region containing the C2H2 DNA binding domains of GipA greatly 
increases the number of fungal organisms that contain a protein with high similarity (data 
not shown).   
 
7.2 Characterization of GipB 
GipB is a hybrid sensor kinase, containing a histidine kinase A (phospho-acceptor) 
domain, a GHKL (ATPase) domain, and a response regulator receiver domain.  Hybrid 
sensor kinases are common in fungi, in contrast to bacterial systems, which have mainly 
separate sensor kinases and response regulators [126, 127].  Hybrid sensor kinases will 
autophosphorylate a Histidine (His) residue in the histidine kinase domain, in response to 
external stimuli, followed by a transfer of the phosphate to an Aspartic Acid (Asp) residue in 
the response regulator domain [126, 127].  Within the 5’ UTR of gipB are two µORFs, which 
implies that gipB may also be under post-transcriptional regulation, as suggested for gipA 
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(Fig. 3.6a).  Similar to what was observed with gipA, RNA levels of gipB remained low 
throughout all growth conditions I tested.  Investigation of the protein sequence of GipB did 
not reveal any transmembrane domains, thereby presenting GipB as a cytosolic hybrid 
sensor kinase.  In filamentous fungi, these cytosolic hybrid sensor kinases appear to play 
more of a role in controlling morphogenesis and differentiation, compared to 
transmembrane histidine kinases [127].  The first cytosolic hybrid sensor kinase identified in 
filamentous fungi was Nik-1/Os-1 of Neurospora crassa.  Nik-1 is exclusively expressed 
during vegetative growth and is nonexistent in the sexual phase of growth.  Aberrant hyphal 
development is observed when nik-1 is deleted from N. crassa, thereby demonstrating that 
Nik-1 positively regulates vegetative growth [127].   
GipB positively regulates the gliotoxin cluster, as high-copy expression of gipB 
resulted in an increase in mRNA levels for gliA and gliT at 24 hours growth (Fig. 5.2a).  In 
addition, gliotoxin levels were higher than the empty vector control in repressing conditions 
at 24 hours (Fig. 5.2b).  At 48 hours, however, mRNA levels of all genes tested in the high-
copy gipB strain were comparable to the empty vector control.  Gliotoxin was still detectable 
in the surrounding medium at levels higher than the AMA.GL control, but this is likely a 
result of activation of GipB earlier in the growth phase.  This indicates that activity of GipB 
may be specific to certain phases of development.  The growth conditions I employed 
(stationary cultures) were conducive to asexual development and conidiation, as strains 
grew heavily at the air interface and conidiated robustly.  Therefore, the fact that high-copy 
expression of gipB did not induce the gliotoxin cluster at 48 hours of growth suggests that 
GipB is not activated through phosphorylation in the later stages of conidiation (Fig. 5.2b).   
GipB does not appear to be essential for gliotoxin production, as loss of gipB only 
caused a decrease in gliT mRNA levels in non-repressing conditions, compared to the wild-
type control, as well as a 10% decrease in gliotoxin levels (Fig. 5.5).  Although cytosolic 
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hybrid sensor kinases have often been found to regulate fungal morphology and 
differentiation, I did not observe any significant growth abnormalities in the ∆gipB mutant or 
the high-copy gipB strain, suggesting that either GipB does not regulate vegetative growth 
or conidiophore development or that another hybrid sensor kinase shares a redundant role 
with GipB (Fig. 5.3 & 5.6).  Similarly, I did not observe a significant effect on virulence of A. 
fumigatus in a Toll-deficient D. melanogaster model with either the ∆gipB mutant or the 
high-copy gipB strain, although the high-copy gipB strain displayed a trend towards 
increased death of the fruit flies (Fig. 5.4 & 5.7).  It would be interesting to test a 
constitutively-active mutant and a constitutively-inactive mutant of GipB, which might prove 
more helpful in uncovering a clear role for GipB activity.   
 
7.3 Model for gliA Regulation 
I have devised a model for regulation of gliA that involves GliZ, GipA, and AreA (Fig. 
7.1a).  I propose that GliZ and GipA work together at the same binding site to induce gliA.  
In this model, GipA and GliZ are dependent on each other for inducing gene expression of 
gliA.  I further posit that AreA contributes to the overall induction of gliA in the presence of 
non-preferred nitrogen sources.  As shown in Figure 3.8b, a non-preferred nitrogen source 
causes increased expression of several genes within the gliotoxin cluster, indicating that 
AreA is acting on the gliotoxin cluster to induce gene expression.  This most likely occurs 
via AreA-mediated induction of gliZ first, possibly followed by direct binding of AreA to 
promoter regions of other genes in the cluster.  There is an AreA recognition sequence in 
the gliA promoter, 37 base pairs upstream of the ATG start site, but the close proximity of 
the recognition element in relation to the ATG likely means that AreA does not induce gliA 
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Figure 7.1. Model for gliA regulation. (a) I propose that both GliZ and 
GipA work together to induce gliA.  (b) Furthermore, I propose that 
AreA acts to enhance gliA expression in nitrogen-specific non-
repressing conditions.  (c) Layout of the GipA/GliZ binding sites in the 
gliA promoter region, relative to the gliA start site. GliZ tandem 
repeats are purple and the GipA DNA binding site is underlined in 
orange.  The AreA binding site is signified by the yellow triangle. 
a 
b 
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expression from that site (Fig. 7.1b).  Although GipB is not included in this model, there are 
several possible models that involve GipB in the regulation of gliA, which are discussed 
below. 
 
7.4 GliZ, GipA, and GipB:  Independent or Interdependent? 
I created two double deletion mutants to verify that either GliZ and GipA or GipA and 
GipB are signaling within a pathway and not independently.  The ΔgliZ/ΔgipA double mutant 
appeared comparable to the ΔgliZ single mutant, with respect to gliotoxin biosynthesis (Fig. 
6.2).  I did not observe an additive effect, indicating that these two proteins do not signal 
through independent pathways and that GipA may signal cooperatively with GliZ.  This 
supports my model of gliA regulation, in which GliZ and GipA are not independently 
activating gliA expression.  These data are not completely clear, though, as the decrease in 
mRNA levels and gliotoxin production in a ΔgliZ mutant were already so low, there may not 
be any possibility of an additive effect, even if GipA and GliZ are independent of one 
another.  The possibility of GliZ and GipA acting independently, although not entirely 
impossible, is highly unlikely, as transcription factors located within biosynthetic clusters are 
often required for induction of other genes within the cluster.  There have been examples of 
independent gene regulation, though.  For instance, gliT is positively regulated by GliZ, as 
are all the other genes within the gliotoxin cluster.  However, when A. fumigatus was 
exposed to exogenous gliotoxin, gliT was induced, even in the absence of gliZ [27].  This 
raises the possibility that based on the toxic nature of some secondary metabolites, 
alternative regulation of certain genes within these clusters may have evolved to ensure 
protection of the organism from the toxin itself or possibly other toxins with similar 
structures that are produced by competing organisms.  I did not create a ΔgliZ/ΔgipB double 
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mutant, as I hypothesized that the results would not show an additive effect, again because 
loss of gliZ already affects gene expression so drastically.   
In the ΔgipA/ΔgipB double mutant, mRNA levels of gliotoxin-specific genes were 
comparable to the gipA single deletion mutant (Fig. 6.5).  Loss of gipA does not reduce 
mRNA levels as drastically as ΔgliZ, so I was able to discern if an additive effect was 
present in the ΔgipA/ΔgipB strain.  Since there was in fact no additive effect, it is possible 
that GipA and GipB are part of a linear pathway and that GipA is downstream of GipB.  
However, the effect of the gipB single mutant on the gliotoxin cluster was so mild, that an 
additive effect may not be possible.  One explanation is that there are other hybrid sensor 
kinases that are redundant for GipB with respect to gliotoxin production.  Neither double 
mutant displayed abnormal growth or virulence in a Toll-deficient D. melanogaster model, 
indicating that there is not an additive effect with respect to growth rate or virulence of A. 
fumigatus (Fig. 6.3, 6.4, 6.6 & 6.7).  However, although conidiation was not drastically 
affected by loss of either gipA or gipB, the ΔgipA/ΔgipB double mutant displayed a 50% 
reduction in spores/cm2 on rich medium, suggesting that GipA and GipB may be involved in 
independent signaling pathways in regards to conidiation (Fig. 6.6b).  This raises the 
possibility that GipB and GipA are signaling independent of each other for gliotoxin cluster 
expression as well. 
A possible consensus DNA binding site for GipA was identified through protein 
binding microarray (Fig. 4.8), which I verified using in vivo mutagenesis of the gliA promoter 
(Fig. 4.9).  A few interesting discoveries came out of the in vivo promoter mutagenesis 
experiments.  First is the possibility of an unknown transcriptional activator binding to a 
sequence near the GipA binding site.  I propose this based on the fact that mutation of the 
single 5’ T residue resulted in a significant decrease (8-fold in repressing conditions and 4-
fold in non-repressing conditions) in lacZ expression in AMA.SD1 (background LacZ) (Fig. 
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4.9a), yet GipA-specific lacZ expression was significantly induced (53-fold), compared to 
the empty vector control (Fig. 4.9b).  This observation could also be explained by weaker 
GipA binding, which is rescued by high-copy expression of GipA.  However, when a core 
region of the GipA binding site was mutated, I discovered that basal lacZ expression not 
only increased, but exceeded the basal levels of the wild-type binding site (5-fold in 
repressing conditions and 2-fold in non-repressing conditions) (Fig. 4.9b), yet GipA-specific 
lacZ induction was significantly reduced, almost to the level of the empty vector control (Fig. 
4.7b).  This supports my hypothesis that an unknown transcriptional activator is binding in 
close proximity to the GipA binding site and that mutation of the single T residue negatively 
affects this.  If there was not an additional transcriptional activator present and both 
mutations were only affecting GipA binding, I would expect the basal LacZ levels to remain 
low for both binding site mutants.  The fact that mutation of the core sequence in the 
binding site raised basal LacZ levels higher than they were with the wild-type binding site 
suggests two possibilities:  (1) GipA and this unknown transcriptional activator are 
competing for binding or (2) GipA and this unknown transcriptional activator play 
antagonistic roles in gliA expression.  This is further supported by the fact that GipA-specific 
induction of lacZ was higher when the single T residue was mutated than it was when 
exposed to the wild-type binding site. 
The second interesting discovery was the fact that GliZ-specific lacZ induction was 
similar to that observed with GipA-specific induction (Fig. 4.9).  I expected GliZ-specific 
induction of lacZ to be independent of the GipA binding site, but this was not the case.  
Upon further examination, I realized that the GipA binding site is embedded within possible 
GliZ binding sites (Fig. 7.1c).  Although a GliZ binding site has not yet been tested, one has 
been predicted (TCGGN3CCGA).  This sequence is present in the intergenic region of 
every gene within the gliotoxin cluster, except gliZ and gliA [15].  Studies have shown that 
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recognition of these sequences by Zn2Cys6 binuclear finger transcription factors is very 
specific and even a slight change to the length or base composition of the linker sequence 
can result in reduced binding in vivo [16, 18, 19].  Within the gliA promoter region, there are 
four sequences commonly found to be recognized by Zn2Cys6 transcription factors (Fig. 
7.1c).  The innermost two are inverted repeats with an 8 bp linker sequence, while the outer 
two, which are also inverted repeats, contain a 27 bp linker sequence, although the longer 
linker sequence seems less likely to be recognized by a Zn2Cys6 transcription factor.  
Furthermore, the core sequence of the GipA binding site that I mutated contains the CCG of 
the smaller GliZ-like binding site (Fig. 7.1c).  Therefore, mutation of the core sequence 
changed one of the inverted repeats, likely abolishing GliZ-mediated lacZ induction.  From 
these data, I cannot distinguish whether GliZ binding is independent of GipA or dependent, 
because in the process of mutating the GipA binding site, I also inadvertently mutated an 
essential part of a possible GliZ binding site.   
To test this, I expressed high-copy plasmids in various deletion backgrounds and 
measured RNA levels of gliA, as well as gliP.  For gliP regulation, GipA was dependent on 
GliZ but GliZ did not require the presence of GipA (Fig. 6.8b).  Furthermore, GipB appeared 
dependent on both GliZ and GipA to induce gliP (Fig. 6.8b).  For gliA regulation, I observed 
a different pattern, as GliZ and GipA were dependent on each other to induce gliA (Fig. 
6.8a).  Dependent dual regulation of two transcription factors has been uncovered in other 
organisms.  For example, in A. nidulans, FlbB and FlbD both bind in close proximity to the 
brlA promoter to regulate asexual development through brlA activation [39, 135].  FlbB, in a 
complex with FlbE, induces flbD expression by direct binding to the flbD promoter [135-
137].  Once FlbD is translated, FlbD and FlbB are both necessary to activate brlA.  
Furthermore, FlbB does not bind to the brlA promoter in the absence of FlbD, indicating that 
these two transcription factors are dependent on each other for DNA binding and activation 
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of brlA [135].  GipB also appeared dependent on both GliZ and GipA for gliA induction (Fig. 
6.8a).  I did not test the high-copy plasmids in a ΔgipB deletion background.  I attempted to 
isolate this mutant, but experienced issues that led us to focus on the gliZ and gipA deletion 
backgrounds.  I created a gipB deletion mutant for earlier experiments, but these were done 
in an nkuB deletion background to facilitate homologous recombination.  I suspect that in a 
ΔgipB background, GliZ and GipA are both able to induce gliA and gliP, as GipB encodes a 
hybrid sensor kinase that is likely acting upstream of both proteins.     
These data support a model in which GliZ and GipA are working together to regulate 
gliA (Fig. 7.1). There appears to be a dependency with regards to gliA expression that I 
demonstrated in my experiments.  I cannot say if GliZ and GipA are physically interacting 
by forming a complex, but the intimate nature of the DNA binding sites suggests this may 
be the case.  C2H2 transcription factors have been shown to be involved in protein-protein 
interactions [138].  One well characterized example of these protein-protein interactions is 
that of FOG-1 and GATA-1.  FOG-1 is a C2H2 zinc finger transcription factor containing nine 
zinc finger domains, only four of which carry the classical C2H2 motif.  The other five motifs 
harbor the natural variant C2HC motif [139].  Studies have demonstrated that zinc finger 
motifs 1, 5, 6, and 9, which all contain the C2HC variant, are involved in the protein-protein 
interaction of FOG-1 with GATA-1 [122, 138, 139].  Interestingly, despite the fact that C2H2 
domains and C2HC domains display an almost identical folding pattern, these domains are 
not interchangeable.  This was demonstrated by the fact that mutation of the third cysteine 
residue in zinc finger domains 1 and 9 to histidine (C2HC  C2H2) in FOG-1 did not disrupt 
their folding, but abolished their ability to interact with GATA-1 in a yeast two-hybrid assay 
[122, 138].  This pattern may not apply to all protein-protein interactions involving C2H2 zinc 
finger transcription factors, but it does support the possibility that these natural C2HC 
variants are involved in protein-protein interactions.   
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GipA contains two zinc finger binding domains, one of which is the classical C2H2 
motif and the other is the variant C2HC motif.  Perhaps GipA and GliZ form a protein-protein 
complex, involving the C2HC motif of GipA, to facilitate DNA binding and activation of gliA.  
Mutational analysis of the C2HC motif and pull-down assays would possibly be able to 
elucidate the presence of such a complex.  It would also be interesting to see if mutation of 
the GipA binding site, without mutating the GliZ palindromic sequence, would reinstate GliZ-
mediated expression of lacZ, although I suspect this would not be the case as GipA is 
required for GliZ-mediated expression of gliA and loss of GipA binding might negatively 
affect GliZ binding.  This model does not apply to every gene within the gliotoxin cluster, as 
no other genes have a GipA binding site embedded within a possible GliZ binding site, 
except gliZ, although these sequence are located farther upstream of the gliZ start site (Fig. 
7.2).  Perhaps GipA serves to aid GliZ in binding to the gliA promoter region, as this binding 
site is different from the others present in the gliotoxin cluster.   
Although there are possible GipA binding sites in all gliotoxin gene promoters, 
except gliM, I cannot say with certainty whether GipA is directly binding to these other 
promoter regions or if GipA is simply binding in the gliA promoter in conjunction with GliZ.  
This adds to mounting evidence that genes within a gene cluster are typically coordinately 
regulated, but can also be individually expressed in response to certain stimuli.  It is 
possible that gliT and gliA are both independently regulated to protect the fungus from 
exogenous gliotoxin, although gliA was not induced in a ΔgliZ mutant in the presence of 
exogenous gliotoxin as gliT was [27].  Another possibility is that gliA is independently 
regulated to aid in the transport and/or expression of other secondary metabolism clusters 
in A. fumigatus.  There has been evidence in other fungal species that crosstalk between 
these gene clusters exists [140].  For instance, in A. nidulans, biosynthesis of asperthecin is 
enhanced in a strain over-expressing RsmA, a bZIP transcription factor [84].  Interestingly,  
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Figure 7.2. Layout of two potential GipA binding sites that are embedded in putative GliZ 
binding sites in the gliZ promoter.  GliZ putative trinucleotide repeats are purple, the 
putative GipA binding sites are signified with orange, and binding cluster 1 additionally 
contains an AreA recognition element (yellow). 
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asperthecin synthesis is reduced when aflR is deleted in an RsmA over-expression 
background.  AflR is a Zn2Cys6 binuclear finger transcription factor necessary for 
expression of aflatoxin and sterigmatocystin secondary metabolism clusters.  Therefore, 
RsmA exerts its effects on the asperthecin biosynthetic cluster through AflR, which is 
located in a separate cluster [84].   
Interestingly, RsmA has recently been characterized in A. fumigatus.  Similar to 
what is seen in A. nidulans, over-expression of RsmA results in a significant increase in 
gliotoxin production, as well as an increase in mRNA transcript levels of multiple gliotoxin-
specific genes [108].  High-copy expression of gipA also induced the gliotoxin cluster 
(Fig.4.2), although contrary to what was observed with rsmA, loss of gipA significantly 
reduced the level of gliotoxin in surrounding medium (Fig. 4.5).  RsmA cannot induce the 
gliotoxin cluster in the absence of either gliZ or laeA, suggesting that both proteins are 
necessary for RsmA-mediated signaling [108].  I found a similar pattern for GipA-mediated 
signaling, as loss of gliZ negatively affected the ability of GipA to induce gliP and gliA, 
although there was a slight increase in gliA mRNA transcript levels, compared to basal 
levels (Fig. 6.8).  Therefore GliZ is essential for complete GipA-mediated induction.  I did 
not test the high-copy gipA strain in a ΔlaeA background, but this test would be worthwhile, 
as chromatin remodeling could contribute to GipA binding.  Based on microarray data from 
a ∆laeA strain, GipA is not regulated by LaeA, as gipA gene expression was not altered 
with loss of laeA, compared to a wild-type strain.  Interestingly, GipB showed a moderate 
up-regulation in gene expression in the laeA deletion mutant, suggesting that LaeA 
negatively regulates GipB, which could be a result of developmental regulation (personal 
communication, Nancy P. Keller).  
Although the experiments I performed give evidence for my model connecting GliZ 
and GipA, additional models further including GipB are more speculative.  For instance, one 
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model could involve GipB signaling upstream of GliZ and GipA, suggesting that both 
transcription factors are required for GipB-mediated gliA expression (Fig. 7.3).  This is 
supported by the fact that high-copy expression of gipB could not induce gliA in the 
absence of either gliZ or gipA.  However, this pattern was also observed with respect to gliP 
expression, even though the interdependency of gliZ and gipA was not present.  One 
explanation for this pattern is that GipB signals through GliZ and GipA to induce all genes in 
the gliotoxin cluster.  An alternative explanation is that the experiment itself was not 
conclusive for GipB-mediated induction.  As discussed earlier, high-copy expression of gipB 
induces the gliotoxin cluster at 24 hours growth, but not 48 hours growth, possibly due to 
temporal control of the activation of GipB.  The gliA and gliP mRNA levels I measured in 
response to high-copy expression of gipB in various deletion backgrounds were collected 
after 48 hours growth.  Therefore the results could falsely exhibit a dependency of GipB 
signaling on GliZ and GipA, when in fact GipB is simply not activated at this time point and 
can therefore not induce these gliotoxin genes.  A second model would involved GliZ and 
GipA acting in an interdependent fashion, as I have proposed, but also involving GipB 
positively regulating the gliotoxin cluster independently of GipA, but most likely through GliZ 
(Fig. 7.3).   
Although the ∆gipA/∆gipB double mutant did not display an additive phenotype with 
respect to gliotoxin production, it did exhibit a 50% reduction in sporulation.  This 
sporulation defect was not observed with the ∆gipA single mutant or the ∆gipB single 
mutant, indicating that it was in fact an additive effect, possibly as a result of GipA and GipB 
being involved in separate signaling pathways.  While the ∆gipA single mutant had 
significantly reduced gliotoxin production (50%), the loss of gipB did not significantly affect 
gliotoxin production, so loss of both might not display an additive reduction in gliotoxin 
levels, even if they are both involved in separate pathways.  Therefore, the sporulation  
 158 
 
  
Figure 7.3. Possible models for gliA regulation involving GipB, GipA, and 
GliZ. (a) In this model, GipB is regulating gliA in a signaling pathway that is 
separate from GipA.  Furthermore, there is possibly another hybrid sensor 
kinase that acts in a redundant fashion to GipB with respect to gliA 
expression.  (b) In this model, GipB is regulating gliA upstream of both GipA 
and GliZ.  All three proteins are involved in the same pathway. 
a 
b 
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phenotype of the ∆gipA/∆gipB double mutant raises the possibility that GipB plays a role in 
regulating the gliotoxin cluster independently of GipA.  The fact that the ΔgipB deletion 
strain did not significantly reduce gliotoxin production does not rule out the possibility that 
GipB is involved in gliotoxin gene cluster expression, as high-copy expression of gipB 
induces gliotoxin production.  However, it is not clear if the positive effects exerted by GipB 
are direct (e.g. through a specific pathway) or indirect (e.g. altering other proteins that 
happen to effect gliotoxin production).  If GipB is directly regulating the gliotoxin cluster, 
there could be other hybrid sensor kinases that play a redundant role in gliotoxin cluster 
expression, which would mask any effects from the loss of gipB alone.  Further exploring 
these possibilities would serve to uncover a stronger model that explains the role of GipB in 
regulation of the gliotoxin cluster. 
 
7.5 Future Perspectives 
 GipB and GipA are novel proteins in A. fumigatus that have not been characterized 
before my work.  I originally discovered these proteins in a high-copy inducer screen 
searching for genes that induce a gliAP-lacZ expression plasmid and presumably the entire 
gliotoxin cluster.  Therefore, the work I completed for this project focused on gliotoxin 
production and gliA regulation specifically.  Obviously there are many more experiments to 
be done to truly understand the mechanism by which GipB and GipA regulate gliA 
expression, as well as the gliotoxin cluster as a whole.  For instance, as mentioned above, 
there are putative GipA binding sites in the intergenic regions upstream of every gliotoxin 
cluster gene, except gliM.  There is a putative GipA binding site upstream of gliM, but it is 
upstream of the stop codon of the preceding gene.  I showed from RNA dot blot analysis 
that GipA positively regulates multiple genes in the gliotoxin cluster.  Although I obtained 
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evidence that GipA is directly binding to the gliA promoter, I do not know for certain whether 
GipA is regulating other genes in the cluster by directly binding to every promoter or 
through modulation of gliZ expression only.  This could be tested through promoter 
mutagenesis of each promoter region, as was done for gliA, or through chromatin 
Immunoprecipitation. 
Interestingly, there are two “binding clusters” in the upstream region of gliZ that 
contain a putative GipA binding site embedded within potential GliZ binding sites.  I call 
these regions “potential GliZ binding sites” because of the presence of CGG trinucleotide 
repeats that are common recognition elements of Zn2Cys6 transcription factors, although 
the linker sequences are longer than those predicted for GliZ recognition.  A potential GliZ 
binding site (TCGGN3CCGA) has been proposed and is present upstream of every gliotoxin 
cluster gene, except gliZ and gliA, though this has not been experimentally studied [15].  In 
addition, these “binding clusters” that include putative binding sites for both GliZ and GipA 
are only present in the upstream regions of gliZ and gliA.  Both “binding clusters” upstream 
of gliZ comprise 6 bp linker sequences, while the “binding cluster” upstream of gliA contains 
an 8 bp linker sequence.  It would be advantageous to discover if either of the “binding 
clusters” in the gliZ upstream region are necessary for or contribute to gliZ expression, as 
was shown for the “binding cluster” in the gliA promoter, as would finding out if GipA directly 
binds to the promoter regions of the other gliotoxin cluster genes. 
In verifying that GipA induces gliA through a particular GipA recognition site, I 
inadvertently discovered that GliZ also relies on this site for full gliA induction.  Although I 
showed that mutation of part of the GipA binding site, which happened to contain a CCG 
trinucleotide, reduced GliZ-mediated induction of a gliAP-lacZ expression plasmid, I did not 
experimentally verify direct binding of GliZ to this region.  Although unlikely, GipA could be 
interacting with GliZ and directly binding to the DNA sequence, without GliZ directly binding 
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to the DNA.  On the other hand, GliZ and GipA could be involved in a protein-protein 
interaction, in which, under certain conditions, GipA facilitates the direct binding of GliZ to a 
binding site that GliZ would not normally recognize, due to the longer linker sequence 
between the trinucleotide repeats.  Further studies need to be performed to verify direct 
binding of GliZ to the gliA promoter, as well as the presence of a protein-protein interaction 
between GliZ and GipA.  C2H2 transcription factors often contain zinc finger domains 
harboring the classical C2H2 motif, but some encode a natural variant, C2HC, which displays 
an almost identical folding pattern to the C2H2 region [138].  This C2HC variation has been 
shown to be involved in protein-protein interactions in other organisms, although this is not 
considered to be ubiquitous to all C2HC variants [138].  As discussed above, GipA contains 
two zinc finger regions, one being the classical C2H2 motif and the other being the natural 
variation of C2HC.  Therefore, it is possible that GipA is directly interacting with GliZ through 
this C2HC domain.  Uncovering such an interaction would greatly contribute to the 
understanding of the GliZ-GipA interdependent relationship with regards to gliA expression, 
and possibly gliZ expression as well. 
GipB, being a hybrid sensor kinase, likely activates downstream proteins to induce 
the gliotoxin cluster.  In fungal systems, these hybrid sensor kinases are generally thought 
to autophosphorylate in response to certain stimuli, followed by transfer of the phosphate to 
an HPt protein and subsequent transfer of the phosphate from the HPt protein to a 
response regulator.  These response regulators can directly act on transcription factors or 
can activate signaling cascades, oftentimes composed of MAP kinase proteins.  Therefore, 
it is likely that GipB is not directly activating the gliotoxin cluster, but is signaling through 
several proteins.  Interestingly, research has provided evidence that only one HPt protein 
exists in all fungi that have been studied [127].  If GipB does activate downstream targets 
through this two-component relay system, it is highly likely that the single HPt protein in A. 
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fumigatus, which has not been characterized, is involved in this process.  Research in other 
fungal species has suggested that cytosolic hybrid sensor kinases are likely involved in 
morphogenesis and development [127].  As the gipB DNA sequence does not show any 
obvious transmembrane domains, I predict that GipB is a cytosolic hybrid sensor kinase.  
Furthermore, RNA dot blot analysis indicated that GipB is activated during specific stages 
of conidiation, as high-copy expression of gipB induced gliotoxin production at 24 hours of 
growth, but not at 48 hours, which supports the possibility that GipB is involved in 
developmental processes.  Studying a constitutively-active or constitutively-inactive form of 
GipB would be advantageous in elucidating a specific role for GipB activation. 
 The effects of nitrogen metabolite repression on gliotoxin production was studied by 
growing cultures in different nitrogen sources, however, other environmental regulatory 
networks were not researched for my project, including carbon catabolite repression and 
pH-mediated regulation.  All growth conditions were under carbon catabolite repression, as 
repressing carbon sources were used throughout the experiments.  Furthermore, pH-
mediated induction was not observed, as medium was properly buffered preventing any pH 
changes to either acidic or alkaline conditions.  In all conditions tested, gipB and gipA 
mRNA levels remained low, suggesting that nitrogen metabolite repression does not affect 
the expression of gipA or gipB.  Upon examination of the promoter regions of both genes, I 
discovered a multitude of recognition elements belonging to global regulators, such as 
Area, CreA and PacC, and developmental regulators, such as AbaA, BrlA, and FlbC (Fig. 
7.4).  The presence of such recognition elements does not guarantee that they are actively 
recognized by the regulatory protein, but it does suggest that GipB and GipA may be under 
the control of both environmental global regulators and developmental regulatory networks.  
Further work focusing on uncovering specific regulators of gipB and gipA expression could 
contribute our understanding of these two novel proteins in A. fumigatus. 
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Figure 7.4. Layout of putative regulatory elements in the gipA and gipB promoter regions.  
The green bars represent the predicted 5’ UTRs of each mRNA, based on data from the 
λ phage library screen.  Binding sites displayed:  CreA (red), AreA (yellow), PacC (light 
green), AbaA(green), FlbD (cyan), BrlA (magenta), and FlbC (purple).   
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